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ABSTRACT 
Oxidoreductases, the enzymes that catalyze the transfer of electrons between molecules, represent 
the largest group of enzymes in metabolism, and the vast majority of these enzymes use the 
functionally-equivalent cofactors nicotinamide adenine dinucleotide (NAD) or nicotinamide 
adenine dinucleotide phosphate (NADP) for the storage and transport of the electrons. 
Understanding the interactions of these proteins with their cofactors is therefore crucial to the 
engineering of biological pathways and systems that involve these enzymes. In particular, because 
cells tightly regulate the levels of oxidized and reduced NAD and NADP, it is often valuable to 
engineer the specificity of enzymes to better integrate them into particular metabolic contexts. 
The first section of this thesis focuses on this specificity, taking as a model system the ketol-acid 
reductoisomerase (KARI) enzyme family. Prior to the work described here, all known members of 
the KARI enzyme family displayed a strict specificity for NADP over NAD. However, the use of 
these enzymes in a constructed pathway for the production of medium-chain alcohols created a 
clear need for NAD-specific KARIs to improve yields. Chapter 1 briefly summarizes the prior 
state of the art in nicotinamide cofactor specificity engineering before describing how a previous 
switching of the KARI from E. coli was extended to create a simple recipe for the specificity 
reversal of any KARI enzyme. Chapter 2 then uses the insights into cofactor specificity in KARIs 
afforded by the engineering in Chapter 1 to search databases of KARI sequences and predict 
naturally NAD-specific KARIs, resulting in the discovery of extremophilic NAD-utilizing KARIs 
with properties that outstrip those of the best engineered enzymes. Chapter 3 extends this 
prediction approach into another enzyme family, xylose reductases, and discusses its strengths and 
limitations across diverse enzyme folds and families. 
The next section of the thesis diverges from the topic of cofactor specificity engineering to briefly 
explore three structural questions which arise from the study of KARIs. Chapter 4 covers an 
analysis of several new KARI crystal structures, including those obtained during the efforts 
described in Chapters 1 and 2. From a comprehensive comparison of these structures, two topics are 
addressed: (1) the effect of insertions and deletions in the cofactor specificity loop on the binding 
geometry of NAD and NADP, and (2) the conformational motions involved in the binding of 
cofactor, substrate, and metal ions. Based on a pair of structures from Chapter 4, Chapter 5 
experimentally explores the structural evolution of the KARI enzyme family’s two distinct 
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structural classes, replicating in a class I KARI the structural duplication that produced the class II 
KARI fold, and demonstrating a remarkable retention of enzymatic activity. Chapter 6 explores a 
curious sensitivity to mutations observed around the adenine moiety of several KARIs, and extends 
this observation to a range of other NADP- and NAD-dependent enzymes, with implications both 
for engineering these proteins and for understanding protein evolution more generally. 
The third and final section discusses the development of a general method for the cofactor 
specificity reversal of any NAD(P)-utilizing enzyme. Chapter 7 explains the approach used and 
how it represents a new paradigm in protein engineering, as well as covering the thorough 
experimental validation to which the method was subjected. This method was developed into a web 
applet (CSR-SALAD) for public use, and Chapter 8 discusses the development and use of this tool. 
This third section represents the culmination of the preceeding work, drawing from an 
understanding of the sequence and structural determinants of cofactor binding as explored in the 
preceeding six chapters to create the heuristic picture of specificity which informed the 
comprehensive engineering approach. 
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C h a p t e r  1  
REVERSING COFACTOR PREFERENCE IN THE KETOL-ACID 
REDUCTOISOMERASE ENZYME FAMILY 
Material from this chapter appears in Brinkmann-Chen S., Flock T., Cahn 
J. K. B., Snow C. D., Brustad E. M. McIntosh J. A., Meinhold P., Zhang 
L., Arnold F. H. (2013). General approach to reversing ketol-acid 
reductoisomerase cofactor dependence from NADPH to NADH, 
Proceedings of the National Academy of Sciences 110(27), 10946-10951, 
and is reprinted by permission from the National Academy of Sciences.  
Abstract 
To date, efforts to switch the cofactor specificity of oxidoreductases from nicotinamide 
adenine dinucleotide phosphate (NADP) to nicotinamide adenine dinucleotide (NAD) have 
been made on a case-by-case basis with varying degrees of success. Here we present a 
straightforward recipe for altering the cofactor specificity of one family of NADP-
dependent oxidoreductases, the ketol-acid reductoisomerases (KARIs). Combining 
previous results for an engineered NAD-dependent variant of Escherichia coli KARI with 
available KARI crystal structures and a comprehensive KARI-sequence alignment, we 
identified key cofactor specificity determinants and used this information to construct five 
KARIs with reversed cofactor preference. Additional directed evolution generated two 
enzymes having NAD-dependent catalytic efficiencies that are greater than the wild-type 
enzymes with NADP. High-resolution structures of a wild-type/variant pair reveal the 
molecular basis of the cofactor switch.  
Introduction 
Oxidation and reduction chemistry is involved in every component of cellular 
metabolism, and in every organism on Earth the primary means for storing and transporting 
reducing equivalents is the nicotinamide moiety. Evolution has developed two ubiquitous 
nicotinamide-containing molecules for mediating this chemistry (Figure 1-1): nicotinamide 
adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide phosphate (NADP). 
These cofactors differ only in the absence or presence of a phosphate diesterified to the 2’ 
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hydroxyl of the adenosine ribose, generally more than 15 Å from the chemically active 
carbon of the nicotinamide. This phosphate has no effect on the reduction potential of the 
molecule, yet the vast majority of enzymes display a strict specificity for one cofactor or 
the other. This allows the cell to partition metabolic reactions into two groups for separate 
regulation, but can pose an engineering hurdle. 
For purposes of in vitro catalysis NADPH (the reduced form of NADP) is 16 times 
more expensive than NADH and has a shorter shelf life.1,2  Even more importantly, for the 
purposes of in vivo biocatalysis, NADP-dependent enzymes cannot be used under the 
anaerobic conditions favored for industrial biotechnology because in many organisms 
NADPH is only produced during aerobic metabolism.3,4  As bioengineering and metabolic 
engineering have developed as fields, cofactor specificity has proven a common 
engineering hurdle. Because of this, NAD(P)-binding enzymes have been the subject of 
many studies attempting to understand the molecular determinants of cofactor specificity 
and to engineer specificity reversal (Tables 1-1 and 1-2). However, despite the use of 
numerous approaches including combinatorial active-site saturation,5 computational 
design,6 and homology guided design,7 no single method has developed which has been 
consistently successful in the reversal of cofactor specificity, and many of the published 
results have been only marginally successful. 
Two factors contribute to the challenge of cofactor switching. First, the ubiquity 
and proposed ancient origin of NAD(P) – potentially dating back to the ‘RNA world’8 – 
have lead to the evolution of cofactor binding in diverse folds and orientations.9,10  Even 
within single enzyme families, the binding of the cofactor molecule can use different 
geometries between homologues,11,12 and this structural diversity has limited the 
development of general methods. Furthermore, a survey of the studies in Tables 1-1 and 1-
2 shows that nearly all of these proteins have required multiple simultaneous mutations to 
achieve reversal of specificity;3 as a result many traditional protein engineering techniques, 
which operate by walking up a fitness landscape one beneficial mutation at a time, cannot 
be used because of the enormously non-additive nature of the specificity fitness landscape.  
Ketol-acid reductoisomerases (KARI; EC 1.1.1.86) are a family of NADP-
dependent oxidoreductases that catalyze an alkyl-migration followed by a ketone reduction, 
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converting (S)-2-acetolactate (S2AL) or 2-aceto-2-hydroxybutyrate to (R)-2,3-dihydroxy-
isovalerate (RDHIV) and (R)-2,3-dihydroxy-3-methylvalerate, respectively,13 essential 
intermediates in the biosynthesis of branched-chain amino acids (BCAAs).14,15 The demand 
for these essential amino acids, used in the preparation of animal feed, human dietary 
supplements, and pharmaceuticals, is currently estimated to exceed 1,500 tons per year.16 In 
addition, the BCAA pathway has been engineered to produce fine chemicals and biofuels, 
including 1-butanol and isobutanol.17,18 Under the anaerobic conditions preferred for large-
scale fermentations, biosynthesis of BCAAs and other products that use this pathway is 
limited by the pathway’s cofactor imbalance and reduced cellular production of 
NADPH.3,19 One approach to overcoming the cofactor imbalance is to engineer KARI to 
use NADH generated in glycolysis, thereby enabling anaerobic production of BCAA 
pathway products.3,19   
The three prior reports of cofactor-switched KARIs from two different organisms 
show few commonalities in terms of approach or even residues targeted for 
engineering.3,19,20 A general recipe for switching KARI cofactor specificity would allow 
metabolic engineers to take advantage of the natural sequence diversity of the KARI family 
and the concomitant diversity in properties such as expression level, pH tolerance, or 
thermal stability. By combining a systematic analysis of all Swiss-Prot-annotated21 KARIs, 
information from previous work in the Arnold Lab on switching the cofactor specificity of 
the Escherichia coli KARI,3 and available KARI structures, we have identified a subset of 
residues in the β2αB-loop of the Rossmann fold that distinguish NADP and NAD. In this 
chapter we provide a nuanced guide to engineering KARI cofactor specificity and apply it 
to six different KARIs that are representatives of the three canonical KARI β2αB-loop 
lengths. We also demonstrate that wild-type-like activity using the NAD cofactor, required 
for industrial applications, can be achieved by directed evolution once cofactor preference 
has been reversed. High-resolution structures of a wild-type KARI and its cofactor-
switched variant with the respective cofactors bound demonstrate how the switch was 
achieved.  
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Figure 1-1. The nicotinamide cofactors, nicotinamide adenine dinucleotide (here shown in 
its reduced (hydride) form (NADH)), and nicotnimamide adenine dinucleotide phosphate 
(NADP). The differences between the molecules are highlighted in magenta, illustrating the 
spatial and covalent distance between the 2’ recognition element (the phosphate of NADP) 
and the chemically relevant element (the hydride). 
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Table 1-1. Previous reports of NADP-to-NAD cofactor specificity reversal. Structures followed by (h) are homology models, while those followed by another 
PDB accession code use the cofactor from that protein and (m) denotes a structure of a mutant protein. For citation information, see Supplementary Material S1-1. 
Study Protein Structure Method Best Mutant Final Specificitya 
Specificity 
Changeb 
Log Relative 
Activityc 
(Banta et al. 2002) C. glutamicum DKR 1A80 Semi-Rational R238H ? ? ? 
(Baroni et al. 2012) P. falciparum FDNR 2OK7 Rational Y258F 0.667 4.7x101 -1.243 
(Bastian et al. 2011) E. coli KARI 3ULK Semi-Rational A71S, R76D, S78D, Q110V 185.000 5.4x104 -0.072 
This study S. sp. KARI 3ULK (h) Rational A71S, R76D, S78D, Q110V 64.000 1.1x105 -2.148 
This study S. exigua KARI 4KQW Rational S61D, S63D, I95V 88.000 7.8x103 -1.561 
This study M. aeolicus KARI 4KQW (h) Rational G50D, S52D 124.000 1.2x103 -0.841 
This study L. lactis KARI 4TSK (h) Semi-Rational V48L, R49P, K52L, S53D, 
E59K, T182S, E320K 151.064 2.3x104 0.038 
This study A. acidocaldarius KARI 4TSK Semi-Rational R48P, S51L, S52D, R84A 110.000 4.5x102 -1.527 
(Chen et al. 1995) E. coli IDH 4AJ3 Homology C201I, C332Y, K344D, Y345I, 
V351A, Y391K, R395S 202.469 1.4x106 -1.457 
(Dambe et al. 2006) S. morelense AFDH 2GLX Homology A13G, S33D 13.581 ? -0.791 
(Döhr et al. 2001) H. sapiens P450R 3QFS Rational W676A 0.236 1.0x103 -0.550 
(Elmore and Porter 2002) R. norvegicus P450R 1AMO Rational W677A 1.156 5.3x104 -1.807 
(Eppink et al. 1999) P. fluorescens PHBH 1K0J (m) Rational R33S, Q34R, P36R, D37A, 
Y38E 3.111 5.0x104 -2.017 
(Fasan et al. 2011) B. megaterium P450R 4DQL Semi-Rational R966N, K972H, Y974F, 
W1046D 0.615 4.4x10
2 -1.072 
(Kamerbeek et al. 2004) P. fluorescens HAPMO 2YLR (h) Semi-Rational K439F 0.615 4.3x102 -2.021 
(Kamerbeek et al. 2004) A. sp. CHMO 4RG3 Semi-Rational K326A 0.096 5.5x101 -2.936 
(Katzberg et al. 2010) S. cerevisae DKR 4PVD Semi-Rational N9E 0.856 1.2x102 -2.936 
(Khoury et al. 2009) C. boidinii XR 1K8C (h) Computational K272G, S273G, N274D >1 ? -1.071 
(Kristan et al. 2007) C. lunatus BHSDH 3QWF Homology Y49D 7.770 ? -4.188 
(Liang et al. 2007) P. stipitis XR 1K8C (h) Semi-Rational K270R, N272D 2.932 9.3 -1.171 
(Maddock et al. 2015) E. coli CaADH 1KEV (h) Homology G198D, S199V, P201E, Y218A >1 ? -4.591 
(Maurer et al. 2005) B. megaterium P450R 4DQL Rational R966D, W1046S 0.372 2.3x102 -0.401 
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Table 1-1. continued 
Study Protein Structure Method Best Mutant Final 
Specificitya 
Specificity 
Changeb 
Log Relative 
Activityc 
(Medina et al. 2001) A. PCC7119 FDNR 2BSA Rational S223D 0.120 8.1x103 -5.352 
(Nakanishi et al. 1997) M. musculus CR 1CYD Rational T38D 30.909 1.3x103 -0.510 
(Paladini et al. 2009) P. sativum FDNR 4AF7 
(1QGA) 
Rational Y308S 
0.015 3.3x102 -1.627 
(B. Petschacher et al. 2005) C. tenuis XR 1K8C Rational K274R, N276D 1.249 1.9x101 -1.170 
(Pick et al. 2014) E. coli AdhZ3 1YQD (h) Semi-Rational S199N, S200N, N201D 1.245 6.9x101 -0.754 
(Pick et al. 2014) E. coli AdhZ2 1UUF 
(1YQD) 
Rational T205D, T206I, S207N 
2.188 3.8x101 0.000 
(Rane and Calvo 1997) E. coli KARI 3ULK Rational R68D, K69L, K75V, R76D 31.435 5.8x104 -0.548 
(Rodriguez-Arnedo et al. 2005) H. volcanii IDH 1AI2 (h) Homology R291S, K343D, Y344I, V350A, 
Y390P >1 ? -0.768 
(Rosell et al. 2003) R. perezi ADH8 1P0F Homology G223D, T224I, H225N 7571.333 8.1x104 0.551 
(Scrutton et al. 1990) E. coli GTR 1GET Homology A179G, A183G, V197E, R198M, 
K199F, H200D, R204P 8.133 1.8x104 -1.482 
(Shiraishi et al. 1998) N. crassa CbR  Rational S920D, R932S 65.000 7.2x104 -2.626 
(Takase et al. 2014) S. sp. A1-R 3AFN Loop Substitution H37N, G38S, R39H, K40V, 
A41D >1 ? -3.241 
(Yaoi et al. 1996) T. thermophilus IDH 2D1C Loop Substitution R231A, K283D, Y284I, N287G, 
V288I, I290A 67.692 5.2x104 -1.051 
(Zeng et al. 2009) P. stipitis XR 1K8C (h) Computational K21A, N272D >1 ? -0.098 
(L. Zhang et al. 1999) V. harveyi ALDH 1EZ0 Semi-Rational T175E 129.545 4.8x103 -0.763 
(R. Z. Zhang et al. 2009) C. parapsilosis SCR 3CTM 
(1CYD) 
Rational S67D, P69D 
0.313 4.6 -0.180 
Catalytic efficiency, CE, is given as kcat/KM when available, or vmax/KM otherwise. 
aFinal specificity is defined as 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫𝑷 
bSpecificity change is defined as 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫𝑷𝑪𝑬𝑾𝑻𝑵𝑨𝑫 𝑪𝑬𝑾𝑻𝑵𝑨𝑫𝑷 
cLog relative activity is defined as 𝐥𝐨𝐠 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫𝑪𝑬𝑾𝑻𝑵𝑨𝑫𝑷  
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Table 1-2. Previous reports of NAD-to-NADP cofactor specificity reversal. Structures followed by (h) are homology models, while those followed by another 
PDB accession code use the cofactor from that protein and (m) denotes a structure of a mutant protein. For citation information, see Supplementary Material S1-1. 
Study	   Protein	   Structure	   Method	   Best	  Mutant	   Final 
Specificitya 
Specificity 
Changeb 
Log Relative 
Activityc (Ashida	  et	  al.	  2004)	   S.	  sp	  AlaDH	   2VHW	  (h)	   Rational	   D198A	   13.846	   3.4x104	   -­‐0.963	  (Bernard	  et	  al.	  1995)	   L.	  delbruckii	  LDH	   1J49	   Rational	   D175A	   1.043	   4.4x101	   -­‐0.962	  (Bocanegra	  et	  al.	  1993)	   E.coli	  DHLDH	   4JQ9	  (1GEU)	   Homology	   E205V,	  M206R,	  F207K,	  D208H,	  P212R	   >1	   ?	   0.668	  (Bubner	  et	  al.	  2008)	   P.	  fluorescens	  M2DH	   1M2W	   Rational	   E68K,	  D69A	   18.667	   4.5x103	   0.766	  (Capone	  et	  al.	  2011)	   C.	  symbiosum	  GDH	   1BGV	  (4XGI)	   Rational	   F238S,	  P262S	   0.323	   5.8x101	   -­‐3.323	  (Chen	  et	  al.	  1996)	   T.	  thermophilus	  IMDH	   2ZTW	   Loop	  Substitution	   N/A	   1000.000	   8.7x104	   0.187	  (Clermont	  et	  al.	  1993)	   B.	  stearothermophilus	  GAPDH	   3CMC	   Rational	   D32A,	  L187A,	  P188S	   1.556	   ?	   -­‐1.699	  (Cui	  et	  al.	  2015)	   G.	  oxydans	  Gox2181	   3AWD	  (2WDZ)	   Computational	   Q20R,	  D43S	   1.457	   ?	   0.073	  (Ehrensberger	  et	  al.	  2006)	   G.	  oxydans	  XDH	   1ZEM	   Rational	   D38S,	  M39R	   >1	   ?	   0.699	  (Ehsani	  et	  al.	  2009)	   S.	  cerevisae	  BDH	   2D8A	  (h)	   Homology	   E221S,	  I222R,	  A223S	   >1	   ?	   0.059	  (Feeney	  et	  al.	  1990)	   B.	  stearothermophilus	  LDH	   1LDN	   Rational	   D53S	   0.152	   3.4	   -­‐1.313	  (Friesen	  et	  al.	  1996)	   P.	  mevalonii	  HMG-­‐CoAR	   4I4B	   Rational	   D146A,	  L148K	   0.135	   7.6x104	   -­‐3.683	  (Galkin	  et	  al.	  1997)	   T.	  intermedius	  LuDH	   1LEH	  (h,1BW9)	   Homology	   D203A,	  I204R,	  D210R	   74.286	   ?	   -­‐1.636	  (Gul-­‐Karaguler	  et	  al.	  2001)	   C.	  methylica	  FDH	   2FSS	  (2NAD)	   Rational	   D195S	   0.024	   6.1x103	   -­‐1.479	  (Hoelsch	  et	  al.	  2013)	   M.	  vaccae	  FDH	   2GSD	  (h)	   Rational	   C145S,	  A198G,	  D221Q,	  C225V	   13.254	   ?	   ?	  (Holmberg	  et	  al.	  1999)	   B.	  stearothermophilus	  LDH	   1LDN	   Homology	   I51K,	  D52S	   2.200	   4.9x101	   -­‐1.582	  (Hsieh	  et	  al.	  2006)	   H.	  sapiens	  m-­‐NAD-­‐ME	   1PJ3	   Rational	   Q362K	   3.169	   2.9x102	   -­‐0.534	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Table 1-2. continued 
Study	   Protein	   Structure	   Method	   Best	  Mutant	   Final 
Specificitya 
Specificity 
Changeb 
Log Relative 
Activityc (Jensen	  et	  al.	  2013)	   S.	  maltphilia	  SMFMO	   4A9W	  (2XLP)	   Homology	   H194T	   0.966	   1.5	   -­‐0.216	  (Ma	  et	  al.	  2010)	   K.	  pneumonia	  PDOR	   3OX4	  (h)	   Computational	   D41G	   1.559	   ?	   -­‐0.655	  (Marohnic	  et	  al.	  2003)	   R.	  norvegicus	  CB5R	   1IB0	   Homology	   D239T	   10.453	   4.1x104	   -­‐0.669	  (Miller	  et	  al.	  2006)	   E.	  coli	  IMDH	   1CM7	  (2ZTW)	   Directed	  Evolution	   K100R,	  A229T,	  D236R,	  L248M,	  D289K,	  I290Y,	  A296V,	  G337Y	   367.000	   5.1x104	   -­‐0.228	  (Nishiyama	  et	  al.	  1993)	   T.	  flavus	  MDH	   1BMD	   Homology	   E41G,	  I42S,	  P43E,	  Q44R,	  A45S,	  M46F,	  K47Q	   24.000	   5.2x102	   -­‐0.470	  (Barbara	  Petschacher	  et	  al.	  2014)	   S.	  mutans	  NOX	   2BC0	  (h,2CDU)	   Homology	   D192A,	  V193R,	  V194H,	  A199R	   10.000	   6.4x104	   0.559	  (Serov	  et	  al.	  2002)	   S.	  cerevisae	  FDH	   2NAD	  (h)	   Rational	   D196A,	  Y197R	   2.311	   ?	   -­‐3.796	  (Takase	  et	  al.	  2014)	   S.	  sp.	  A1-­‐R’	   4TKM	   Loop	  Substitution	   T16S,	  E17Q,	  N37H,	  S38G,	  H39R,	  V40K,	  D41A	   84.628	   1.1x103	   0.665	  (Watanabe	  et	  al.	  2005)	   P.	  stipitis	  XDH	   1PL6	  (h)	   Homology	   D207A,	  I208R,	  F209T	   2.641	   1.1x104	   0.049	  (Woodyer	  et	  al.	  2003)	   P.	  stutzeri	  PDH	   4E5K	   Semi-­‐Rational	   E175A,	  A176R	   2.763	   3.0x102	   0.995	  (Zheng	  et	  al.	  2013)	   B.	  subtilis	  InDH	   3NT2	   Rational	   A12K,	  D35S,	  V36R	   4.750	   ?	   0.032	  
Catalytic efficiency, CE, is given as kcat/KM when available, or vmax/KM otherwise. 
aFinal specificity is defined as 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫𝑷 
bSpecificity change is defined as 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫𝑷𝑪𝑬𝑾𝑻𝑵𝑨𝑫 𝑪𝑬𝑾𝑻𝑵𝑨𝑫𝑷 
cLog relative activity is defined as 𝐥𝐨𝐠 𝑪𝑬𝒎𝒖𝒕𝑵𝑨𝑫𝑪𝑬𝑾𝑻𝑵𝑨𝑫𝑷  
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Materials and Methods 
Cloning and library construction 
The genes encoding S. exigua SeKARI, L. lactis LlKARI, and Shewanella sp. 
ShKARI were obtained from DNA2.0. The genes encoding M. aeolicus MaKARI and A. 
acidocaldarius AaKARI were obtained as gBlocks from Integrated DNA Technologies. 
For each gene, the gBlocks were assembled via PCR, using T7 promoter and terminator 
primers and Phusion polymerase following the manufacturer’s instructions (Thermo 
Scientific). Site-saturation mutagenesis libraries were made by splicing by overlap 
extension PCR, as described.3,22 Error-prone PCR was performed according to a published 
protocol,23 using commercial T7 promoter and terminator primers. All KARIs and libraries 
were cloned into pET22(b)+, using NdeI and XhoI in frame with the C-terminal his-tag for 
expression in E. coli. Heterologous protein expression, high-throughput expression, and 
purification were conducted as described.3 
Kinetic assays and high-throughput screening 
For the high-throughput assays, E. coli cells were lysed with 100 mM potassium 
phosphate at pH 7, 750 mg/L lysozyme, and 10 mg/L DNaseI. KARI activities were then 
assayed by monitoring NAD(P)H consumption in the presence of S2AL at 340 nm in a 
plate reader. The assay buffer contained 100 mM potassium phosphate at pH 7, 1 mM 
DTT, 200 µM NAD(P)H, 12.5 mM S2AL for LlKARI and 2.5 mM for the other KARIs, 
and 10 mM MgCl2. The LlKARI error-prone PCR library was screened at 5 mM S2AL. 
The EcIlvC6E6 library was screened at 1 mM S2AL. The SeKARIDD library was screened at 
100 µM NADH and 2.5 mM S2AL.  
KARI sequence alignment 
Manually annotated and reviewed sequence data for ketol-acid reductoisomerases 
(E.C. 1.1.1.86) were retrieved from the UniProt Database.24 Clustal Omega25,26 was used to 
perform a multiple sequence alignment. The sequence logo plot27 was created with the 
WebLogo 3.3 interface.28  
 
  
11 
Crystallization and data collection 
N-hydroxy-N-isopropyloxamate was prepared as described.29 High-throughput 
screening of crystallization conditions for SeKARI and SeKARIDDV was conducted at the 
Beckman Molecular Observatory at the California Institute of Technology. For SeKARI 
with NADPH, the best condition was an unbuffered 0.2 M di-ammonium tartrate solution 
containing 20% (wt/vol) polyethylene glycol (PEG) 3350 as precipitant. For SeKARIDDV 
with NADH and N-hydroxy-N-isopropyloxamate as inhibitor, the best condition was an 
unbuffered 0.1 M potassium thiocyanate solution with 30% (wt/vol) PEG monomethyl 
ether 2000 as precipitant. The crystals were soaked in Fomblin oil for cryoprotection before 
flash-freezing in liquid nitrogen. Diffraction data were collected using a Dectris Pilatus 6M 
detector on beamline 12–2 at the Stanford Synchrotron Radiation Laboratory at 100 K. 
Diffraction datasets were integrated with XDS30 and scaled using SCALA.31  
Structure determination and refinement 
For SeKARI, the structure of Pseudomonas aeruginosa KARI (PDB code 1NP332) 
was used as for molecular replacement. A multiblock refinement was applied dividing the 
model in six subparts according to secondary structure elements (residues 1–202, 203–228, 
229–252, 253–278, 279–308, and 309–337) to allow automated standard refinement with 
Phenix (CCP4 suite). Refinement was conducted by iterating automatic refinement with 
Refmac5 (CCP4 suite) and manual refinement using Coot.33 We used the refined wild-type 
structure as a model for molecular replacement to obtain the structure for SeKARIDDV. 
After placement of the inhibitor, several iterations of automated refinement with Refmac5 
and manual refinement in Coot were performed. The structures were submitted to the 
protein database as PDB 4KQW (SeKARI) and PDB 4KQX (SeKARIDDV). 
Results and Discussion 
In previous work, Bastian et al. described E. coli KARI variant EcIlvC6E6 with four 
mutations (A71S, R76D, S78D, and Q110V) that resulted in a 54,000-fold reversal in 
cofactor specificity for NAD over NADP.3 This variant was also highly active when using 
NAD (85% of wild-type activity using NADP). Structural analysis of wild-type EcIlvC 
with and without bound cofactor (PDB codes 3ULK and 1YRL34,35) showed that three of 
the four EcIlvC6E6 mutations (A71S, R76D, and S78D) are in a loop connecting the β2-
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strand and the αB-helix of the Rossmann fold,36 herein referred to as the β2αB-loop. R76 
and S78 are in direct contact with the 2′-phosphate of NADP. The existence of β2αB-loops 
of varying lengths obscured sequence patterns of NADP specificity in KARI multiple 
sequence alignments.13,19,20,37 To find the commonalities among KARI β2αB-loops, we 
systematically analyzed the loop regions of the entire enzyme class. We generated a 
multiple sequence alignment of all 643 Swiss-Prot-annotated21 KARI sequences (Table S1-
1) and used structural data to identify and refine the β2αB-loop region in the alignment. An 
excerpt (Figure 1-2a) of the alignment of a few representative KARIs shows the well-
known, conserved GxGxxG motif38 and, 18 amino acids downstream, the β2αB-loop, 
which is diverse in both length and amino acid sequence. 
On the basis of the sequence alignment alone, the diversity of this region might 
seem to argue against a conserved function for loop residues (Figure 1-2a). However, 
analysis of the 643 KARI sequences shows three different loop lengths: six (14%), seven 
(68%), and 12 residues (18%) (Fig. 1-2b). On subalignment of KARIs according to loop 
length, common conservation patterns emerge: a positively charged residue (73% arginine 
and 9% lysine) usually appears at the N-terminal end of the β2αB loop, and small, polar 
residues such as serine (85%) or threonine (11%) predominate at the C-terminal end. The 
last two residues in the six-residue loops are conserved (lysine/arginine and serine), and the 
last three residues follow the pattern SxS in seven-residue and RxS in 12-residue loops.  
Comparison of the β2αB-loop segment of all available KARI structures (seven 
structures from four different organisms32,34,37,39-41) provides an explanation for the trends 
found in the sequence alignment. Three of the seven structures have NADP cocrystallized, 
and in all those cases, the small polar C-terminal residues interact with the NADP 2′-
phosphate. The conserved N-terminal arginine is homologous to R68 in EcIlvC6E6, which 
has recently been shown to form a cation–pi interaction with the NADP adenine ring34 and 
likely plays a dual role in binding the nucleobase, as well as the 2′-phosphate. On the basis 
of these findings, we postulate that the β2αB-loop is a major determinant of NADP cofactor 
specificity in wild-type KARIs. This analysis of the β2αB-loop provides the basis for 
transferring previously reported cofactor-switching mutations in EcIlvC6E6 to corresponding 
residues in KARIs that have similar 12-residue loops, as well as KARIs with six- and 
seven-residue loops.  
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Figure 1-2. Excerpt of a multiple sequence alignment (a) of L. lactis KARI (LlKARI, 
UniProt ID Q02138), A. acidocaldarius KARI (AaKARI, C8WR67), S. exigua KARI 
(SeKARI, D0WGK0), M. aeolicus KARI (MaKARI, A6UW80), Shewanella sp. KARI 
(ShKARI, A0KS29), E. coli KARI (EcIlvC, P05793), and EcIlvC6E6. The GxGxxG motif is 
highlighted in bold and boxed. The β2αB-loop is boxed. Mutations of variant EcIlvC6E6 are 
shown in bold. Subalignments according to β2αB-loop length (b) uncover three different 
conservation patterns we suggest are important for 2′-phosphate interaction. Colors in the 
sequence logo refer to hydrophobic (black), positively charged (blue), negatively charged 
(red), and polar (green) residues. 
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Transfer of a 12-residue cofactor switch solution to seven- and six-residue β2αB-loops 
We examined the transferability of mutations previously reported for EcIlvC6E6, 
which has a 12-residue loop, to KARIs with shorter loops using SeKARI from S. exigua 
(seven residues) and LlKARI from L. lactis (six residues) as models. On inspection of the 
sequence alignment in Figure 1-2a, we identified residues S61 and S63 of SeKARI as 
corresponding to residues R76 and S78 in EcIlvC (R76D and S78D in EcIlvC6E6). EcIlvC 
mutation A71S had no match in the SeKARI amino acid sequence because of the latter 
enzyme’s shorter β2αB-loop. Grafting both aspartates from EcIlvC6E6 into SeKARI resulted 
in variant SeKARIDD (S61D and S63D) and a 7,800-fold reversal of cofactor specificity 
from NADPH to NADH. SeKARIDD (Table 1-3) had an eightfold decreased kcat with 
NADPH (from 0.8 to 0.1 s−1), whereas the kcat with NADH increased from 0.4 to 1.0 s−1. 
The mutations increased the KM for NADPH 880-fold, but only 2.5-fold for NADH. 
Overall, the catalytic efficiency for NADH remained the same, whereas catalytic efficiency 
for NADPH was reduced 7,300-fold to 0.11 mM−1s−1. That switching SeKARI cofactor 
specificity could be achieved with only two mutations suggests that KARIs with seven-
residue and 12-residue β2αB-loops share similar cofactor specificity determinants 
involving interactions with small, polar residues at the end of the β2αB-loop.  
LlKARI is a representative of the 14% of the 643 KARI sequences with a six-
residue β2αB-loop. Whereas in 12- and seven-residue β2αB-loop KARIs the 
antepenultimate and ultimate residues are highly conserved, in six-loop KARIs the ultimate 
conserved serine is usually preceded by a positively charged residue at the penultimate 
position. We hypothesized that residues K52 and S53 of LlKARI were equivalent in 
function to residues R76 and S78 in EcIlvC. LlKARIDD variant with mutations K52D and 
S53D, however, expressed at an extremely low level and exhibited no measurable activity 
with either cofactor, which could be a result of the destabilizing effects of the two adjacent 
aspartate residues. Similar results were obtained with LlKARIED. These two aspartate 
mutations are separated by an additional residue in KARIs with the longer β2αB-loops. The 
failed transfer of E. coli cofactor switch mutations to LlKARI suggests that KARIs with 
six-residue loops require a modified approach.  
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To develop a recipe for switching cofactor specificity in KARIs having a six-
residue β2αB-loop, we generated single-site-saturation mutagenesis libraries at each of the 
six loop residues in LlKARI (V48, R49, H50, G51, K52, and S53), expecting that the 
β2αB-loop also is key to specificity in this KARI family. On screening for activity with 
both cofactors, we found no single mutation that resulted in an NAD-preferring variant 
(rate of NADH consumption > rate of NADPH consumption at saturating substrate 
conditions). Mutations were identified at R49 (proline) and V48 (leucine) that increased 
activity with both cofactors. Saturation mutagenesis at H50, G51, K52, and S53 did not 
yield variants with improved NADH activity. Convinced that NADP specificity in KARIs 
with a six-residue β2αB loop is conveyed in a similar manner as in KARIs with seven- and 
12-residue loops, we built a dual-site library by saturation mutagenesis at Lys52 and Ser53 
while also incorporating the V48L and R49P mutations. Screening this library to ∼80% 
coverage, we identified two variants, LlKARILPLD (mutations V48L, R49P, K52L, and 
S53D) and LlKARILPED (mutations V48L, R49P, K52E, and S53D), with 46-fold and 54-
fold specificity for NADH over NADPH (Table 1-3), representing specificity shifts of 
6,600 (LlKARILPLD) and 7,700 (LlKARILPED).  
These cofactor-switched KARIs with six-residue loops contained mutations to four 
of the six loop residues, suggesting that KARIs with six-residue loops are slightly more 
difficult templates for engineering the cofactor switch. Although mutation of the conserved 
arginine at the beginning of the β2αB-loop was not required to switch cofactor specificity 
in seven- and 12-loop KARIs, variant LlKARILRLD with proline reverted to arginine showed 
that the arginine contributes to NADP cofactor preference in six-residue loop KARIs. 
Reversion of P49 to arginine not only reduced the cofactor KM values (twofold for NADH 
and threefold for NADPH, Table 1-3) but also decreased the kcat on NADH (fourfold), 
thereby reducing the 46-fold preference for NADH over NADPH to only sixfold. 
Reversion of L48 to valine (LlKARIVPLD) lowered the catalytic efficiency on NADH 
threefold (because of a reduction in kcat), whereas the NADPH KM was reduced twofold. 
Although polar residues at the C-terminal end of the loop and charged residues at the N-
terminal end of the loop continue to support NADP specificity, removing the polar residues 
at the C-terminal end of the loop might not be sufficient to switch the specificity of six-
residue loop KARIs in favor of NAD. In the shorter six-residue loop KARIs, the N-
terminal, positively charged arginine residue appears to form stronger interactions with the 
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2′-phosphate than in the seven- and 12-residue loop KARIs, possibly because of its closer 
packing and proximity to the cofactor. The six-amino acid loop KARI structure with 
cofactor that we describe in Chapter 4 will help explain these differences. 
Recovering catalytic activity of cofactor-switched enzymes 
Shifting cofactor preference often decreased the overall activity (i.e., catalytic efficiency 
using NADH) relative to the wild-type enzyme using NADPH in our KARIs, which is also 
true for other cofactor-switched enzymes.20,42-44 To demonstrate that the activity of the 
cofactor-switched variants can be improved to match or even surpass the wild-type enzyme, 
we randomly mutated SeKARIDD, LlKARILPLD, and EcIlvC6E6 and screened for higher total 
activity in cell lysate. For SeKARI, we identified variant SeKARIDDV with mutation I95V. 
Interestingly, this mutation corresponds to Q110V, which was previously found in 
EcIlvC6E6, and is speculated to confer general activation by optimizing cofactor orientation 
for catalysis. With LlKARI, we isolated variant LlKARI2G6, which contained three new 
mutations: E59K, T182S, and E320K. These mutations effectively restored the enzyme to 
wild-type levels of activity; the catalytic efficiency of LlKARI2G6 with NADH was ∼10% 
higher than wild-type LlKARI with NADPH (71 vs. 65 mM−1s−1). The EcIlvC6E6 random 
mutant library yielded variant EcIlvCP2D1-A1, also with three additional mutations (D146G, 
G185R, and K433E) and an approximately twofold greater catalytic efficiency on NAD 
than the wild-type on NADP (Table 1-3). The random mutations in EcIlvCP2D1-A1 and 
LlKARI2G6 are surface mutations, and their effects are difficult to rationalize. These three 
examples demonstrate that the activity of a cofactor-switched enzyme can be improved, 
even to levels that exceed wild-type activity, and that activating mutations can be found 
outside of the specificity-determining β2αB-loop.  
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Table 1-3. Biochemical properties of EcIlvc (12 residues), ShKARI (12 residues), SeKARI (seven residues), MaKARI (seven residues), LlKARI (six residues), 
AaKARI (six residues), and variants. T50  values are given for some enzymes. 
   KM for cofactors [µM] kcat for cofactors [s-1] kcat/KM [mM-1s-1] NADH/NADPH 
of kcat/KM Enzyme Mutations T50 [°]a NADH NADPH NADH NADPH NADH NADPH 
EcIlvC -- 44.0 ± 0.1 1,075 ± 370 41 ± 3 0.3 ± 0.0 3.6 ± 0.4 0.3 ± 0.1 88 ± 11 0.003 ± 0.001 
EcIlvC6E6 A71S, R76D, S78D, Q110V 43.7 ± 0.2 30 ± 6 650 ± 80 2.3 ± 0.2 0.20 ± 0.02 74 ± 15 0.40 ± 0.05 185 ± 50 
EcIlvCP2D1-A1 A71S, R76D, S78D, Q110V, D146G, G185R, K433E 41.3 ± 0.2 26 ± 1 > 1,400 4.3 ± 0.3 0.54 ± 0.20 165 ± 22 < 0.4 > 412 ± 162 
ShKARI  --   415 ± 44 1.0 ± 0.1 1.1 ± 0.1 4.5 ± 0.1 2.6 ± 0.3 4,500 ± 450 0.0006 ± 0.0001 
ShKARIDD R76D, S78D  90 ± 24 > 1,000 1.30 ± 0.01 0.10 ± 0.02 14 ± 4 0.12 ± 0.02 > 119 ± 46 
ShKARI6E6 A71S, R76D, S78D, Q110V  75 ± 10 600 ± 130 2.40 ± 0.01 0.30 ± 0.05 32 ± 4 0.5 ± 0.1 73 ± 23 
SeKARI -- 51.3 ± 0.2 45 ± 10 1.0 ± 0.1 0.41 ± 0.02 0.8 ± 0.1 9 ± 2 800 ± 100 0.01 ± 0.00 
SeKARIDD S61D, S63D 44 ± 1 113 ± 4 880 ± 523 0.97 ± 0.01 0.10 ± 0.01 9 ± 1 0.11 ± 0.07 78 ± 49 
SeKARIDDV S61D, S63D, I95V  47 ± 15 > 1000 1.01 ± 0.01 0.25 ± 0.04 22 ± 7 0.25 ± 0.04 87 ± 32 
bMaKARI --  59 ± 4 17.3 ± 0.2 0.3 ± 0.0 0.7 ± 0.1 4.6 ± 0.3 43 ± 6 0.12 ± 0.02 
bMaKARIDD G50D, S52D  26 ± 2 80 ± 9 0.15 ± 0.01 0.004 ± 0.001 6.2 ± 0.6 0.05 ± 0.01 124 ± 24 
LlKARI -- 50 ± 1 285 ± 30 13 ± 1 0.10 ± 0.01 0.8 ± 0.1 0.43 ± 0.06 65 ± 11 0.007 ± 0.002 
LlKARILPLD V48L, R49P, K52L, S53D 46.5 ± 0.3 108 ± 9 1,000 ± 100 0.40 ± 0.01 0.08 ± 0.01 3.7 ± 0.3 0.08 ± 0.01 46 ± 8 
LlKARILRLD V48L, K52L, S53D  60 ± 8 306 ± 70 0.09 ± 0.00 0.09 ± 0.00 1.7 ± 0.2 0.30 ± 0.07 6 ± 1 
LlKARIVPLD R49P, K52L, S53D  105 ± 7 447 ± 91 0.13 ± 0.01 0.07 ± 0.00 1.2 ± 0.1 0.15 ± 0.03 8 ± 2 
LlKARILPED V48L, R49P, K52E, S53D  128 ± 9 1,180 ± 280 0.35 ± 0.12 0.06 ± 0.01 2.7 ± 0.9 0.05 ± 0.01 54 ± 26 
LlKARI2G6 V48L, R49P, K52L, S53D, E59K, T182S, E320K  15 ± 4 749 ± 95 1.01 ± 0.03 0.35 ± 0.08 70 ± 19 0.47 ± 0.12 153 ± 57 
bAaKARI --  28 ± 2 18.0 ± 0.2 0.26 ± 0.01 0.66 ± 0.01 9 ± 1 37 ±1 0.24 ± 0.02 
bAaKARIPLD R48P, S51L, S52D  43 ± 6 > 1,000 0.03 ± 0.00 0.013 ± 0.0004 0.7 ± 0.1 < 0.013 > 54 ± 20 
bAaKARIPLDA R48P, S51L, S52D, R84A  27 ± 3 > 1,000 0.03 ± 0.00 0.01 ± 0.00 1.1 ± 0.2 < 0.01 > 110 ± 20 
bAaKARILS Loop switch (LS) of LlKARILPLD to AaKARI: 
R48P, P49H, S51L, S52D 
 46 ± 6 > 1,000 0.03 ± 0.00 0.009 ± 0.006 0.6 ± 0.1 < 0.01 > 55 ± 8 
Mutations are given relative to each wild-type sequence. Each value represents the average of three independent measurements. Mutations located within the β2αB-loop are highlighted 
in bold. 
aHalf-denaturation temperature (T50) determination: 30 µL aliquots of purified enzyme were transferred to PCR tubes. Each tube was assigned a specific incubation temperature on the 
block of an Eppendorf master cycler PCR machine. The measurements were conducted in duplicates. The tubes were incubated in their slots for 15 min, and the reactions were 
quenched on ice. Residual activity was determined with the activity assay. T50 is defined as the termperature at which 50% of the initial activity is retained after 15 min incubation. 
aMaKARI, AaKARI, and their variants show cooperative behavior, and their kinetics follow the Hill equation with a Hill coefficient of 2.0 instead of the Michaelis-Menten equation: 
affinity is described as KH and catalytic efficiency as kcat/KH to compare them to the other KARIs. No change in Hill coefficient was observed upon mutations. 
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Cofactor switch guide for the KARI enzyme family 
We propose the following guide for switching KARI cofactor specificity, which 
does not require a priori knowledge of the KARI structure (Figure 1-3). The first step is the 
identification of the β2αB-loop and its length via sequence alignment against the KARIs 
reported in this work or a multiple sequence alignment of KARIs. If the target KARI has a 
12- or seven-residue loop, replacement of the last and third-to-last residue of the loop with 
aspartates is likely to achieve a switch in cofactor specificity. In the case of the six-residue 
loop, a modified approach is required. The last polar loop residue should be mutated to 
aspartate, and the conserved charged residue near the N-terminus of the loop should be 
mutated to proline. Simultaneously, the penultimate loop residue should be targeted for site-
saturation mutagenesis. This approach led to reversed cofactor preference in both test cases. 
Last, to achieve wild-type-like activity for NAD, additional mutations that fine-tune cofactor 
orientation, as exemplified by Q110V or I95V, may be introduced, as will be discussed 
further in Chapter 6. Additional enhancement of activity can be achieved by random 
mutagenesis and screening.  
Application of the cofactor switch guide 
We tested the proposed protocol on three additional KARIs representing the β2αB-
loop lengths (twelve, seven, and six residues) and composition. With the addition of these 
three KARIs, we covered the different phylogenetic subbranches of the KARI enzyme 
family. Representative of 12-residue β2αB-loop KARIs was ShKARI from Shewanella sp. 
Methanococcus aeolicus MaKARI45 exemplifies the seven-residue type, and AaKARI from 
Alicyclobacillus acidocaldarius has a six-residue loop (Table 1-3). We also used this last 
enzyme to test the transferability of the Q110/I95 position by making and screening a site-
saturation library at position R84.  
By introducing a customized set of two to four mutations based on the guide in 
Figure 1-3, we obtained variants with the desired cofactor specificity for KARI family 
members sharing as little as 20% sequence identity (Table S1-2). Low catalytic efficiency in 
cofactor-switched variants can be remedied by directed evolution, as demonstrated for 
EcIlvCP2D1-A1 and LlKARI2G6. Mutations (alanine or valine) at positions corresponding to 
EcIlvC’s Q110 improved activity in three different KARIs. Overall, catalytic efficiency 
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ratios (NADH/NADPH) of more than 400-fold (Figure 1-4) with catalytic efficiencies up 
to 188% of those of the corresponding wild-type enzymes using NADPH were achieved, 
corresponding to shifts in cofactor specificity of 200–200,000-fold. 
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Figure 1-3. Cofactor switch guide for the KARI enzyme family. Steps include (1) identification of 
the loop, (2) determination of the β2αB-loop length and mutation based on loop length, and (3) 
improvement of overall activity on NAD via random mutagenesis. 
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Figure 1-4. Catalytic efficiency NADH/catalytic efficiency NADPH, on log scale, for six 
wild-type KARIs (light gray) and their cofactor-switched variants (dark gray). 
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Molecular determinants of cofactor specificity in KARIs 
We solved the crystal structures of SeKARI wild-type enzyme (1.39 Å, PDB 
4KQW) and variant SeKARIDDV (1.8 Å, PDB 4KQX) with their respective cofactors. The 
crystallographic parameters are summarized in Table 1-4. These structures confirm that only 
the β2αB-loop is involved in interactions with the respective 2′-moiety, and thus is 
responsible for specificity (Figure 1-5). In the wild-type structure, three residues form direct 
interactions with the 2′-phosphate of NADP: R58, S61, and S63. The structures support the 
suggested dual role of R58: the positively charged guanidinium moiety is 3.5 Å from the 
adenine moiety of the cofactor in both structures, forming cation–pi stacking interactions,46 
as reported for E. coli KARI.34 At the same time, this side chain could form a salt bridge to 
the negatively charged 2′-phosphate of NADP (possibly also involving the oxygen of the 
phosphoester bond) and a hydrogen bond to the 2′-hydroxyl of NAD.  
The residues that were mutated to alter cofactor preference, S61 and S63, are in a 
position to hydrogen bond directly to at least a single oxygen atom of the phosphate. The 
high-resolution structures revealed water molecules surrounding the 2′-phosphate group, 
enabling additional, indirect interactions with the side chains of R58, S61, and S63 (Figure 
1-5). The side chain of S62 stabilizes this network of water molecules, as does the R58 
backbone. In the mutant structure, the β2αB-loop is moved slightly closer toward the 
cofactor. Mutations S61D and S63D would interrupt the serine hydrogen bonding 
interactions and also result in electrostatic repulsion to the 2′-phosphate of NADP. The 
carboxyl groups of the two aspartates compensate for the missing 2′-phosphate by filling the 
pocket and substituting its negative charge. In addition, the side-chain carboxylate moiety of 
S61D is at an ideal distance for hydrogen bonding to the 2′-hydroxyl group of NAD. As in 
the wild-type structure, water molecules link the 2′-hydroxyl moiety of the ribose sugar with 
R58 and D63 by hydrogen bonds. All other interactions of SeKARIDDV with the cofactor, for 
instance, involving the GxGxxG motif, remain the same. The remaining loop residues L57, 
E59, and G60 are not involved in binding the cofactor. 
Whereas these mutations shifted the KARI cofactor preference, improved catalytic 
activity was achieved by substituting an additional residue that is not part of the loop, I95, 
with valine. This mutation retained the hydrophobic nature while allowing the adenine 
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moiety to shift about 1 Å toward the side chain of residue 95. This compensates exactly 
the distance the β2αB-loop is reoriented inward in the mutant structure at position R58 and 
preserves the cation–pi stacking of the adenine moiety and the side chain of R58, which is in 
the same rotamer conformation in the wild-type and in the cofactor-switched mutant. We 
propose that this movement compensates for the slightly different conformations of NADP 
and NAD and readjusts the catalytically active nicotinamide moiety of NAD to take on a 
more favorable position for electron transfer. A similar activating mechanism is speculated 
for EcIlvC6E6’s Q110V mutation.3  
Conclusions: General cofactor binding principles for KARIs 
We identified a common motif for cofactor specificity in KARIs by using structural 
knowledge to identify the critical role of the β2αB-loop and deconvolute its three key 
variations in multiple sequence alignments, thereby defining a limited set of mutations that 
generate NAD specificity. Applying this to KARIs with different loop lengths has enabled 
us to develop a robust guide to switching the cofactor preference from NADP to NAD of 
any enzyme in this family. This approach opens the door to exploration of a wealth of 
different KARI properties in the context of valuable BCAA pathways under anaerobic 
conditions.  
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Table 1-4. Crystallographic parameters of wild-type SeKARI and Variant SeKARIDDV. 
 SeKARI SeKARIDDV 
Protein Data bank code 4KQW 4KQX 
Space group P 1211 P 212121 
Monomers per asymmetric unit 2 2 
Water molecules per monomer, n 443 140 
Cocrystallized cofactor NADPH NADH 
Cocrystallized compounds L-(+)-tartarate N-hydroxy-N-isopropyloxamate 
Unit-cell parameters (Å) a = 52.205 a = 49.985 
 b = 118.934 b = 105.346 
 c = 62.158 c = 122.357 
 α = 90.00 α = 90.00 
 β = 101.17 β = 90.00 
 γ = 90.00 γ = 90.00 
Resolution range (Å) 38.81-1.39 79.83-1.80 
Number of unique reflections 130,511 78,635 
Rwork 0.1595 0.2014 
Rfree 0.1866 0.2520 
Refinement parameters   
  RMSD from ideal   
    Bond (Å) 0.0293 0.0210 
    Angle (°) 2.7444 2.1084 
    Chirality 0.1858 0.1499 
  Ramachandran parameters   
    Favored 95.85% 94.33% 
    Allowed 4.15% 5.51% 
    Outliers 0.00% 0.15% 
Crystallographic parameters of solved structures of wild-type SeKARI and variant 
SeKARIDDV. 
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Figure 1-5. Crystal structures of SeKARI wild-type enzyme with cocrystallized NADP (left, 
cyan) and variant SeKARIDDV with cocrystallized NAD (right, green). The β2αB-loop is 
highlighted, and side chains involved in defining cofactor-specificity are shown as sticks. 
Introduced mutations (S61D, S63D, and I95V) are shown with red labels. In SeKARIDDV, 
S61D and S63D compensate for the missing 2′-phosphate and electrostatically and sterically 
exclude NADP. Mutation I95V allows the adenine moiety to shift 1 Å inward. The 
backbone of R58 follows this movement, so that in both structures the cation–pi interaction 
with the adenine moiety is preserved. 
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C h a p t e r  2  
UNCOVERING RARE NAD-PREFERRING KETOL-ACID 
REDUCTOISOMERASES 
Material from this chapter appears in Brinkmann-Chen S., Cahn J. K. B., 
and Arnold F. H. (2014). Uncovering rare NADH-preferring ketol-acid 
reductoisomerases, Metabolic Engineering 26, 17-22, and is reprinted by 
permission from Elsevier, Inc.  
Abstract 
All naturally-occurring members of the ketol-acid reductoisomerase (KARI) enzyme 
family characterized to date have been shown to prefer the nicotinamide adenine 
dinucleotide phosphate (NADP) cofactor to nicotinamide adenine dinucleotide (NAD). 
However, KARIs with the reversed cofactor preference are desirable for industrial 
applications, including anaerobic fermentation to produce branched-chain amino acids. By 
applying insights gained from structural and engineering studies of this enzyme family to a 
comprehensive multiple sequence alignment of KARIs, we identified putative NAD-
utilizing KARIs and characterized eight whose catalytic efficiencies using NAD were equal 
to or greater than NADP. These are the first naturally NAD-preferring KARIs reported and 
demonstrate that this property has evolved independently multiple times, using strategies 
unlike those used previously in the laboratory to engineer a KARI cofactor switch. 
Introduction 
With burgeoning genomic databases and increasing ease of gene synthesis, 
metabolic engineers can now readily mine nature’s rich collection of enzymes. However, 
finding a sequence with specific desired properties can be difficult, particularly when only a 
few members of a protein family have been characterized and a detailed understanding of 
the structure-function relationship is lacking. The ketol-acid reductoisomerase (KARI, EC 
1.1.1.86, also known as acetohydroxyacid isomeroreductase (AHAIR)) enzymes have 
attracted much interest for production of amino acids and biofuels.1-5 These 
oxidoreductases catalyze the second step in the branched chain amino-acid (BCAA) 
biosynthesis pathway,6 conversion of (S)-2-acetolactate (S2AL) to (R)-2,3-
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dihydroxyisovalerate (RDHIV) via a methyl shift coupled to a reduction with concomitant 
oxidation of a nicotinamide adenine dinucleotide cofactor. The BCAA pathway is present 
in many organisms but not in mammals. Because of this, microbial production of branched-
chain amino acids for animal feed or human supplements is a multimillion-dollar 
business.7,8 The BCAA pathway has also been engineered to produce isobutanol, a potential 
source of renewable chemicals and fuels.9 
All wild-type KARIs characterized and described in the literature have displayed a 
strong preference for nicotinamide adenine dinucleotide phosphate (NADP) over 
nicotinamide adenine dinucleotide (NAD).2 Because intracellular levels of NAD are much 
higher than NADP, particularly under fermentative conditions, NAD-dependent 
oxidoreductases are strongly preferred in pathways for large-scale biocatalytic processes.2 
In the engineered isobutanol production pathway, replacement of the natural E. coli KARI 
(EcIlvC) and the alcohol dehydrogenase (ADH) with NAD-preferring engineered proteins 
increased the yield to nearly 100% of theoretical and improved titer and specific 
productivity.2 
In the previous chapter, we used available KARI structure data to identify the 
amino acid residues in the β2αB-loop of the Rossmann fold that distinguish between the 
two cofactors.3 A sequence alignment of Swiss-Prot-annotated KARI sequences allowed us 
to divide this diverse enzyme family into three groups based on β2αB-loop length (6-, 7-, 
and 12-residue loops) and to develop a simple recipe for switching the cofactor specificity 
of each major KARI enzyme subfamily from NADP to NAD. This engineering work 
provided valuable information on the determinants of cofactor binding and also led us to 
question whether nature might have already undertaken a similar engineering task to create 
an NAD-preferring KARI. Despite recent advances in bioinformatic cofactor specificity 
prediction,10 few attempts have been made to find alternate cofactor utilization profiles 
within large enzyme families.11 Because no method existed to predict the cofactor 
specificity of uncharacterized KARIs based on their primary sequences, we used 
knowledge gained from our previous work to exhaustively search known KARI sequences 
for KARIs with β2αB-loops predicted to improve utilization of NAD. Here, we report the 
discovery of the first known bispecific and naturally NAD-preferring KARIs. The catalytic 
efficiencies of two of the naturally NAD-preferring KARIs reported here exceed those of 
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any previously engineered variants. We suggest that rare proteins such as these, with 
properties desirable for metabolic engineering, are available in nature and may be 
uncovered using knowledge gleaned from structural and mutational studies. 
Materials and Methods 
Biological media were purchased from Research Products International (Mt. 
Prospect, IL, USA), NAD(P)H from Codexis, Inc. (Redwood City, CA, USA), 
oligonucleotides and gBlocks from Integrated DNA Technologies (San Diego, CA, USA), 
DNA polymerases, restriction enzymes, and T4 ligase from New England Biolabs 
(Ipswich, MA, USA). (S)-2-acetolactate (S2AL) was provided by Gevo, Inc. (Denver, CO, 
USA). DNA sequencing was performed by Laragen (Los Angeles, CA, USA). Standard 
molecular biology methods were taken from Maniatis et al.12 
Cloning, variant construction, expression, and kinetic assays 
The genes encoding KARIs were obtained as gBlocks, codon-optimized for E. coli. 
For each gene, the gBlocks were assembled either via PCR using T7 promoter and 
terminator primers and Phusion polymerase following the manufacturer’s instructions or 
via Gibson cloning.13 All KARIs were cloned into pET22(b)+ between restriction sites 
NdeI and XhoI in frame with the C-terminal His6-tag for expression in E. coli BL-21(DE3) 
‘E. cloni Express’ cells from Lucigen (Middleton, WI, USA). Heterologous protein 
expression and purification were conducted as described.2 Protein concentration was 
determined via the Bradford assay (Bio-Rad, Hercules, CA, USA).  
KARI activities were assayed by monitoring NAD(P)H consumption in the 
presence of (S)-2-acetolactate (S2AL) at 340 nm in a plate reader (Tecan Infinite M200, 
San Jose, CA, USA). The assay buffer contained 100 mM potassium phosphate pH 7, 1 
mM DTT, 200 mM NAD(P)H, 2.5 mM S2AL, and 10 mM MgCl2. For kinetic assays, we 
monitored the consumption of the cofactors via their fluorescence emission at 440 nm with 
excitation at 340 nm. 
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Sequence alignment 
All sequences annotated as EC 1.1.1.86 and non-fragmentary were downloaded 
from UniProtKB14 on 11/1/2013, a total of 8,043 sequences. The sequences were aligned 
using MAFFT version 7.15 Duplicate sequences were removed, as were those with less than 
20% identity to the Slackia exigua KARI. This left 3,383 unique KARI sequences, with an 
alignment length of 933 positions. The β2αB-loop was identified based on the sequences 
with solved structures deposited in the RCSB PDB16 (E. coli, S. exigua, S. oleracea, O. 
sativa, P. aeruginosa, and A. acidocaldarius3,17-23). Further analysis was completed using a 
custom-written Python script (Supplementary Material 2-1). 
Results and Discussion 
To develop a recipe for changing the cofactor specificity of any KARI from NADP 
to NAD in the previous chapter, we used an alignment of 643 Swiss-Prot-annotated KARI 
sequences.3 In this chapter, we use an expanded alignment that includes un-reviewed 
UniProt Knowledgebase (UniProtKB)14 sequences and searched this expanded sequence 
space for β2αB-loops deviating from the classic NADP-preferring KARI motifs. To do so, 
all 8,043 sequences annotated as EC 1.1.1.86 from UniProtKB were aligned using MAFFT; 
duplicate and low-identity sequences were removed as described in the Methods section. 
The β2αB-loop and its context were then identified based on KARI crystal structures.3,17-23 
The distribution of amino acids at each position, including positions present in only a very 
small number of sequences, is shown in Figure 2-1. The four phosphate-binding residues 
are highly conserved, but there is considerable variation at most of the other positions of the 
loop as well as in the length of the loop. Figure 2-2 shows these positions in the NADP co-
crystal structure of Slackia exigua KARI obtained in the previous chapter. SeKARI is a 7-
residue loop KARI whose β2αB-loop is near the consensus sequence. 
As previously reported,3 KARIs can be divided into three sub-families based on the 
length of the β2αB-loop. Of the 3,383 unique KARIs in our expanded alignment, 2,262 
(66.8%) had 7-residue loops, 593 (17.5%) had 6-residue loops, and 512 (15.1%) had 12-
residue loops, which is in good agreement with previous alignment results. Eleven 
sequences were missing the β2αB-loops (these were unlabeled fragmentary sequences), 
leaving just six KARIs with other loop lengths. 
  
34 
Based on previous structural studies and mutational analysis,4,9,24 we have proposed 
that cofactor specificity is controlled by up to four amino acid residues in the loop as 
outlined in Chapter 1: the first two positions, the antepenultimate position, and the ultimate 
position, as indicated by red arrows in Figure 2-1 and labeled for the S. exigua KARI in 
Figure 2-2. We searched the expanded sequence alignment for proteins having an acidic 
residue at any of these four positions. In our previous work, introduction of acidic residues 
into the β2αB-loop was crucial for switching the cofactor specificity;2,3 this has also been 
shown to be a major determinant of cofactor specificity in nature25-28 and in engineered 
proteins.29 For the six KARI sequences with non-standard β2αB-loop length we could not 
predict which residues would interact directly with the cofactor. We therefore visually 
inspected those loops for the presence of multiple acidic residues in their N-terminal or C-
terminal ends. Ultimately, from the alignment of 3,383 KARI sequences, 58 were identified 
by this method as being possibly NAD-preferring, including four of the six KARIs with 
nonstandard β2αB-loop lengths. To avoid over-representing KARIs from closely related 
organisms, the full sequences of these KARIs were clustered using the UniProt alignment 
tool, and for each of the 26 clusters one representative sequence was selected to create the 
list of putative NAD-dependent KARIs shown in Figure 2-3. Most of the clusters were 
singletons or contained only a handful of sequences; the two largest clusters are represented 
by Metallosphaera sedula and Sulfolobus islandicus. 
From this list, we successfully expressed, purified, and assayed the activity toward 
both cofactors of eight of the putative NAD-utilizing KARIs, highlighted in Figure 2-3. The 
kinetic values in Table 2-1 show that none of these KARIs has the typical preference for 
NADP. Four of the eight – Hydrogenobaculum sp. KARI (HsKARI), Ignisphaera 
aggregans KARI (IaKARI), Metallosphaera sedula KARI (MsKARI), and 
Syntrophomonas wolfei KARI (SwKARI) – showed roughly equal catalytic efficiency 
using NADPH and NADH (catalytic efficiency ratio of NADH/NADPH ~ 1), while four – 
Archaeoglobus fulgidus KARI (AfKARI), Desulfococcus oleovorans KARI (DoKARI), 
Thermacetogenium phaeum KARI (TpKARI), and an uncultured archaeon KARI 
(UaKARI) – were NAD-preferring, with catalytic efficiency ratios (NADH/NADPH) 
ranging from 13 to 152 (Table 2-1). The NADH KM or KH values of these KARIs were 
equal to or lower than the NADPH values of the NADPH-preferring KARI from E. coli, 
EcIlvC. IaKARI in particular stood out, with very low KM values for both cofactors. 
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Two of the naturally NAD-preferring KARIs, TpKARI and UaKARI, have 
catalytic efficiencies on NADH that exceeded the best engineered NAD-preferring KARI, 
EcIlvCP2D1-A1, by 2.8-fold and 1.2-fold, respectively. Both TpKARI and UaKARI have very 
low (~1 mM) KH for NAD (Table 2-1). These features render these two excellent 
candidates for anaerobic BCAA or isobutanol fermentations. IaKARI may also be of value 
due to its ability to utilize both cofactors and its good activity at low cofactor 
concentrations. 
In the NAD-preferring KARIs engineered in the previous chapter,2,3 most, if not all, 
NADP-dependent activity was abolished by the mutations. In contrast, nature achieved 
NAD cofactor utilization with NADPH KM or KH values equivalent to NADP-preferring 
KARIs, leading to lower specificities than many of our engineered KARIs.3 We also 
demonstrated in the previous chapter that NADP-preferring KARIs can have their 
specificity reversed by mutation of the ultimate and antepenultimate residues of the β2αB-
loop to aspartate in the case of the 7- or 12-residue loops, or, in the case of the 6-residue 
loop, mutation of the ultimate position to aspartate and of the second to proline. 
Interestingly, none of the naturally NAD-utilizing KARIs we found follow this recipe. 
Aspartate is present in only four out of 26 ultimate positions and one out of 21 
antepenultimate positions, although SwKARI has a glutamate at both positions. Of all 26 
sequences, only SwKARI has acidic residues at more than one of the four key positions. 
Only two of the sequences have proline at the second position, and neither of those KARIs 
has a 6-residue β2αB-loop or an aspartate at the ultimate position. These differences may 
reflect different selective pressures (e.g., specificity reversal in the engineered enzymes 
versus utilization of NAD in the natural enzymes). They could also arise from the very 
different evolutionary paths taken. 
Eight of the 26 putative NAD-utilizing KARIs possess acidic residues at the first 
position of the loop, six at the second, three at the antepenultimate position, and five at the 
ultimate position. It is interesting that the plurality of these putative NADH-utilizing 
KARIs have acidic residues the first position of the β2αB-loop. Although none of our 
previous cofactor-specificity reversals required an acidic residue at this position, Hasegawa 
et al. introduced a mutation to glutamate at this position, suggested by comparison with the 
NAD-dependent dihydrolipoamide dehydrogenases, in an attempt to reverse the cofactor 
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specificity of the C. glutamicum KARI.4 The resulting mutant enzyme was specific for 
NAD, but had less activity with NADH than the wild-type enzyme. It is also worth noting 
that all five KARIs with 6-membered β2αB-loops have an aspartate at the antepenultimate 
position, but that the structure of the KARI from Alicyclobacillus acidocaldarius,23 an 
NADP-preferring enzyme with a 6-membered β2αB-loop which will be discussed in 
Chapter 4, shows this position to be structurally homologous with the non-interacting pre-
antepenultimate position of the 7-membered loop KARIs. Thus it is unclear whether and 
how this aspartate would interact with the cofactor. Outside the β2αB-loop, the 58 putative 
NAD-utilizing KARIs have no unique conserved residues.  
All of the KARIs described here are members of the class I (short chain) KARI 
subfamily, which is believed to be evolutionarily older than the class II (long chain) KARIs 
such as E. coli KARI,17 and all originate from microbial hosts adapted to extreme 
conditions (thermophiles, acidophiles, and halophiles).30-35 Additionally, with the exception 
of the archaeote M. sedula, all hosts are anaerobes. However, adaptation to anoxic 
environments does not automatically imply the presence of an NAD-preferring KARI, as 
among the thousands of sequences there are many NADP-preferring KARIs from anaerobe 
hosts. For each of the eight characterized KARIs, we examined the three KARIs with the 
highest overall sequence identity and predicted their cofactor specificity using the sequence 
of their cofactor binding loops (Table 2-2). For six of the eight newly characterized KARIs, 
the majority of these nearest neighbors, which generally came from closely related 
organisms, have loops sequences that suggest a conventional NADP binding mode. For the 
remaining two KARIs, IaKARI and MsKARI, which are 64% identical to each other, the 
nearest neighbors have very similar sequences and were filtered out during the clustering 
step. That these eight enzymes have used differing sets of substitutions for cofactor 
utilization and that each is phylogenetically isolated from the others but close to non-
reversed sequences suggests that NAD-utilization has arisen independently in KARIs of 
several different organisms. 
In many protein families, the few characterized representatives have come from 
commonly studied mesophilic organisms. The properties of these enzymes are often 
assumed to be representative of the enzyme family as a whole. However, a rational, 
knowledge-guided search of all available sequences can uncover novel properties in more 
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distantly related organisms, many of which can be valuable tools for metabolic engineers. 
In this study, we have shown that the presence of acidic residues at conserved phosphate-
binding positions can be used to identify candidate genes encoding NAD-preferring 
proteins in the industrially important KARI enzyme family. With minor modifications, we 
expect this approach to be useful in finding enzymes with differing cofactor requirements 
in other oxidoreductase families. 
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Figure 2-1. The distribution of amino acids at each position of the β2αB-loop and flanking 
structures, as aligned by MAFFT. Gaps show positions that have amino acids in only a 
small number of the 3,383 sequences considered. The β2-sheet and αB-helix are indicated. 
Red arrows indicate the positions known to interact with the NADP phosphate in published 
crystal structures. The green asterisk marks the residue present in the 7-residue-loop KARIs 
but absent in the 6-residue loops. The blue asterisk shows the residues present in the 12-
residue loop but absent in the 7- and 6-residue loops. Logo was made using Berkeley 
WebLogo.36 
 
Figure 2-2. The structure of the cofactor-binding site of Slackia exigua KARI with bound 
NADPH (PDB 4KQW3), showing the canonical NADP-binding motif of four key residues. 
The S. exigua KARI sequence is close to the consensus sequence. 
  
39 
 
Figure 2-3. An alignment of the 26 KARI sequences identified as putatively NAD-
utilizing, as compared to the consensus sequence of 3,383 KARIs (top). Sequences shown 
in bold and with asterisks were experimentally characterized; blue indicates a bispecific 
KARI and red a NAD-preferring KARI. For each KARI, the UniProt identifier is shown 
along with the host name. The secondary structural elements are shown at top, along with 
the four key positions for phosphate binding (red arrows). Some of the sequences have been 
manually realigned. 
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Table 2-1. Biochemical characterization of bispecific and naturally NAD-specific KARIs 
and comparison to wild-type E. coli KARI (EcIlvc) and engineered EcIlvc6E6 and 
EcIlvcP2D1-A1.2 
 
 
All enzymes were His6-tagged and purified prior to characterization. Enzyme activities 
were determined in 100 mM potassium phosphate pH 7 with 1 mM DTT, 200 µM NADPH 
or NADH, 2.5mM S2AL, and 10 mM MgCl2. Concentrations of the purified enzymes were 
determined using the Bradford assay. The KM or KH values for the cofactors, corresponding 
to the concentration of the half-maximum activity, were measured with appropriate 
dilutions of NADPH and NADH in the presence of saturating concentrations of substrate 
S2AL. Mutations located within the cofactor-binding pocket of EcIlvC6E6: A71S, R76D, 
S78D, and Q110V. Additional mutations in EcIlvCP2D1-A1: D146G, G185R, and K433E. For 
standard errors and Hill coefficients, refer to Table S2-1. n.a. = not active. 
  
Enzyme KM or KH (µM)  kcat (s-1)  kcat/KM or KH (mM-1 s-1) Ratio 
NADH NADPH  NADH NADPH  NADH NADPH 
EcIlvc 1075 41  0.3 3.6  0.3 88 0.0003 
EcIlvc6E6 30 650  2.3 0.20  74 0.40 185 
EcIlvcP2D1-A1 26 > 1400  4.3 0.54  165 < 0.4 > 412 
HsKARI 39 46  0.12 0.12  3.2 2.7 1.2 
IaKARI < 1 < 1  0.02 0.03  > 20 > 25 ~ 0.8 
MsKARI 24 31  0.06 0.07  2.5 2.1 1.2 
SwKARI 57 44  0.28 0.22  5.0 5.0 1.0 
AfKARI 5 26  0.1 0.04  20 1.5 13 
DoKARI 32 n.a.  0.25 n.a.  8.0 n.a. - 
TpKARI < 1 40  0.46 0.25  460 6.0 7.4 
UaKARI 1.1 38  0.22 0.05  200 1.3 152 
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Table 2-2 
Nearest neighbors of the eight KARIs characterized in this work. Results are limited to the 
top three hits, and the cofactor binding loop and predicted cofactor specificity are shown. 
KARI 
(β2αb-loop sequence) 
% 
ID Organism 
Oxygen 
requirementsa 
β2αb-loop 
sequence 
Predicted 
cofactor 
specificity 
DoKARI 
(QLEGDAY) 
86 
80 
78 
Uncultured Desulfobacterium 
Desulfococcus multivorans 
Desulfatibacillum alkenivorans 
Anaerobic 
Anaerobic 
Anaerobic 
QMEGDAY 
QREGGAS 
QRDGGKS 
NADH 
NADPH 
NADPH 
SwKARI 
(LRKPFDEASEKE) 
73 
72 
71 
Syntrophothermus lipocalidus 
Desulfitobacterium dehalogenans 
Syntrophobotulus glycolicus 
Anaerobic 
Anaerobic 
Anaerobic 
LRKPEDDFTTAE 
LRADSRR 
LRKDSSR 
Bispecific 
NADPH 
NADPH 
AfKARI 
(LPEWDKAT) 
77 
77 
76 
Archaeoglobus veneficus 
Archaeoglobus profundus 
Archaeoglobus sulfaticallidus 
Anaerobic 
Anaerobic 
Anaerobic 
LYKGSRS 
LYKGSKS 
DKKGTRN 
NADPH 
NADPH 
unclear 
TpKARI 
(DIPSSEN) 
72 
72 
71 
Caldicellulosiruptor saccharolyticus 
Caldicellulosiruptor hydrothermalis 
Caldicellulosiruptor obsidiansis 
Anaerobic 
Anaerobic 
Anaerobic 
LYHGSKS 
LYHGSKS 
LYQGSKS 
NADPH 
NADPH 
NADPH 
UaKARI 
(ETEILGGNKNPS) 
98 
64 
52 
Uncultured archaeon 
Akkermansia muciniphila 
Paenibacillus lactis 
Anaerobic 
Anaerobic 
Facul. anaerobic 
ETEILGGNKNPS 
VRPGKS 
LREGKS 
NADH 
NADPH 
NADPH 
IaKARI 
(LERQGDS) 
73 
73 
69 
Sulfolobus solfataricus 
Sulfolobus islandicus 
Acidianus hospitalis 
Facul. anaerobic 
Facul. anaerobic 
Aerobic 
LEREGKS 
LEREGKS 
LEREGNS 
Bispecific 
Bispecific 
Bispecific 
MsKARI 
(LEREGKS) 
90 
88 
80 
Metallosphaera cuprina 
Metallosphaera yellowstonensis 
Acidianus hospitalis 
Aerobic 
Aerobic 
Aerobic 
LEREGKS 
LEREGKS 
LEREGNS 
Bispecific 
Bispecific 
Bispecific 
HsKARI 
(LDDKSPH) 
79 
77 
77 
Thermocrinis albus 
Hydrogenobacter thermophilus 
Hydrogenivirga sp. 
Microaerophilic 
Aerobic 
Microaerophilic 
LPAGSKS 
LPEGSKS 
LHEKSRS 
NADPH 
NADPH 
NADPH 
% ID: percent identity of the nearest neighbor to its respective KARI. 
aOxygen requirements of the host organism were obtained from various microbiological 
databases. 
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C h a p t e r  3  
DISCOVERY OF AN NAD-PREFERRING XYLOSE REDUCTASE 
Abstract 
The inherent cofactor imbalance in the xylose uptake pathway has made D-xylose reductase 
a prime target of cofactor specificity engineering. In the previous chapter we demonstrated 
that an understanding of the structure-function relationship in the NADP cofactor 
specificity-determining loop of ketol-acid reductoisomerases enabled discovery of rare 
homologs that prefer NAD. Here we used this knowledge-based approach to identify a 
naturally-occurring NAD-dependent xylose reductase, which is of interest for engineering 
xylose metabolism and efficient microbial utilization of plant biomass. 
Introduction 
Enzymes that catalyze oxidation and reduction reactions primarily use 
nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide 
phosphate (NADP) to transport and store hydride reducing equivalents. Though the 
chemically active nicotinamide group is the same in both molecules, phosphorylation of the 
adenine ribose moiety allows enzymes to distinguish between the two pools of reducing 
equivalents, which is valuable for regulation of metabolism and partitioning of pathways. 
Rectifying imbalances in the production and depletion of these cofactors, however, 
can be a significant hurdle in the engineering of metabolic pathways. This has led to a 
significant body of protein engineering work focused on adjusting the cofactor utilization of 
enzymes to the reducing equivalents available within the cell. Engineering is required when 
the natural homologs of the target enzyme all have the same cofactor preference, as is 
widely believed to be the case for many important enzyme classes. In the previous chapter, 
we used knowledge gained from enzyme structural and engineering studies, to uncover 
naturally NAD-utilizing ketol-acid reductoisomerases (KARIs, EC 1.1.1.86), an enzyme 
class previously believed to be uniformly NADP-preferring.1 To do this, we identified the 
residues involved in binding the NADP phosphate based on the structures of enzymes 
representing each of three recurrent motifs. Because acidic residues are enriched in the 
adenine ribose-binding pockets of natural NAD-binding proteins and depleted in those of 
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natural NADP-binding proteins, and because nearly all engineered NADP-to-NAD cofactor 
specificity switches have involved the addition of acidic residues, we looked for natural 
sequences having acidic residues at the positions normally used for phosphate binding. Of 
58 such KARIs identified, we experimentally characterized eight, all of which used NAD 
as well as or better than NADP. 
The enzyme D-xylose reductase (EC 1.1.1.307, XR) has received more attention 
than any other enzyme as a target for switching cofactor preference. XR catalyzes the first 
step in the isomerization of xylose to xylulose, which is required for the entry of the sugar 
into metabolism. However, this isomerization pathway represents a major bottleneck in 
engineered xylose utilization because XR prefers NADP whereas the next enzyme, xylitol 
dehydrogenase (XDH), has a strict preference for NAD (Figure 3-1a). This was recognized 
as a problem as early as 1983,2 and many efforts have focused on reversing the cofactor 
specificity of one of the enzymes in order to produce a cofactor-closed loop, where each 
enzyme regenerates the cofactor required by the other.3-21 These engineering efforts were 
universally motivated by the belief that “using known natural enzymes, the assembly of a 
chimeric pathway in which XR and XDH show exactly comparable utilization of 
NADP(H) and NAD(H) appears to be currently out of reach.”16 Only one naturally NAD-
preferring XR, from Candida parapsilosis, discovered by screening of fungal strains for 
xylitol production, has been reported.22,23 To our knowledge, however, this XR has not been 
used in metabolic engineering, highlighting the need for more candidate NAD-utilizing 
enzymes. Because XRs can come from a diverse assortment of organisms, experimental 
screening poses significant challenges. The structure-based approach we developed for the 
KARI enzymes, however, can easily evaluate sequences from a broad range of organisms 
and identify candidates for experimental verification. 
Materials and Methods 
Genes encoding the selected XRs were codon-optimized for E. coli expression 
using GeneDesigner software (DNA 2.0) or the IDT Codon Optimization Tool (Integrated 
DNA Technologies) and synthesized as gBlocks (Integrated DNA Technologies). Each was 
inserted into a pET22b(+) vector using standard Gibson ligation and the resulting plasmids 
were used to transform BL-21(DE3) E. coli. Initial characterization of these putative XRs 
was performed in lysate. 
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For characterization, at least four 700 µL Luria Broth cultures in 96-well blocks 
were inoculated with saturated overnight culture and grown at 37 °C for 3 hours before 
induction with IPTG to a final concentration of 500 µM. After inoculation, the cultures 
were held at 20 °C for 24 hours prior to centrifugal harvesting. The cell pellets were frozen 
at -20 °C until assayed. After thawing, the cell pellets were resuspended in 200 µL of a 
buffer containing 50 mM sodium phosphate pH 7.0, 750mg/L hen egg white lysozyme, and 
10mg/L DNase I. XR activity was assayed by monitoring the depletion of NAD(P)H using 
A340 on a Tecan plate reader. The assay buffer contained 400 mM D-xylose (Alfa Aesar) 
and 300 µM NADH (Sigma Aldrich) or NADPH (Codexis).  
For expression, 500 mL of Terrific Broth medium was inoculated with 2 mL of 
saturated overnight culture and grown at 37 °C for four hours before expression and harvest 
as before. After thawing, the cell pellet was resuspended in 25 mL of a buffer containing 20 
mM Tris, 100 mM NaCl, and 20 mM imidazole and lysed by sonication. The lysate was 
clarified on the centrifuge, and MbmXR was purified from the supernatant using an ÄKTA 
FPLC (GE Healthcare) and a His-Trap column (GE Healthcare). The protein was buffer-
exchanged twice into half a volume of 20 mM Tris buffer pH 7 using an Centricon filter 
(Amicon), with a final yield of approximately 0.9 mg protein/mL culture. XR activity was 
assayed by monitoring the depletion of NAD(P)H using A340 on a Tecan plate reader. For 
determining cofactor KM values, where low concentrations could not be measured using 
absorbance, the fluorescence of the reduced nicotinamide was used, exciting at 340 nm and 
measuring emission at 440 nm, as described.1 
Results and Discussion 
Compared to the highly diverse KARI family, the key phosphate-binding loop of 
xylose reductase is more conserved, with no major deviations in length (Figure 3-1b). As 
exemplified by the extensively studied XR of Candida tenuis (Figure 3-1c), four largely 
conserved residues determine specificity for NADP. From an initial set of 721 XR enzymes 
downloaded from UniProt and aligned with Clustal Omega,24 we searched for sequences 
possessing acidic residues at these positions, finding five (Figure 3-1d). Because three 
shared the same four cofactor binding residues (differing only by an N6D substitution 
relative to the consensus sequence), we selected only one (BspXR) for experimental 
characterization. We also selected the two unique sequences, MbmXR and RmcXR. For 
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comparison, we also expressed three previously-characterized XRs, the highly NADP-
preferring TemXR,19 the “bispecific” CteXR,25 and the one XR known to be NAD-specific, 
CpaXR.23 
Of the new enzymes tested, only MbmXR shows faster consumption of NADH 
than of NADPH (Table 3-1). The other enzymes, BspXR and RmcXR, are more active with 
NADP, despite having acidic amino acids at the putative specificity-determining positions. 
The MbmXR enzyme has the N6D substitution (numbered based on the alignment in 
Figure 3-1b) common to three of the others, but also possesses an R10M substitution that 
eliminates two potential hydrogen bonds to the NADP phosphate. This R10M substitution 
seems to be particularly important to specificity because BspXR, which lacks it, shows a 
clear preference for NADP. Additionally, RmcXR, which also is two substitutions away 
from the consensus sequence (Figure 3-1d) but still possesses R10, is bispecific with a 
preference for NADP. However, all of the prior attempts to engineer xylose reductases have 
focused on the positions corresponding to K4 and N6; only Liang and coworkers included 
the R10 position in their protein engineering strategy.13 Their resulting XR (with R10F) had 
the greatest specificity towards NADH of any engineered XR, albeit with poor catalytic 
efficiency. Out of 134 XRs for which the homologous position can be identified, 81% have 
R and only MbmXR has M. However, 9.7% have other hydrophobic amino acids. 
We scaled up the expression of MbmXR and purified the enzyme for further 
studies. As was observed in lysate, MbmXR has a pronounced preference for NAD over 
NADP, with a ratio of kcat/KM(NADH) to kcat/KM(NADPH) of approximately 4.6 (Table 3-
2). This distinction comes entirely from a difference in KM, as the kcat values are similar for 
both cofactors. The xylose KM is approximately 400 mM, which is higher than that reported 
for other XRs.6,13,19-21 However, the catalytic efficiency of MbmXR towards NAD exceeds 
by an order of magnitude that of any engineered NAD-preferring XR (Table 3-3) for which 
data are available. 
The catalytic efficiency of MbmXR towards NAD is roughly equivalent to that of 
the NAD-dependent CpaXR;23 however, its specificity for NAD is less. Interestingly, 
CpaXR is not predicted to be NAD-utilizing by our approach because it lacks negatively-
charged amino acids in the structurally relevant positions. Instead, it has only a single, 
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relatively conservative K4R substitution from consensus. This mutation has come up in 
multiple efforts to engineer specificity,5,20 but in a crystal structure of the mutant CteXR 
enzyme the residue points away from the cofactor, with no clear structural role in 
conferring specificity.6 
In a previous study, Wilson and co-workers attempted to predict naturally NAD-
preferring members of the aldo-keto reductase (AKR) enzyme superfamily, which contains 
XR.26 In that study, they hypothesize that a glutamate residue on a helix near the cofactor is 
responsible for the bispecificity of CteXR based on structures of that protein bound to both 
cofactors.25 On this basis, they select nine proteins for expression and discover a new NAD-
dependent methylglyoxal reductase. However, in our set of XRs, 95% have this glutamate 
residue, with an additional 4% having aspartate. Since nearly all XRs are NADP-preferring, 
this method is of negligible utility in the prediction of cofactor specificity of XRs. Clearly, 
any attempt to assign specificity to a single residue or set of residues necessarily 
oversimplifies the complicated nature of specificity determination within the dynamic and 
complex binding pockets of proteins. 
Unlike in KARIs, where 58 putative NAD-utilizing homologs could be identified, 
we were only able to find one bispecific XR and one NAD-utilizing XR in this set of 721. 
This may be due to the smaller number of sequences available for search (about 10-fold 
fewer), but is more likely due to the related issue of phylogenetic distribution. KARIs are 
present in plants, bacteria, archaea, and fungi, while XR is known only in fungi. Therefore, 
XRs may not have had sufficient opportunities to evolve NAD utilization, as we postulated 
occurred multiple times in KARIs. Furthermore, the NAD-utilizing KARIs primarily came 
from organisms under heightened selective pressures,1 i.e., extremophiles, which are rare 
among fungi. Marssonina brunnea, in particular, is neither; instead it is a fungus which 
specifically infects the leaves of poplar trees and is the causative pathogen of the 
Marssonina leaf spot disease.27 It is unclear what selective advantage, if any, NAD-
dependent xylose reduction has in this context. Nevertheless, MbmXR serves as a useful 
demonstration of the fact that the diversity of nature can often provide engineers with 
access to useful enzyme properties, and that a proper understanding of the sequence-
structure-function relationships obtained with the help of protein engineering can be used to 
uncover them.  
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Figure 3-1. The two-step enzymatic conversion of xylose to xylulose by xylose reductase 
(XR) and xylitol dehydrogenase (XDH) (a), showing an imbalance of cofactor utilization. 
The amino acid distribution in and around the cofactor specificity-determining loop of an 
alignment of 724 xylose reductases (b). Orange bars indicate the phosphate-binding amino 
acids. The phosphate binding mode of CteXR (c), showing the four canonical interactions 
with the phosphate, from PDB 1K8C.28 An alignment of the sequences of the cofactor 
specificity-determining loops of the xylose reductases discussed in this study (d). Asterisks 
mark enzymes experimentally characterized. UniProt accession codes are provided for 
each. Phosphate-binding amino acids (or homologous positions) are shown in orange; 
deviations from conserved consensus residues are highlighted with grey. 
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Table 3-1. Relative cofactor consumption rates by xylose reductases, as measured in E. coli 
lysate. 
 MbmXR BspXR RmcXR CpaXR TemXR CteXR 
NADH consumption rate 
as percent of NADPH 
consumption rate 
227  ± 18% 14  ± 5 % 82  ± 6 % 186  ± 10% 5  ± 4 % 93  ± 31 % 
 
 
 
Table 3-2. Kinetic parameters for purified MbmXR.  
kcat (s-1) 
[NADH] 
KM (µM) 
[NADH] 
kcat / KM 
(s-1 mM-1) 
[NADH] 
kcat (s-1) 
[NADPH] 
KM (µM) 
[NADPH] 
kcat / KM 
(s-1 mM-1) 
[NADPH] 
KM (mM) 
D-xylose 
575 ± 26 49 ± 18 11800 ± 4080 648 ± 49 253 ± 90 2560 ± 926 402 ± 60 
 
 
 
Table 3-3. Catalytic efficiency of MbmXR compared to engineered NAD-
preferring XRs and their wild type sources (WT). NADP-preferring engineered 
enzymes are not shown, nor are enzymes where Michaelis-Menten kinetics are not 
available.  
 kcat / KM (s-1 mM-1) [NADH] 
kcat / KM 
(s-1 mM-1) [NADPH] 
Ratio 
(NADH / 
NADPH) 
Citation 
CteXR 
WT 289 4330 0.07 (Petschacher 
et al., 2005)6 CteXR 
K274R/N276D 293 234 1.25 
PstXR 
WT 654 1340 0.49 (Zeng et al., 
2009)21 PstXR 
K21A/N276D 1270 N/A N/A 
PstXR 
WT 1460 4650 0.31 
(Liang et al., 
2007)13 
PstXR 
K270S/S271G/N272P/R276F 82 6 13.24 
PstXR 
K270R/N272D 313 107 2.93 
MbmXR 
WT 11800 2560 4.61 This study 
N/A = Not available. 
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reductoisomerases 
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evolutionary history of ketol-acid reductoisomerases 
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C h a p t e r  4  
COFACTOR SPECIFICITY MOTIFS AND THE INDUCED FIT MECHANISM IN 
CLASS I KETOL-ACID REDUCTOISOMERASES 
Material from this chapter appears in Cahn J. K. B., Brinkmann-Chen S., 
Spatzal T., Wiig J. A., Buller A. R., Einsle O., Hu Y., Ribbe M. W., 
Arnold F. H. (2015). Cofactor specificity motifs and the induced fit 
mechanism in class I ketol-acid reductoisomerases, Biochemical 
Journal 468(3), 475-484, and is reprinted by permission from Portland 
Press.  
Abstract 
Although most sequenced members of the industrially important ketol-acid 
reductoisomerase (KARI) family are class I enzymes, structural studies to date have 
focused primarily on the class II KARIs, which arose through domain duplication. In the 
present study, we present five new crystal structures of class I KARIs. These include the 
first structure of a KARI with a six-residue β2αB- (cofactor specificity determining) loop 
and an NADP phosphate-binding geometry distinct from that of the seven- and 12-residue 
loops. We also present the first structures of naturally occurring KARIs that utilize NAD as 
their preferred cofactor. These results show insertions in the specificity loops that 
confounded previous attempts to classify them according to loop length. Lastly, we explore 
the conformational changes that occur in class I KARIs upon binding of cofactor and metal 
ions. The class I KARI structures indicate that the active sites close upon binding NAD(P), 
similar to what is observed in the class II KARIs of rice and spinach and different from the 
opening of the active site observed in the class II KARI of Escherichia coli. This 
conformational change involves a decrease in the bending of the helix that runs between the 
domains and a rearrangement of the nicotinamide-binding site. 
Introduction 
The bifunctional enzyme ketol-acid reductoisomerase (KARI, EC 1.1.1.86, also 
known as acetohydroxyacid isomeroreductase (AHIR or AHAIR)) catalyses the second 
step in the biosynthesis of the branched-chain amino acids (BCAAs) valine, leucine and 
isoleucine.1 The enzyme converts 2-(S)-acetolactate (2SAL) into (R)-dihydroxyisovalerate 
  
57 
(RDHIV) in an ordered two-step reaction, wherein an Mg2+-dependent alkyl migration is 
followed by reduction using a hydride from NAD(P) (Figure 4-1a).1 This unusual reaction 
has inspired much work to characterize the order of binding, metal ion requirements, and 
NAD(P) specificity.1-7 
Because animals lack the BCAA pathway, there is a sizable market for these amino 
acids produced in microorganisms for human and animal dietary supplements8-11 and 
inhibitors of KARIs such as N-hydroxy-N-isopropyloxamate (IpOHA) are an active area of 
research as potential herbicides and antibiotics.12-16 Beyond this, the BCAA pathway has 
been re-engineered in microbes for production of isobutanol, a promising second-
generation biofuel and chemical feedstock.17 
KARIs are divided into two classes based on their length and oligomerization state 
(see Figure 5-1). Class I KARIs include all fungal KARIs and are ∼340 amino acid residues 
in length. Class II KARIs include all plant KARIs and are ∼490 residues long. Bacterial 
KARIs can be either class I or class II.18 KARIs are composed of two types of domains: an 
N-terminal Rossmann domain and one or two C-terminal knotted domains. Two 
intertwined knotted domains are required for function, and in the short-chain or class I 
KARIs, each polypeptide chain has one knotted domain. As a result, dimerization of two 
monomers forms two complete KARI active sites (Figure 4-2). In the long-chain or class II 
KARIs, a duplication of the knotted domain has occurred and, as a result, the protein does 
not require dimerization to complete its active site. As first proposed by Ahn et al.,18 this 
domain duplication suggests that class II KARIs evolved from a primordial class I KARI. 
This pair of knotted domains is extensively intertwined to form a figure-of-eight knot. 
Dimerization of the class I KARIs also forms this knot, albeit with an additional 
disconnection due to being composed of two chains. The class II KARI from spinach was 
the first deeply knotted protein identified19 and remains the most deeply embedded knot 
observed in a protein crystal structure.20 
Class I and class II KARIs are also distinguished by the length of the Rossmann 
fold's β2αB-loop, which binds the adenine ribose of NAD(P) and has been shown to be the 
primary determinant of whether an enzyme prefers NAD or NADP.2,21 From a set of 558 
class II KARI sequences downloaded from Pfam,22 all but 20 have a 12-residue β2αB-loop. 
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In contrast, only five of 2,860 class I KARIs do. Class I KARIs instead favor six- and 
seven-residue loops (Table 4-1). Prior to the present study, no KARI from the significant 
proportion of class I homologues having a six-residue β2αB-loop had been crystallized, nor 
had any of the class I KARIs with 12-residue β2αB-loops. This loop, which we term the 
‘specificity loop’, was the target of our efforts to engineer  and predict the cofactor 
specificity of KARIs in Chapters 1 and 2.21,23 The lack of crystal structures for KARIs 
having six-residue loops, however, prevented a thorough understanding of the loop 
structure–function relationship. 
The other major gap in our knowledge of KARIs is how the class I enzymes 
change conformation upon binding the Mg2+ ions, substrate and cofactor. Two 
crystallographic studies by Guddat and co-workers on substrate-induced rearrangements of 
class II KARIs reported different mechanisms of induced fit in plant KARIs24 and 
Escherichia coli KARI.25  Though both enzymes show an ordered binding in which Mg2+ 
and NADP bind before substrate,1,26 the structural effects of binding are dramatically 
different. In the plant enzymes, the hinge between the Rossmann domain and the knotted 
domain moves freely in the apo state, an observation supported by H-D exchange mass 
spectrometry.5 Binding of Mg2+ and NADP draws the domains together, closing the active 
site and rearranges the α3+1-helix to pre-organize the enzyme for substrate binding. In 
contrast, in the bacterial enzyme the active site is closed in the apo crystal structure, but 
binding of Mg2+ and NADP opens the interface between the domains and allows the 
substrate to bind. Nothing, however, is known about the conformational changes in class I 
KARIs, which may be complicated by the dimeric nature of the protein. 
In the present study, we present five new class I KARI structures from four 
previously un-crystallized enzymes. Three of these structures give insight into the 
unexpected diversity of the specificity loop. With the other two structures, we demonstrate 
that the mechanism of induced fit in the bacterial class I KARIs we studied involves closure 
of the interdomain hinge, coupled with a rearrangement in the nicotinamide amide-binding 
portion of the active site. This behaviour is opposite to that observed in the bacterial class II 
KARI previously described by Wong et al.25 and more closely resembles the behavior of 
the plant KARIs.24 Taken together, these structures enhance our understanding of the 
structural and functional diversity of this enzyme class. 
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Figure 4-1. The two step reaction catalyzed by KARI (a). The four substrate analogues (b) 
that have been crystallized in the active sites of KARIs, including in the present study. PDB 
ligand IDs are shown in parentheses. 
 
 
Figure 4-2. The crystal structure of the IaKARIholo dimer (a) showing bound NADP and 
inhibitor (white) and Mg2+ ions (cyan). One monomer is shown in grey; the other is shown 
in green (Rossmann domain) and magenta (knotted domain). The topology of class I 
KARIs (b) is illustrated schematically with cyan helices and red β-strands in the Rossmann 
domain; the knotted domain has blue helices. Also shown is the knotted domain of the 
dimeric partner (magenta), which has been truncated for simplicity. The figure was 
constructed using TopDraw.50 
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Table 4-1. Specificity loop length and KARI classes of 3,422 unique KARIs retrieved from 
Pfam. Four additional class I KARIs had other specificity loops. Numbers in parentheses 
indicate the number of structures available before this study. 
Loop length Sources 6 7 12 
Class I Bacteria, archea, fungi 595 (0) 2260 (3) 5 (0) 
Class II Bacteria, plants 0 (0) 20 (4) 538 (2) 
 
 
Materials and Methods 
Cloning, expression, and purification of KARIs 
Cloning, expression and purification of AaKARI (Alicyclobacillus acidocaldarius), 
UaKARI (uncultured archaeon) and IaKARI (Ignisphaera aggregans) were described 
previously.2,21 AvKARI was isolated from Azotobacter vinelandii strain AvOP (ATCC 
BAA-1303). Cell growth and AvKARI purification by anion exchange and gel filtration 
chromatography were performed as published earlier.27 
Crystallization and data collection of AaKARI, UaKARI, and IaKARI 
IpOHA was prepared as described.21 High-throughput screening of crystallization 
conditions was conducted at the Beckman Molecular Observatory at the California Institute 
of Technology. For AaKARI in the presence of NADPH, the best condition was 1M 
sodium potassium tartrate, 200 mM sodium chloride, 100 mM imidazole, pH 8. For 
IaKARI in the presence of NADPH and with IpOHA as inhibitor, the best condition was a 
0.1 M Bis-Tris, pH 6, solution with 22% polyethylene glycol (PEG) monomethylether 
5000. The apo crystal of IaKARI was obtained from the same conditions, but with 200 µM 
NADH instead of NADPH. For UaKARI in the presence of NADH and with IpOHA as 
inhibitor, the best condition was a 0.1 M Bis-Tris, pH 5, solution with 20% w/v PEG 1500 
as precipitant. For cryoprotection, the crystals were soaked in a mother liquor containing 
25% glycerol prior to flash-freezing in liquid nitrogen. Diffraction data were collected 
using a Dectris Pilatus 6M detector on beamline 12-2 at the Stanford Synchrotron Radiation 
Laboratory SSRL at 100 K. Diffraction datasets were integrated with XDS28 and scaled 
using SCALA.29 
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Crystallization and data collection of AvKARI 
AvKARI was crystallized under strictly anaerobic conditions using 0.25 M NaCl, 
28% PEG 3350 and 0.1 M bis-tris, pH 5.5. Partial dehydration of the observed crystals was 
achieved by equilibrating the crystals against 40% PEG 3350 for 12 h, followed by 
subsequent flash-freezing in liquid nitrogen. Diffraction experiments were carried out at 
100 K at the Swiss-Light-Source PXI beamline X06SA (Paul-Scherrer-Institute). Data were 
integrated using iMOSFLM30 and scaled in SCALA.29 
Structure solution 
For AaKARIholo the structure of Slackia exigua KARI (SeKARIholo, PDB code 
4KQW) was used for molecular replacement with MOLREP;31 IaKARIholo and UaKARIholo 
used the structure of the DDV mutant of that enzyme (SeKARIDDV, PDB code 4KQX) and 
molecular replacement was performed using Phaser.32 For IaKARIapo, the structure of 
IaKARIholo was used for molecular replacement with Phaser; the structure was split into two 
PDB files containing the Rossmann and knotted domains, which were fit as separate 
ensembles. Molecular replacement for AvKARImet used PaKARIapo (PDB code 1NP318) for 
molecular replacement with MOLREP, with determination and refinement of iron-sites 
performed using SHELX.33 After molecular replacement, several iterations of automated 
refinement with Refmac534 (CCP4 suite35) and manual refinement in Coot36 were 
performed. 
Structure analysis 
For the whole-enzyme alignments (i.e., Figure 4-4), the alignment was performed 
using PyMOL;37 for the domain-specific alignments, LSQ superposition was performed 
using Coot.36 For analysis of helix bending, the HELANAL-Plus web server38 was used, 
with the helices of each structure assigned by STRIDE. From the first half of the α1-helix 
(i.e., before the break in helicity) the l, m, n direction cosines of the first and last i/i-3 pair 
were extracted and the angle between them was computed. 
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IaKARI thermostability determination 
T50 is defined as the temperature at which 50% of the initial activity is retained 
after 1 h incubation. Thirty-microlitre aliquots of purified enzyme were transferred to PCR 
tubes. Each tube was assigned a specific incubation temperature on the block of an 
Eppendorf Mastercycler. The measurements were conducted in duplicates. The tubes were 
incubated in their slots for 1 h and then quenched on ice. Residual activity was determined 
with the activity assay described previously.2 
Results and Discussion 
We present five crystal structures representing four class I KARIs, with resolutions 
of 1.15–2.50 Å (Table 4-2). We previously described three of these KARIs in our work on 
cofactor specificity engineering. In Chapter 1, the cofactor specificity of AaKARI from A. 
acidocaldarius was inverted by the introduction of three mutations in its specificity loop.21 
In Chapter 2, UaKARI from an uncultured organism and IaKARI from I. aggregans were 
correctly predicted to utilize NAD, based on their loop sequences.2 The fourth KARI, from 
A. vinelandii, crystallized serendipitously as an impurity of another protein purified from A. 
vinelandii lysate. Table 4-3 places these enzymes and the structures reported in the present 
study in the context of the previously available KARI structural data. For some proteins, 
including IaKARI in the present study, multiple structures are available with different 
bound cofactors, metals, and substrate analogues. Refinement statistics of the structures 
reported in the present study are provided in Table 4-2. All of these KARIs have the same 
fold as previously solved class I KARIs (Figure 4-2). Their active sites, particularly the 
metal-binding sites, are also in agreement with those of previous structures (see, e.g., Biou 
et al.39). 
Various nomenclatures have been used to discuss the structures of KARIs. In this 
thesis, we refer to the N-terminal domain as the Rossmann domain and the C-terminal 
domain as the knotted domain. The topology of the class I enzyme is shown and labelled in 
Figure 4-2b. Secondary structure elements are numbered starting from the first β-strand that 
makes up the canonical Rossmann fold; secondary structure prior to this strand is not 
conserved. In the Rossmann domain, β-strands are numbered 1–8 and α-helices are 
assigned the letters from A–G. In the knotted domain, which is entirely α-helical, helices 
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are assigned numbers from 1 to 7. Loops between secondary structural elements are named 
based on the flanking secondary structural elements, as in β2αB-loop or α3α4-loop. We 
refer to the β2αB-loop of the Rossmann domain as the specificity loop. Figure 4-3, which 
has an alignment of the KARI sequences discussed herein, is also annotated with the 
secondary structure labels used. In class I KARIs, the secondary structural elements of the 
dimeric partner are denoted with a prime as in α3′-helix. In class II KARIs, the duplicated 
elements are denoted with ‘+1’, as in α3+1-helix. Lastly, we refer to the proteins 
themselves using a two-letter code plus ‘KARI’ (i.e., AaKARI) and the structures with the 
addition of a superscript (AaKARIholo) indicating their complexation state. 
 
Table 4-2. Data collection and refinement statistics for structures presented in this chapter. 
Values in parentheses represent statistics from the highest resolution shell. 
 AaKARIholo 
4TSK 
UaKARIholo 
4XDY 
IaKARIholo 
4XDZ 
IaKARIapo 
4XEH 
AvKARImet 
4XIY 
Data Collection 
Space Group P 2 3 P 21 21 2 P 21 P 21 21 2 P 21 3 
Cell Dimensions      
    a,b,c (Å) 124.10, 124.10, 
124.10 
141.75, 148.60, 
49.70 
54.58, 90.75, 
69.53 
67.48, 112.35, 
46.07 
185.05, 185.05, 
185.05 
   α,β,γ (°) 90, 90, 90 90, 90, 90 90, 100.3, 90 90, 90, 90 90, 90, 90 
Resolution (Å) 124.10-2.50 
(2.57-2.50) 
102.57-1.54 
(1.58-1.54) 
68.42-1.15 
(1.21-1.15) 
57.85-1.39 
(1.43-1.39) 
82.76-2.50 
(2.64-2.50) 
Rp.i.m (%) 5.3 (61.8) 4.4 (49.8) 5.4 (64.3) 2.2 (107.9) 5.7 (31.3) 
Mn(I)/sd 8.9 (0.8) 11.1 (1.5) 6.9 (0.9) 13.6 (0.6) 10.9 (2.6) 
Completeness (%) 97.7 (89.1) 97.3 (71.8) 95.0 (82.4) 96.8 (76.0) 99.5 (99.9) 
Redundancy 3.4 (2.9) 4.5 (4.5) 3.0 (2.5) 3.6 (3.9) 3.5 (3.6) 
Refinement 
No. reflections 22,066 145,320 224,341 65,375 72,509 
Rwork/Rfree (%) 15.6/18.2 
(21.2/27.2) 
17.9/20.9 
(39.1/38.4) 
15.8/19.0 
(33.2/34.1) 
18.0/23.5 
(38.2/38.0) 
19.4/24.4 
(28.7/32.1) 
No. atoms      
    Protein 2,585 5,296 5,139 2,561 10,017 
    Ligand/ion 61 126 178 0 48 
    Water 46 359 595 101 40 
RMSD      
    Bond lengths (Å) 0.018 0.023 0.024 0.019 0.015 
    Bond angles (°) 1.998 2.038 2.461 1.930 1.719 
Ramachandran 
map analysis 
     
    Favored 313 653 589 309 1,194 
    Allowed 17 20 29 13 99 
    Outliers 1 0 0 0 23 
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Table 4-3. Published KARI structures (above the line) and the new ones presented below. 
Each is given a name for discussion in this paper. For each, the metals and bound ligands 
are given. Cofactor IDs are as follows: NDP = NADPH, NAP = NADP+, NAD = NAD+, 
APX = 2’-monophosphate adenosine diphosphate ribose; see Figure 4-1b for structures of 
substrate analogues. KARI class and β2αB-loop (specificity loop) length are also given for 
each enzyme. 
PDB ID Name Host Resn. 
(Å) 
Metal Cofactor Analogue Class β2αB-loop 
1YVE (39) SoKARIholo S. oleracea 1.65 2xMg2+ NDP HIO II 7 
1QMG (40) SoKARIprod S. oleracea 1.60 2xMn2+ APX DMV II 7 
1NP3 (18) PaKARIapo P. aeruginosa 2.00 -- -- -- I 7 
1YRL (49) EcKARIapo E. coli 2.60 -- -- -- II 12 
3FR7 (24) OsKARImet O. sativa 1.55 2xMg2+ -- -- II 7 
3FR8 (24) OsKARIholo O. sativa 2.80 1xMg2+ NDP -- II 7 
3ULK (25) EcKARIholo E. coli 2.30 2xMg2+ NDP -- II 12 
4KQW (21) SeKARIholo S. exigua 1.38 2xMg2+ NAP TLA I 7 
4KQX (21) SeKARIDDV S. exigua  1.80 2xMg2+ NAD HIO I 7 
4TSK AaKARIholo A. acidocaldarius 2.50 2xMg2+ NAP TLA I 6 
4XDY UaKARIholo Uncultured archaeon 1.54 2xMg2+ NAD HIO I 12 
4XDZ IaKARIholo I. aggregans 1.15 2xMg2+ NDP 40E I 7 
4XEH IaKARIapo I. aggregans 1.39 -- -- -- I 7 
4XIY AvKARImet A. vinelandii 2.50 1xMg2+, 
1xFe2+ 
-- -- I 7 
 
 
 
Figure 4-3. (next page) Sequence alignment of crystallized KARIs. Helices are colored in 
magenta and β-strands in cyan. Yellow indicates special features, labeled with the 
following abbreviations: motif = diphosphate binding motif; specific. = specificity loop; m 
= metal-binding residue; n = nicotinamide amide-binding residue; h = hinge point (when 
unambiguously definable). Metal-binding and nicotinamide amide-binding residues are 
shown only for one active site in the class I proteins. The knotted domain of the class I 
KARIs has been duplicated for clarity; duplicate residues are shown with grey text. 
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IaKARI  ----------------------AKIYKDEDI---SL-EPIKN-KTIAILGYGSQGRAWALNLRDSG------ 
UaKARI  ----------------------MEILHDEDV---DD-SILRD-KTIAVMGYGAQGDAQANCLKDSG------ 
AvKARI  ----------------------MKVYYDKDC---DL-SIIQS-KKVAIIGYGSQGHAHACNLKDSG------ 
PaKARI  ----------------------MRVFYDKDC---DL-SIIQG-KKVAIIGYGSQGHAHACNLKDSG------ 
AaKARI  -----------------------KIYYDADI---SI-QPLAD-KRIAVIGYGSQGHAHAQNLRDSG------ 
SeKARI  -----------------------TILYEQDV---DP-KVIQG-LKVGIIGYGSQGHAHALNLMDSG------ 
EcKARI  ---MANYFNTLNLRQQLAQLGKCRFMGRDEF-ADGA-SYLQG-KKVVIVGCGAQGLNQGLNMRDSG------ 
SoKARI  ATTFDFDSSVFKKEKVTLSGHDEYIVRGGRNLFPLLPDAFKGIKQIGVIGWGSQAPAQAQNLKDSLTEAKSD 
OsKARI  ---LDFDTSVFNKEKVSLAGHEEYIVRGGRNLFPLLPEAFKGIKQIGVIGWGSQGPAQAQNLRDSLAEAKSD 
Features                                              b1  motif   aA 
 
IaKARI  LNVVVGLER-----QGDSWRRAIDDGF-----KPMYTKDAVAIADIIVFLVPDMVQKSLWLNSVKDFMKKGA 
UaKARI  INVVIGETEILGGNKNPSWEKAKEDGF-----EVLPIDKAAEKGDVVHILLPDEVQPAIYENQIKPQLKAGK 
AvKARI  VDVYVGLRA-----GSASVAKAEAHGL-----TVKSVKDAVAAADVVMILTPDEFQGRLYKDEIEPNLKKGA 
PaKARI  VDVTVGLRS-----GSATVAKAEAHGL-----KVADVKTAVAAADVVMILTPDEFQGRLYKEEIEPNLKKGA 
AaKARI  FDVVIGLRP-----G-SSWAKAEADGF-----RVMAVGDAVEESDVIMILLPDERQPAVYEREIRPYLTAGK 
SeKARI  VDVRVGLRE-----GSSSWKTAEEAGL-----KVTDMDTAAEEADVIMVLVPDEIQPKVYQEHIAAHLKAGN 
EcKARI  LDISYALRKEAIAEKRASWRKATENGF-----KVGTYEELIPQADLVINLTPDKQHSDVVR-TVQPLMKDGA 
SoKARI  VVVKIGLRK-----GSNSFAEARAAGFSEENGTLGDMWETISGSDLVLLLISDSAQADNYE-KVFSHMKPNS 
OsKARI  IVVKIGLRK-----GSKSFDEARAAGFTEESGTLGDIWETVSGSDLVLLLISDAAQADNYE-KIFSHMKPNS 
Features   b2   specific.   aB           b5   aC      b4          aD 
 
IaKARI  DLVFAHGFNIHFK---IIEPPKDSDVYMIAPKSPGPIVRRSYEMG-----GGVPALVAVYQ---NVSG 
UaKARI  ALCFSHGFNICFK---RIVPPEDVDVIMVAPKAPGTEERKAYLEG-----FGVPGLVAVKQ---NPSG 
AvKARI  TLAFAHGFSIHYN---QVVPRADLDVIMIAPKAPGHTVRSEFVRG-----GGIPDLIAVYQ---DASG 
PaKARI  TLAFAHGFSIHYN---QVVPRADLDVIMIAPKAPGHTVRSEFVKG-----GGIPDLIAIYQ---DASG 
AaKARI  ALAFAHGFNIHFS---QIQPPKDVDVFMVAPKGPGHLVRRVYEAG-----GGVPALIAVHQ---DASG 
SeKARI  TLAFAHGFNIHYG---YIVPPEDVNVIMCAPKGPGHIVRRQFTEG-----SGVPDLACVQQ---DATG 
EcKARI  ALGYSHGFNIVEV---GEQIRKDITVVMVAPKCPGTEVREEYKRG-----FGVPTLIAVH-PENDPKG 
SoKARI  ILGLSHGFLLGHLQSLGQDFPKNISVIAVCPKGMGPSVRRLYVQGKEVNGAGINSSFAVHQ---DVDG 
OsKARI  ILGLSHGFLLGHLQSAGLDFPKNISVIAVCPKGMGPSVRRLYVQGKEINGAGINSSFAVHQ---DVDG 
Features b5  m  aE                 b6  m  n   aF                b7 
 
IaKARI  EALQKALAIAKGIGCARAGVIESTFKEETETDLFGEQVILVGGIMELIKASFETLVEEGY 
UaKARI  EAREVALAMTKAMHWTKAGILECTFEQETYEDLFGEQCVLCGGLVELMRNGFEVLVEAGY 
AvKARI  NAKNLALSYACGVGGGRTGIIETTFKDETETDLFGEQAVLCGGCVELVKAGFETLVEAGY 
PaKARI  NAKNVALSYACGVGGGRTGIIETTFKDETETDLFGEQAVLCGGCVELVKAGFETLVEAGY 
AaKARI  QAKDLALAYARGIGAGRAGILTTTFREETETDLFGEQAVLCGGLSALIKAGFETLVEAGY 
SeKARI  NAWDIVLSYCWGVGGARSGIIKATFAEETEEDLFGEQAVLCGGLVELVKAGFETLTEAGY 
EcKARI  EGMAIAKAWAAATGGHRAGVLESSFVAEVKSDLMGEQTILCGMLQAGSLLCFDKLVEEGT 
SoKARI  RATDVALGWSIALGS--PFTFATTLEQEYKSDIFGERGILLGAVHGIVECLFRRYTESGM 
OsKARI  RATDVALGWSVALGS--PFTFATTLEQEYKSDIFGERGILLGAVHGIVEALFRRYTEQGM 
Features        aG          b8       h     m   a1 
 
IaKARI  QPEVAYFETVNEL-KLIVDLIYEKGLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERG 
UaKARI  PPEMAYFECVHEM-KLIVDLVWQGGIKRMAEVISNTAEYGMWAVGHQIIGPEVKEKMKEALKRVENGEFANEWVDEYKRG 
AvKARI  APEMAYFECLHEL-KLIVDLMFEGGIANMNYSISNNAEYGEYVTGPEVINEQSRQAMRNALKRIQDGEYAKMFITEGAAN 
PaKARI  APEMAYFECLHEL-KLIVDLMYEGGIANMNYSISNNAEYGEYVTGPEVINAESRAAMRNALKRIQDGEYAKMFITEGAAN 
AaKARI  QPEIAYFECLHEM-KLIVDLIYEGGLEYMRYSISDTAQWGDFTSGPRIINEETKKEMRRILADIQSGAFAKSWILENQAN 
SeKARI  PPELAYFECYHEM-KMIVDLMYESGIHFMNYSISNTAEYGEYYAGPKVINEQSREAMKEILKRIQDGSFAQEFVDDCNNG 
EcKARI  DPAYAEKLIQFGW-ETITEALKQGGITLMMDRLSNPAKLRAYALSEQ-LKEIMAPLFQKHMDDIISGEFSSGMMADWAND 
SoKARI  SEDLAYKNTVECITGVISKTISTKGMLALYNSLSEEGKKDFQAAYSAS-YYPSMDILYECYEDVASGSEIRSVVLAGRRF 
OsKARI  DEEMAYKNTVEGITGIISKTISKKGMLEVYNSLTEEGKKEFNKAYSAS-FYPCMDILYECYEDVASGSEIRSVVLAGRRF 
Features            a2             a3                    a4                     a5 
 
IaKARI  ---MPTVFKELSELEGSTIETVGRKLREMMFRGM-----TFKEETETDLFGEQVILVGGIMELIKASFETLVEEGY 
UaKARI  ---IPFLKASREKMGEHQVETVGAEIRKLFAQHH-----TFEQETYEDLFGEQCVLCGGLVELMRNGFEVLVEAGY 
AvKARI  ---YPSMTAYRRNNAAHQIEVVGEKLRTMMPWIA-----TFKDETETDLFGEQAVLCGGCVELVKAGFETLVEAGY 
PaKARI  ---YPSMTAYRRNNAAHPIEQIGEKLRAMMPWI------TFKDETETDLFGEQAVLCGGCVELVKAGFETLVEAGY 
AaKARI  ---RPMFNAINRREIEHPIEVVGRKLRSMMPFKAKRPGDTFREETETDLFGEQAVLCGGLSALIKAGFETLVEAGY 
SeKARI  ---HKRLLEQREAINTHPIETTGAQIRSMFSWI------TFAEETEEDLFGEQAVLCGGLVELVKAGFETLTEAGY 
EcKARI  ---DKKLLTWREETGKTAFETAPQYEGKI---------------GEQEYFDKGVLMIAMVKAGVELAFETMVDSGI 
SoKARI  YEKEGLPAFPMGKIDQTRMWKVGEKVRSVRPAGDLGPL--------------YPFTAGVYVALMMAQIEILRKKGH 
OsKARI  YEKEGLPAFPMGNIDQTRMWKVGEKVRSTRPENDLGPL--------------HPFTAGVYVALMMAQIEVLRKKGH 
Features        a6             a7                    h          a1+1 
 
IaKARI  QPEVAYFETVNEL-KLIVDLIYEK-GLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRS 
UaKARI  PPEMAYFECVHEM-KLIVDLVWQG-GIKRMAEVISNTAEYGMWAVGHQIIGPEVKEKMKEALKRVEN 
AvKARI  APEMAYFECLHEL-KLIVDLMFEG-GIANMNYSISNNAEYGEYVTGPEVINEQSRQAMRNALKRIQD 
PaKARI  APEMAYFECLHEL-KLIVDLMYEG-GIANMNYSISNNAEYGEYVTGPEVINAESRAAMRNALKRIQD 
AaKARI  QPEIAYFECLHEM-KLIVDLIYEG-GLEYMRYSISDTAQWGDFTSGPRIINEETKKEMRRILADIQS 
SeKARI  PPELAYFECYHEM-KMIVDLMYES-GIHFMNYSISNTAEYGEYYAGPKVINEQSREAMKEILKRIQD 
EcKARI  IEESAYYESLHELPLIANTI--ARKRLYEMNVVISDTAEYGNYLFSYACVPLLKP-FMAELQP---- 
SoKARI  SYSEIINESVIEAVDSLNPFMHAR-GVSFMVDNCSTTARLGSRKWAPRFDYILSQQALVAVDN---- 
OsKARI  SYSEIINESVIESVDSLNPFMHAR-GVAFMVDNCSTTARLGSRKWAPRFDYILTQQAFVTVDK---- 
Features       m   m a2+1          a3+1 n n          a4+1                         
 
IaKARI  GEFAREWIKEYERGMPTVFKELSELEGSTIETVGRKLREMMFRGM---------------- 
UaKARI  GEFANEWVDEYKRGIPFLKASREKMGEHQVETVGAEIRKLFAQHH---------------- 
AvKARI  GEYAKMFITEGAANYPSMTAYRRNNAAHQIEVVGEKLRTMMPWIA---------------- 
PaKARI  GEYAKMFITEGAANYPSMTAYRRNNAAHPIEQIGEKLRAMMPWI----------------- 
AaKARI  GAFAKSWILENQANRPMFNAINRREIEHPIEVVGRKLRSMMPFKAKRPGD----------- 
SeKARI  GSFAQEFVDDCNNGHKRLLEQREAINTHPIETTGAQIRSMFSWI----------------- 
EcKARI  GDLGKAIP-EGAVDNGQLRDVNEAIRSHAIEQVGKKLRGYMTDMKR-IAV----------- 
SoKARI  -------------GAPINQDLISNFLSDPVHEAIGVCAQLRPSVDISVTADADFVRPELRQA 
OsKARI  -------------DAPINQDLISNFMSDPVHGAIEVCAELRPTVDIS--------------- 
Features     a5+1           a6+1         a7+1 
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Structural diversity of the specificity loop: Structure of AaKARI’s six-residue specificity 
loop 
Until the work in Chapter 2, KARI family enzymes were believed to be exclusively 
NADP-dependent.2 Because NAD utilization is advantageous in the industrial production 
of amino acids and biofuels,21,23 engineering KARI cofactor specificity has been of 
considerable interest. Previous studies by our group aimed at reversing KARI cofactor 
specificity focused extensively on the specificity loop of the Rossmann domain due to its 
key role in binding the adenine ribose of the cofactor.2,21,23  Structures of enzymes with a 
12-residue specificity loop25 and multiple structures with seven-residue specificity 
loops21,39,40 with bound NADP were available. However, no structure of a KARI having a 
six-residue specificity loop was available, with or without NADP. In Chapter 1, we found 
that whereas similar mutations reversed the specificity of KARIs with seven- and 12-
residue specificity loops, a modified approach was required for the six-residue specificity 
loop enzymes.21 Ambiguities in the alignments of the different length of the loop sequences 
limited our ability to propose a structural model to explain the different sets of mutations 
(see the alignment in Figure 4-4). For that reason, we selected for structural analysis the 
KARI from A. acidocaldarius (AaKARI), a mildly thermophilic enzyme that was 
engineered for NAD preference in Chapter 1.21 AaKARI crystallized readily, and we 
obtained a crystal that diffracted to 2.5 Å. 
The overall structure of AaKARIholo is very similar to that of the other class I 
KARIs that have been published, with RMSDs of 0.48 and 1.56 Å against SeKARIholo and 
PaKARIapo,18,21 respectively. Figure 4-5 shows the specificity loop of AaKARIholo (part c) as 
well as other KARIs, including ones that will be discussed later in this chapter. Although 
the side chains of three residues of the seven- and 12-member specificity loops form 
hydrogen bonds to the NADP phosphate (e.g., R58, S61, and S63 in SeKARIholo), only the 
side-chains of two residues do so for the six-member specificity loop of AaKARIholo, R48 
and S52. However, the rearrangement of the loop brings the αB-helix closer to the adenine 
ring, allowing the terminal serine residue's side chain to hydrogen bond not only with the 
phosphate but also with the O2′ and O3′ of the ribose, and creating a hydrogen bond 
between the backbone N-H group of S52 and the phosphate oxygen. This interaction 
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between the phosphate and the dipole of the αB-helix has not been observed previously in a 
KARI. 
In Chapter 1, we found that reversing the cofactor specificity of KARIs having 
seven- and 12-residue specificity loops from NADP to NAD required installation of 
aspartate residues at the ultimate and antepenultimate loop positions.21 Existing structures 
showed that these two residues provide the primary hydrogen bonding interactions with the 
NADP phosphate.21,25 The six-residue specificity loops, in contrast, only required a single 
aspartate along with mutation of the arginine to proline at the second position of the loop to 
switch cofactor preference to NAD. Having obtained the first structure of a KARI with a 
six-residue specificity loop, we can now explain why. Only the ultimate residue of 
AaKARIholo's specificity loop forms a hydrogen bond with the phosphate. There is no 
residue corresponding to the interaction provided by the antepenultimate position. 
Presumably to compensate for this missing interaction, the contact between the arginine at 
the second position of the loop and the phosphate is more extensive, such that mutation of 
this residue is also critical in order to abolish phosphate binding and switch cofactor 
specificity. 
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Figure 4-4. A structure-guided alignment of the specificity loops (including four residues 
on either side) of some of the KARIs discussed in this chapter, annotated with the length of 
the loop, the class of the KARI, the kingdom of origin, and the cofactor preference. 
Residues contacting the phosphate are highlighted in orange. 
 
 
 
Figure 4-5. The β2αB-loops of SeKARIholo ((a); PDB 4KQW21), EcKARIholo ((b); PDB 
3ULK25), AaKARIholo (c), UaKARIholo (d), IaKARIholo (e) and apo (f). Polar interactions (i.e., 
hydrogen bonds) of 3.5 Å or less to the 2’ or 3’ moieties of the ribose are shown with 
dashed lines, as are selected interactions between amino acid residues. 
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Structural diversity of the specificity loop: Structure of the naturally NAD-preferring 
UaKARI 
In the past, it had been assumed that all KARIs were specific for NADP.23 
However, in Chapter 2 we showed that some native KARIs display strong preference for 
NAD or at least exhibit equal activity with NADP and NAD.2 The KARI with the greatest 
preference for NAD (in terms of catalytic efficiency, kcat/KM) came from an uncultured 
archaeon (UaKARI)2 and was also one of the only five known class I KARIs to possess a 
12-residue specificity loop (Table 4-1). However, we could not predict the arrangement of 
the residues around the NAD based on sequence alone because the loop sequence was so 
different from any previously crystallized KARI (Figure 4-4). It also did not allow us to 
effectively compare it to the recipe we proposed previously for engineering naturally 
NADP-preferring KARIs to use NAD.21 For the present study, we were able to obtain a 
crystal of UaKARI bound to NAD, which diffracted to 1.54 Å. 
UaKARIholo possesses the same overall KARI fold as other class I KARIs, with a 
0.62 Å RMSD to SeKARIholo. However, the specificity loop of UaKARIholo differs 
significantly from any other crystallized KARI (Figure 4-5d). Glu46, the first residue of the 
β2αB-loop, lies along the N3 edge of the adenine moiety and forms a bidentate interaction 
with the O2′ hydroxy of the ribose. This residue is structurally homologous to the 
conserved leucine that makes a similar interaction with the adenine in other KARIs (see 
e.g., Figures 1-2 and 2-1). The position of this glutamate is stabilized by a hydrogen bond 
interaction with N55. 
In most KARIs, an arginine in the position immediately following the conserved 
leucine forms a cation–pi interaction with the adenine and a salt bridge with the phosphate 
of the cofactor.18 In UaKARIholo, the arginine is replaced by L49, which removes the 
positive charge. Additionally, the specificity loop is extended by five residues that 
accommodate the structural differences between arginine and leucine. In E. coli KARI, 
which also has a 12-residue loop, the five additional residues form a short helix inserted 
after the arginine. In UaKARIholo, by contrast, there are three residues before Leu49 and 
two after. This leads to a reorientation of the specificity loop (Figure 4-5d). As with the 
canonical NADP-binding seven- and 12-residue specificity loops, UaKARIholo's specificity 
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loop has two additional residues that provide contacts to the (phospho-) ribose. S57 at the 
C-terminal end of the specificity loop is highly conserved and, as in AaKARIholo, forms 
hydrogen bonds with both O2′ and O3′ of the ribose. Though there is no phosphate to 
hydrogen bond to its backbone amine, this backbone nitrogen hydrogen-bonds to the side 
chain of another residue, the antepenultimate N55. The increased size of N55 over the 
consensus serine at this position allows it to make contact with O2′ rather than the absent 
phosphate and the nitrogen forms a hydrogen bond with E46, as noted above. 
The lack of a short helix within the loop suggests that the ancestral UaKARI did 
not have a canonical 12-residue specificity loop. UaKARI may have evolved from a KARI 
possessing a shorter loop. This is supported by the fact that the KARIs with the sequences 
most similar to UaKARI (other than a 98% identical one from another uncultured archaeon) 
both had six-residue specificity loops, as discussed in Chapter 2.2 
Structural diversity of the specificity loop: The unusual β2αB-loop of the bispecific IaKARI 
The I. aggregans KARI identified in Chapter 2 (IaKARI) displayed sub-
micromolar KM values for both NAD and NADP2 and measurements carried out for the 
present study confirmed that it is highly thermostable, with half-maximal residual activity 
(T50) after an hour at 95°C. We were unable to obtain a structure of IaKARI bound to NAD, 
but did succeed in cocrystallizing it with NADP and the transition state analogue N-
isopropyloxamate (Figure 4-1b). The substrate analogue's electron density indicated that it 
had been reduced at the N position (cause unknown) and a water molecule had taken the 
place of the missing -OH group (Figure 4-6). 
Because IaKARIholo has a seven-residue specificity loop, we had expected the 
second loop residue, a glutamate, to make contact with the face of the adenine ring and the 
antepenultimate and ultimate residues to bind the phosphate. Surprisingly, the binding 
mode for NADP closely resembles that of the six-residue loop from AaKARIholo, with a 
single serine residue at the ultimate position of the loop hydrogen bonding with both the 
O3′ hydroxy and the phosphate (Figure 4-5e). Furthermore, the glutamate at the second 
position of the loop faces away from the cofactor entirely, whereas the arginine at the third 
position forms the typical packing interaction against the adenine ring. Without an NAD 
co-crystal structure, it is difficult to speculate what functional role this glutamate serves or 
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how it contributes to the enzyme's cofactor bispecificity. However, it is possible that a 
rearrangement of the loop might allow it to occupy the position of either of the conserved 
residues flanking it. Such rearrangements of adenosine ribose-binding loops have been 
observed in bispecific glucose-6-phosphate dehydrogenase,41 xylose reductase,42 
glyceraldehyde-3-phosphate dehydrogenase,43 and coenzyme A-disulfide reductase.44 
It is interesting that both the naturally NAD-utilizing KARIs, UaKARI and 
IaKARI, had amino acid insertions relative to other structurally similar enzymes. Insertions 
and deletions in genes represent a major source of sequence and function variation in 
natural evolution,45,46 but are rarely used in protein engineering and directed evolution. In 
the guide proposed in Chapter 1, classifying the binding mode based on the length of the 
specificity loop was the first step to identifying a protein engineering strategy for 
engineering KARI cofactor specificity.21 These results, however, demonstrate that loop 
length may be an insufficient indicator of binding geometry. 
 
 
Figure 4-6. Electron density around the substrate of IaKARIholo indicates the 
dehydroxylation of IpoHA. Left: modeled with N-isopropyloxamate (ligand 40E). Right: 
modeled with N-hydroxy-N-isopropyloxamate (IpoHA; ligand HIO). The Fo-Fc map (red 
and green) clearly shows the absence of the N-hydroxy moiety. (2Fo-Fc map contoured to 
1.5σ, Fo-Fc map contoured to 4σ.) 
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Conformational changes in class I KARIs: Induced fit in IaKARI 
The IaKARI structures with and without bound metals or ligands allowed us to 
observe the changes in the protein structure upon the binding of NADP, metals, and N-
isopropyloxamate. As in the plant and the E. coli class II KARIs, the two domains of 
IaKARI undergo a rigid body movement, where only the angle between them changes 
significantly. With metals, cofactor, and inhibitor bound, the Rossmann domains have 
moved closer together, sealing off the active sites and generating a ‘closed’ state. Either 
domain of the ligand-bound protein can be superimposed on its respective apo-protein 
domain, but the full structures do not superimpose. Figure 4-7 shows a plot of the Cα-Cα 
distances along the length of the chain for IaKARIholo and IaKARIapo, aligned by Rossmann 
domain (blue) or knotted domain (red). With either alignment a distinct jump in the Cα-Cα 
distances indicates a ‘hinge point’ at E189. E189 is on the α1-helix of the knotted domain 
rather than the β8α1-loop between the domains, which stays rigid with respect to the N-
terminal domain. In the ligand-bound structure, the α1-helix is less bent, with an angle of 
4.7° compared with 8.7° in the apo structure, as measured using HELANAL-Plus.38 Figure 
4-8 shows this movement structurally (a and b) and quantitatively (c) for IaKARI as well as 
other structure pairs to be discussed later. However, there is no significant rearrangement in 
the helix to explain this change in curvature. The changes are subtle and cumulative at the 
various backbone positions. Only a handful of residues in the protein change rotamer state 
between the two crystals, most notably H108, K131, D191, and E195, all of which are 
involved in the binding of the two Mg2+ ions. Similarly, R49 and R56, which are involved 
in binding the NADP cofactor, reorient slightly. 
Three regions have notably non-rigid-body behaviour: the N-terminus of the αA-
helix (including the latter half of the Rossmann-identifying GXGXXG motif47), the β6αF-
loop, and the N-terminus of the αF-helix and the α3α4-loop. Indeed, in the ligand-bound 
structure, the αA-helix and β6αF-loop interact with the α3-helix not of their own chain but 
of their dimeric partner. This interaction makes up the opposite side of the active site from 
the D191/E95/α1 face closer to the hinge. A rearrangement of the α3+1-helix was 
previously identified in the plant KARIs and was thought to be involved in binding IpOHA 
and ‘capping’ the active site.24 In the IaKARIapo structure, a combination of this 
rearrangement and an increase in the α1-helix curvature means that the interaction between 
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these regions is absent. The distance between the α-carbons of G134 (on the αF-helix) and 
A250' (on the dimeric partner's α3-helix) goes from 11.8 Å in the apo structure to 6.6 Å in 
the ligand-bound structure. 
Critically, this closure is centred around the nicotinamide moiety of NADP, in 
particular the C7N amide. As shown schematically in Figure 4-9a, the side chain of Q28 
hydrogen bonds to the backbone amine of G134 in the absence of the cofactor. With 
cofactor bound, the terminal amide is inserted into this gap, with O7N hydrogen bonding to 
the backbone amine of G134 and Q28 flipped out of the way. The N7N nitrogen of the 
amide recruits the α3′-helix, specifically the backbone carbonyl of A250', as well as the 
side chain of S27. S27 hydrogen bonds to the cofactor, G134 and A250', holding the 
complex together and ‘capping’ the active site. Figure 4-10 shows this motion in the 
structure.  
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Figure 4-7. Cα-Cα distances for residues of IaKARIholo aligned against IaKARIapo. Because 
of the rigid body movement of the interdomain hinge, the Rossmann (blue) and knotted 
(red) domains have been aligned separately. The non-aligned domains are shown in a 
lighter color. Points of interest are numbered as follows: (1) αA-loop, (2) specificity loop, 
(3) β6αF-loop, (4) hinge, (5) α3-helix. 
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Figure 4-8. Bending of α1-helix is responsible for induced fit. An alignment (a) between 
the apo and holo dimers of IaKARI. The structures are aligned based on their rightmost 
Rossmann domains. The apo structure is shown in green and cyan and the holo structure is 
shown in magenta and tan. The Rossmann domains and α1-helices (b) of the apo (green) 
and holo (magenta) crystals of IaKARI, showing the change in the bend of the first half of 
the α1-helix. Quantitative analysis of the bending of the first half of the α1-helix (c). Error 
bars show the standard deviation of the values for multiple chains in the asymmetric unit of 
the crystal. Bars are denoted with an ‘O’ or a ‘C’ to designate open and closed states of the 
active site, as assigned visually. EcKARI is a clear outlier, both because it goes from a 
closed to open state upon binding cofactor and because there is no corresponding change in 
the α1-helix bending.  
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Figure 4-9. Hydrogen bond rearrangements around the nicotinamide amide. Hydrogen 
bonds involved in the recruitment of the α3′α4′-loop upon cofactor binding in (a) IaKARIapo 
and IaKARIholo, and (b) AvKARImet and SeKARIholo. R=adenosine diphosphate ribose 
phosphate. 
 
 
Figure 4-10. Structural rearrangements around the NADP nicotinamide in IaKARI. 
Binding of the nicotinamide of NADP (magenta) to the αA-helix and the β6αF-loop recruits 
the α3-helix of the other chain of the dimer (cyan). 
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Conformational changes in class I KARIs: Induced fit in other class I KARIs 
From this pair of structures, it was unclear to what extent the gross conformational 
change was driven by the smaller-scale rearrangements related to metal binding, cofactor 
binding, or some combination thereof. However, we were also able to obtain a structure of 
another KARI, from A. vinelandii, with metal ions (Mg2+ and Fe2+) bound in the active site, 
but without a cofactor or a substrate analogue. Because AvKARImet is from a mesophile and 
possesses a seven-residue NADP-dependent β2αB-loop, we have compared it not to 
IaKARI, but to the structures of Pseudomonas aeruginosa KARI (PaKARIapo), which was 
crystallized in the apo form18 and S. exigua (SeKARIholo), which was crystallized in Chapter 
1 with cofactor, substrate analogue, and metals.21 Additionally, AvKARI has higher 
sequence identity (Table S4-1) to these than to IaKARI. Below, residues will be discussed 
using the numberings in AvKARI; the corresponding numberings in PaKARI and SeKARI 
are given in Table S4-2. 
The structure of AvKARImet aligns very well with that of PaKARIapo, deviating 
only in the β2αB-loop and at the C-terminus. The former deviation is probably a result of 
increased flexibility in this loop due to the lack of a cofactor. Both structures are in an 
‘open’ state, with their active sites exposed to solvent. SeKARIholo is in the ‘closed’ state 
and to align AvKARImet to SeKARIholo, we were forced to align the N- and C-termini 
separately, as in Figure 4-7. As with IaKARI, it is clear that each domain is separate and 
rigid, with a hinge between them and again this hinge is the α1-helix. This provides an 
unambiguous answer to the question above: the bending of the α1-helix is driven not by the 
binding of metal ions to the acidic residues on this helix, but by the binding of the cofactor. 
It is worth noting that of the six metal-binding residues, only K130, D190, and 
Q226' undergo rotamer changes upon metal binding, and that these are much more subtle 
than the changes observed with IaKARI. The residues of PaKARIapo are therefore more pre-
organized for metal binding, although it is not clear whether this is an artifact of 
crystallization or a function of the protein structure. Nevertheless, this is further evidence 
that metal ion binding is not a driver of a larger rearrangement. 
The gross conformational change between AvKARImet and SeKARIholo closely 
resembles that observed in IaKARI, as does the correlated reorganization of the α3′α4′-loop 
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and the αF-helix around the nicotinamide amide group. The reorganization in 
AvKARImet/SeKARIholo however, involves a more intricate hydrogen bond network (Figure 
4-9b, Figure 4-11). In place of A250', AvKARI has S249', the side chain of which is 
capable of hydrogen-bonding. Likewise, P135 of the αF-helix, which did not participate in 
the rearrangement, is replaced with H134, which is reoriented upon cofactor binding and 
hydrogen bonds to the side chains of both S249' and S26. Furthermore, Q27, instead of 
hydrogen-bonding to the backbone amine of G133 in the cofactor-free structure, hydrogen-
bonds to the carbonyl of A131. This hydrogen bond is not interrupted by the binding of the 
cofactor. A different network of interactions is present in PaKARIapo, but inspection of the 
electron density unambiguously shows this to be a modelling error (Figure S4-1). 
It is interesting that this mechanism (open apo state and closed cofactor-bound 
state) resembles that of the plant class II KARIs rather than the one from the bacterial class 
II KARIs. The plant KARIs also undergo rearrangement of the α3+1-helix upon binding of 
NADP, though the plant KARI conformational change is more complex, involving a 
reorganization of a long C-terminal tail, absent from class I KARIs, upon cofactor 
binding.24 In contrast, E. coli KARI adopts an open conformation after binding of cofactor 
and substrate, the reverse of what is observed in the plant KARIs and the bacterial class I 
KARIs discussed in this chapter. Nonetheless, the conformational change in E. coli KARI 
also involves rearrangements centered around the nicotinamide amide. In E. coli KARI, the 
α2+1- and α3+1-helices interact with the β6αF-loop in the absence of cofactor; the binding 
of nicotinamide into the active site collapses the β6αF-loop (as briefly discussed by Wong 
et al.25) and breaks this interaction (Figure 4-12). Until more structural information is 
available, it is impossible to say whether E. coli KARI is unique in this regard or what 
evolutionary pathway led it to have this induced fit mechanism opposite to that of the other 
KARIs. 
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Figure 4-11. Structural rearrangements around the NADP nicotinamide in 
AvKARI/SeKARI. As with IaKARI, binding of the nicotinamide of NADP (magenta) to 
the αA-helix and the β6αF-loop recruits the α3-helix of the other chain of the dimer (cyan); 
in these KARIs more hydrogen bonds are present and undergo further rearrangements. 
 
 
 
Figure 4-12. Structural rearrangements around the NADP nicotinamide in EcKARI, as 
described above. Structures from Guddat and coworkers.25,49 
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Conclusions 
Understanding and controlling the cofactor specificity of KARI enzymes has been 
a goal for protein engineers for nearly two decades.48 These efforts have, by necessity, 
relied heavily on incomplete structural data to guide mutagenesis strategies. With the 
addition of the structures described in the present paper to those previously available, we 
now have representatives of all known canonical KARI cofactor specificity loop lengths. 
These data show that the six-residue specificity loops use a distinct binding arrangement for 
the phosphate of NADP, providing a clear structural explanation for results from previous 
cofactor engineering efforts.21 Furthermore, structures of two of the naturally NAD-
utilizing KARIs show that insertions near the N-terminus of the specificity loop probably 
determine cofactor specificity, whereas the laboratory engineering of NAD preference 
involved specific loop substitutions. 
These structures also provide insight into the large conformational change 
associated with KARI cofactor binding and catalysis. The rearrangement observed in these 
class I KARIs facilitates hydrogen bond interactions with the nicotinamide group and 
effectively closes the enzyme active site through motion of the α1-helix. This geometry 
resembles that observed in plant KARIs,24 but is distinct from that of E. coli KARI, which 
goes from a closed conformation to an open one upon cofactor binding.25 The principal 
study on order of ligand binding in KARIs was conducted using E. coli KARI,1 raising the 
question of whether the kinetic mechanism for ordered binding has been maintained 
throughout divergent evolution. The structures provided in this chapter answer several 
outstanding questions about the structural and functional diversity of KARIs and bring us 
closer to a comprehensive understanding of this enzyme class. 
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C h a p t e r  5  
ARTIFICIAL DOMAIN DUPLICATION REPLICATES EVOLUTIONARY 
HISTORY OF KETOL-ACID REDUCTOISOMERASES 
Material from this chapter appears in Cahn J. K. B., Brinkmann-Chen S., 
Buller A. R., Arnold F. H. (2016). Artificial domain duplication 
replicates evolutionary history of ketol-acid reductoisomerases, 
Protein Science Epub ahead of print, and is reprinted by permission from 
John Wiley and Sons.  
Abstract 
The duplication of protein structural domains has been proposed as a common mechanism 
for the generation of new protein folds. A particularly interesting case is the class II ketol-
acid reductoisomerase (KARI), which putatively arose from an ancestral class I KARI by 
duplication of the C-terminal domain and corresponding loss of obligate dimerization. As a 
result, the class II enzymes acquired a deeply embedded figure-of-eight knot. To test this 
evolutionary hypothesis we constructed a novel class II KARI by duplicating the C-
terminal domain of a hyperthermostable class I KARI. The new protein is monomeric, as 
confirmed by gel filtration and X-ray crystallography, and has the deeply-knotted class II 
KARI fold. Surprisingly, its catalytic activity is nearly unchanged from the parent KARI. 
This provides strong evidence in support of domain duplication as the mechanism for the 
evolution of the class II KARI fold and demonstrates the ability of domain duplication to 
generate topological novelty in a function-neutral manner.  
Introduction 
The mechanisms by which new protein folds arise and diversify are difficult to test 
experimentally and remain important open questions in evolutionary biology, molecular 
biology, and biophysics.1-4 The presence of internal symmetry in proteins has led to the 
hypothesis that ancient domains arose by fusion of short peptide ancestors5,6 and that they 
further diversified by fusion with other duplicate or non-duplicate domains.7-10 One possible 
outcome for tandem domain duplication is that it provides a structural alternative to homo-
oligomerization, with multiple monomers combined on a single polypeptide chain forming 
a pseudo-oligomer.8,11 This evolutionary model has been used as a basis to deconstruct 
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proteins in fold classes with high symmetry, such as β-propellers and β-trefoils, into 
oligomerizing monomers5,12-15 and for reconstructing novel proteins by monomer fusion.5,15-
20 Modular domains have also been recombined in new stoichiometries, such as with 
ankyrin repeats.21,22 
The evidence supporting domain duplication as a mechanism for fold evolution is 
strongest in cases where monomeric and dimeric forms of a protein are known and are 
shown to be functionally equivalent,1,11 such as with chorismate mutases23 and isocitrate 
dehydrogenases.24 A particularly interesting example is that of the class II ketol-acid 
reductoisomerase (KARI).25,26 KARI (EC 1.1.1.86, also known as acetohydroxyacid 
isomeroreductase (AHAIR)) is a key enzyme in the biosynthetic pathway for the branched-
chain amino acids where it converts (S)-2-acetolactate (S2AL) into (R)-2,3-
dihydroxyisovalerate (RDHIV) via an alkyl migration and an NAD(P)-dependent 
reduction.27 KARIs are divided into two classes on the basis of sequence length and 
oligomerization state (Figure 5-1). Following nomenclature introduced in 2003 by Ahn and 
coworkers,25 class I KARIs are dimers (or oligomers of dimers) with monomers that are 
~340 amino acids in length and composed of an N-terminal Rossmann domain that binds 
NAD(P) and a C-terminal knotted domain. Each C-terminal domain intertwines with the 
knotted domain of a second monomer and contributes to the active site (two per dimer).25,28 
The monomeric class II KARIs, on the other hand, possess two copies of the knotted 
domain that fold together to mimic the dimeric state of the class I enzymes and circumvent 
the requirement for dimerization to form the (single) active site (Figure 5-1).26,29 The term 
pseudosesquimer, from the Latin root referring to one-and-a-half, might be more 
appropriate to describe the class II KARIs, but we use the term pseudodimer to be in line 
with prior literature.8 The all-α knotted domain has no known sequence or structural 
similarity to any stand-alone domain in nature, suggesting that its stability or ability to fold 
is compromised in the absence of the partner Rossmann domain. The two knotted domains 
are extensively intertwined and when fused form the eponymous figure-of-eight knot. The 
knot of class II KARIs was the first protein knot identified30 and remains the most deeply 
embedded knot observed in a protein structure.31 
Knotted proteins offer a particularly challenging test of the domain duplication 
hypothesis. Whereas the simple or symmetrical proteins discussed above fold in a fashion 
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similar to how their individual repeats fold,20,21 introduction of topological complexity such 
as a protein knot can dramatically alter the folding pathway by introducing the requirement 
that one portion of the polypeptide thread through another.32,33 Previously, it was shown 
that a synthetic trefoil-knotted pseudodimer could be formed by domain duplication when a 
9-residue linker was introduced to span the two domains.33 However, domain duplication 
must produce a functional protein even before subsequent adaptation to the new topology, 
and no studies have addressed how readily this can occur. Though a domain-duplicated 
protein having identical knotted domain sequences was a necessary intermediate in the 
evolution of the class II KARI fold, the putative duplicated domains within class II KARIs 
now share only 12–24% sequence identity. The functionality of an evolutionarily naïve 
KARI pseudodimer is particularly uncertain because the active sites each include residues 
from both knotted domains. As such, the catalytic activity will be highly sensitive to the 
relative positioning of these domains. Here we sought to test domain duplication in a 
contemporary class I KARI and determine whether it could generate a folded, knotted, and, 
most importantly, functional class II KARI protein. 
 
 
 
Figure 5-1. Cartoon representation of the class I KARI dimer (left) and class II KARI 
monomer (right), illustrating the figure-of-eight knot, the duplication of the knotted 
domain, and the fact that the substrate makes contact with the Rossmann domain as well as 
with components of both knotted domains.  
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Materials and Methods 
Cloning and expression 
Each 2Ia_KARI gene construct was codon-optimized using Integrated DNA 
Technologies’ (San Diego, CA) Codon Optimization Tool and obtained from IDT as 
gBlocks. The gBlocks were cloned into pET22b(+) vectors using Gibson cloning.34 Electro-
competent E. coli BL-21(DE3) ‘E. cloni Express’ cells from Lucigen (Middleton, WI) cells 
were transformed with the constructs. For expression, 1 L of Terrific Broth media was 
inoculated with 5 mL saturated overnight culture and grown at 37 °C for 4 h before 
induction with IPTG to a final concentration of 500 µM. Upon induction, the temperature 
was dropped to 20 °C and protein expression proceeded for 24 h prior to centrifugal 
harvesting. 
Protein purification and characterization 
Protein purification via the C-terminal His6-tags was performed as described.35 The 
protein concentration was determined with the Bradford assay. Values for kcat were 
determined at 85 °C with the standard assay in the presence of 200 mM NAD(P)H, 2.5 mM 
S2AL, and 10 mM MgCl2 in 100 mM phosphate buffer, pH 7.0. Michaelis-Menten 
constants for the substrate were determined in the presence of varying S2AL concentrations 
and 200 mM NADPH. Michaelis-Menten constants for the cofactors were measured under 
saturating substrate conditions and varying cofactor concentrations in a fluorescence plate 
reader at 25 °C.  
To determine the half-denaturation temperatures (T50) of IaKARI and 2Ia_KARIs, 
40mL aliquots of purified enzyme were transferred into PCR tubes. Each tube was assigned 
a specific incubation temperature on the block of an Eppendorf Master Cycler PCR 
machine. The measurements were conducted in duplicates. The tubes were incubated in 
their slots for 60 min, and the reactions were then quenched on ice. Residual activity was 
determined with the standard activity assay at 25 °C in a plate reader. T50 is defined as the 
temperature at which 50% of the initial activity is retained after 60 min incubation.  
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Gel filtration analysis 
The oligomerization states of IaKARI and the 2Ia_KARI constructs were 
determined by size exclusion chromatrography (SEC) on a Superdex 75 10/300 GL column 
with 100 mM phosphate buffer, pH 7.0 using an Akta purifier FPL system (GE 
Healthcare). Myoglobin (16.7 kDa) and BSA (66.5 kDa) served as standards.  
Crystallization and X-ray data collection 
For crystallization, purified protein was buffer exchanged into 20 mM Tris pH 7 
and concentrated to ~110 mg/mL using an Ultracon centrifugal concentrator (Millipore, 
Billerica, MA). High-throughput screening of crystallization conditions was conducted at 
the Beckman Molecular Observatory at the California Institute of Technology. The best 
crystals were obtained from 2 M sodium formate, 100 mM sodium acetate, pH 4.6. For 
cryoprotection, the crystal was briefly soaked in a mother liquor containing 20% glycerol 
prior to flash-freezing in liquid nitrogen. Diffraction data were collected using a Dectris 
Pilatus 6M detector on beamline 12-2 at the Stanford Synchrotron Radiation Laboratory 
SSRL at 100 K. Diffraction datasets were integrated with XDS36 and scaled using 
SCALA.37 
Structure solution 
For molecular replacement, one monomer from the prior holo structure of 
Ia_KARI (PDB 4XDZ) was split into two PDB files containing the Rossmann and knotted 
domains, and Phaser molecular replacement38 was performed, searching for one copy of the 
Rossmann domain and two copies of the knotted domain on the basis of the Matthews 
coefficient39 as calculated in CCP4.40 After removal of portions of the chain with poor fit to 
the density, the structure was rebuilt and refined over several iterations of automated 
refinement with Refmac541 (CCP4 suite40) and manual refinement in Coot.42 TLS operators 
were included in the final round of refinement.43   
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Results 
Design of constructs 
We selected as a starting point the class I KARI from Ignisphaera aggregans 
(IaKARI), a hyperthermostable, NADH/NADPH-bispecific enzyme with good 
heterologous expression in Escherichia coli.28,44 In the previous chapter, we obtained high 
resolution structures of IaKARI in the apo (without co-crystallized cofactor and inhibitor) 
and holo (cofactor- and inhibitor-bound) forms, which allowed us to determine the location 
of the interdomain hinge and describe the role of dimerization in the function of the 
enzyme.28 The structure of IaKARI is similar to the other class I KARIs that have been 
crystallized.25,28,45 
It was unclear how the class I KARI would respond to the addition of 
approximately 140 additional amino acids. We therefore designed four potential class II 
KARIs (Figure 5-2). The first construct, 2Ia_KARI-DD (domain duplication), has a simple 
duplication of the knotted domain using as a start point for the duplication E189, the 
position previously identified as the interdomain hinge.28 The design of the other constructs 
was based on an alignment between the IaKARI holo structure (PDB 4XDZ28) and that of 
the class II KARI from E. coli (EcKARI; PDB 3ULK46). The EcKARI structure was used 
because it is only crystallized class II KARI from a bacterial host. For a description of the 
notation we use to describe the KARI architecture, the previous chapter. Inspection of the 
EcKARI structure revealed that the α1+1-helix was truncated at its N-terminal end with 
respect to the corresponding α1’-helix of the IaKARI dimer. Therefore, in the second 
construct, 2Ia_KARI-HT (helix truncation), we began the duplicate knotted domain at the 
first position of this helix which could be aligned to a corresponding position of the 
EcKARI structure, V197. As a result, 2Ia_KARI-HT is eight amino acids shorter than 
2Ia_KARI-DD. Next, we noted that in IaKARI, the final 24 amino acid residues of the 
knotted domain form the α7-helix, which is absent in EcKARI. Instead, EcKARI possesses 
a 23-residue loop, the α6α1+1-loop, which links the two knotted domains (Figure 5-3). 
Therefore, in 2Ia_KARI-LT (loop transplant), we replaced the final residue of IaKARI’s 
α6-helix and all subsequent residues with the final residue from EcKARI’s α6-helix and the 
EcKARI α6α1+1-loop. The α7’-helix, at the C-terminus of the duplicate knotted domain, is 
intact. Comparing the two knotted domains of EcKARI, one final structural difference is 
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clear. The second knotted domain of EcKARI does not have an α5-helix, which is replaced 
by the long α4+1α6+1-loop (Figure 5-3), and the α6+1 helix is shifted and rotated with 
respect to an alignment with IaKARI. Our fourth and final construct, 2Ia_KARI-2L (two 
[transplanted] loops), is constructed from 2Ia_KARI-LT by identification of the final 
positions which can be aligned around this dissymmetry, K264 and E315 of IaKARI, and 
replacing the 50 residues between them, which compose the C-terminal of the α4’-helix, the 
α4’α5’-loop, the α5’-helix, the α5’α6’-loop, the α6’-helix, and the α6’α7’-loop, with the 44 
residues composing the C-terminal of the α4+1-helix, the α4+1α6+1-loop, the α6+1helix, 
and the α6+1α7+1 loop of EcKARI.  
All 2Ia_KARI gene constructs were codon-optimized for E. coli and cloned into 
the pET22(b)+ vector in frame with a C-terminal His6-tag.47 Expression under standard 
conditions for heterologous expression of KARIs45 produced folded 2Ia_KARI-DD and 
2Ia_KARI-LT with yields comparable to wild-type IaKARI after Ni-NTA purification. 
2Ia_KARI-HT and 2Ia_KARI-2L had considerably decreased expression, and were not 
characterized further. 
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Figure 5-2. Secondary structure schematics of KARIs described in this chapter. Helices are 
indicated by cylinders and beta-strands by arrows. Sequence elements are colored 
according to their source and domain: IaKARI sequence elements are blue (Rossmann 
domain) or green (knotted domain) and EcKARI sequence elements are purple (Rossmann 
domain), orange (first knotted domain), or red (second knotted domain). The Rossmann 
domain of the second IaKARI monomer is truncated for clarity. Full sequence alignment is 
shown in Figure S5-2. 
 
Figure 5-3. A view of EcKARI (PDB 3ULK) showing the two structural deviations from 
class I KARIs. The Rossmann domain is shown in green, the first knotted domain is shown 
in purple, and the second is shown in pink. The α6α1+1-loop  is shown in orange, 
connecting the two knotted domains, and the α4+1α6+1-loop  is shown in red. 
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Characterization of the 2Ia_KARIs 
Both artificially domain-duplicated 2Ia_KARI-DD and 2Ia_KARI-LT enzymes are 
highly active for the transformation of (S)-2-acetolactate (S2AL) to (R)-2,3-
dihydroxyisovalerate (RDHIV) at 85 °C. We measured the kinetic parameters of both and 
compared them to IaKARI wild type (Table 5-1). The NADPH and NADH cofactor KM 
values remained below the instrument’s 1 mM detection limit. On NADPH, 2Ia_KARI-DD 
showed a similar kcat to wild type; the kcat of 2Ia_KARI-LT was 3-fold lower (Table 5-1). 
Like the wild-type enzyme, 2Ia_KARI-LT displays roughly equal catalytic efficiency on 
NADPH and NADH, while 2Ia_KARI-DD’s cofactor preference was slightly shifted 
toward NADPH (Table 5-2). Surprisingly, the two 2Ia_KARIs had lower KM values for the 
substrate S2AL than did the wild type, with a 3-fold reduction observed for 2Ia_KARI-DD 
and a 6-fold reduction for 2Ia_KARI-LT. Both 2Ia_KARIs therefore had higher catalytic 
efficiencies for S2AL than the wild-type enzyme (Table 5-1). 
2Ia_KARI-DD and 2Ia_KARI-LT were highly thermostable with temperatures of 
half-activity loss (T50) of 92 and 88 °C, respectively, only slightly less than wild-type 
IaKARI’s 95 °C (Table 5-1). Size exclusion chromatography confirmed the dimeric state of 
wild-type IaKARI28; in contrast, the 2Ia_KARIs elute as monomers in solution (Figure 5-
4). The catalytic activity of 2Ia_KARI-DD depended linearly on protein concentration, 
further indicating that it is monomeric (Figure 5-5). 
Table 5-1. Biochemical parameters of IaKARI and two domain-duplicated 2Ia_KARIs. 
 
Enzyme 
 
KM 
NADPH 
[µM] 
kcat  
NADPH 
[s-1] 
kcat/KM  
NADPH 
[s-1mM-1] 
KM S2AL 
[mM] 
kcat/KM 
S2AL 
[s-1mM-1] 
T50 [°C] 
IaKARI < 1 3.3 >3,300 3.1 1.1 95 
2Ia_KARI-DD < 1 3.0 >3,000 1.0 3.0 92 
2Ia_KARI-LT < 1 1.0 >1,000 0.5 2.0 88 
Each value represents the average of three independent measurements. Enzyme activities 
were determined in 100 mM potassium phosphate pH 7 with 200 mM NADPH or NADH, 
10 mM S2AL, and 10 mM MgCl2. See Materials and Methods for details. 
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Table 5-2. Comparison between catalytic parameters on NADH and NADPH for selected 
KARIs. 
Enzyme 
 
KM 
NADH 
[µM] 
KM 
NADPH 
[µM] 
kcat  
NADH 
[s-1] 
kcat  
NADPH 
[s-1] 
kcat/KM  
NADH 
[s-1mM-1] 
kcat/KM  
NADPH 
[s-1mM-1] 
Catalytic 
Efficiency Ratio 
(NADH/NADPH) 
IaKARI < 1 < 1 2.6 3.3 >2,600 >3,300 0.8 
2Ia_KARI-DD < 1 < 1 1.7 3.0 >1,700 >3,000 0.6 
2Ia_KARI-LT < 1 < 1 0.8 1.0 >800 >1,000 0.88 
 
 
 
Figure 5-4. Gel filtration chromatography analysis of 2Ia_KARIs. Gel filtration curves are 
shown for 2Ia_KARI-DD and 2Ia_KARI-LT, along with dimeric IaKARI WT and flanking 
controls (BSA and myoglobin). Inset shows proper power-law correspondence for 
predicted monomeric molecular weight. 
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Figure 5-5. Linear relationship between enzyme concentration and activity across a 512-
fold range of dilutions for 2Ia_KARI-DD, showing monomeric behavior. 
 
 
X-ray crystal structure 
To confirm that domain duplication had produced a canonical class II KARI fold, 
we obtained the crystal structure of 2Ia_KARI-DD. This protein was noticeably more 
soluble than IaKARI: at a protein concentration of 20 mg/mL, the concentration used to 
crystallize IaKARI,28 very few wells of our high-throughput crystallization screens gave 
even amorphous precipitate. However, by increasing the protein concentration to ~110 
mg/mL, we were able to obtain two crystals in sodium formate, one of which diffracted to 
1.94 Å (Figure 5-6b, Table 5-3). The protein crystallized in the P 43 2 2 space group with a 
single molecule of 2Ia_KARI-DD in the asymmetric unit (for crystal packing, see Figure 
S5-1), and a monomeric biological assembly is predicted by the Protein Interfaces, 
Surfaces, and Assemblies server (PISA).48 
The structure of 2Ia_KARI-DD contains NADP and the inhibitor N-
isopropyloxamate, and its fold closely resembles that of the class II KARIs. Overall, the 
structure also shows remarkable agreement with the structure of the native IaKARI dimer 
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in its cofactor-bound state (PDB ID 4XDZ28), as shown in Figure 5-6. The Rossmann 
domain and the active site components from both knotted domains in the new class II 
enzyme align very well with the IaKARI structure, including the contacts to the cofactor 
and substrate from the α3+1α4+1-loop. While the overall Cα RMSD is 0.3 Å for aligned 
residues, the deviation is considerably higher in a handful of regions as shown in Figure 5-
7. The amino acids immediately before and after the linker as well as those that were in 
close proximity to the dimeric partner’s now-deleted Rossmann domain show the largest 
perturbations (Figure 5-8). In particular, the α5+1-helix (residues 430–441), exhibits 
considerable structural heterogeneity, with two distinct parallel conformations observable 
in the maps, separated by an average of 2.2 Å (Figure 5-9). Interesting, EcKARI lacks an 
α5+1-helix altogether, possessing instead an extended α4+1α6+1-loop (Figure 5-3). In the 
wild-type IaKARI structures, the α5’-helix forms significant contacts with the αD’- and 
αE’-helices of the dimeric partner’s Rossmann domain. Elimination of this domain removes 
these stabilizing contacts from the α5+1-helix, leading to the conformational heterogeneity 
observed in the domain-duplicated protein. This instability may underlie the eventual 
evolution away from helicity observed in EcKARI, which lacks an α5+1-helix, as do all 
other crystallized class II KARIs.28,29,49 
The residues connecting the first and second knotted domains are disordered in the 
2Ia_KARI-DD crystal structure. Interestingly, the final residue of the first knotted domain 
that could be resolved, M329, is also the final residue that could be resolved in the IaKARI 
structure, so the linkage between the domains is composed of the same six residues that 
made up the disordered C-terminus of the parent protein. The first three residues of the 
second knotted domain are also disordered. This is in contrast to the apparent structural 
rigidity in the interdomain linker that has evolved in EcKARI and other naturally-occurring 
class II KARIs.29,49 
EcKARI undergoes an induced fit conformational change upon binding NADP 
opposite that of IaKARI and all other KARIs for which the analysis is possible: it goes 
from an active-site-closed conformation in the apo state to an open one in the cofactor-
bound state, whereas IaKARI and others adopt a closed conformation upon cofactor 
binding by bringing together the Rossmann and knotted domains.28,46 This raised the 
question of whether the 2Ia_KARIs would adopt the behavior of their parent class I enzyme 
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or that of the closest known class II enzyme. The structure of 2Ia_KARI-DD in its cofactor-
bound state clearly shows a closed active site, suggesting that the induced fit behavior of 
the parent class I protein has been preserved upon domain duplication. 
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Figure 5-6. Structures of class I and class II KARs, highlighting their knotted domains. 
Rossmann domains are shown in grey. The class I IaKARI (a; PDB 4DXZ28) is shown with 
knotted domains colored separately to illustrate the dimeric interaction or with spectral 
coloring corresponding to the class II KARIs. The class II 2Ia_KARI-DD (b) was 
engineered by duplication and concatenation of the IaKARI knotted domain. The natural 
class II EcKARI (c; PDB 3ULK34) has evolved away from perfect symmetry. 
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Table 5-3. Data collection and refinement statistics for the structure of 2Ia_KARI-DD 
(PDB 5E4R). Values in parentheses refer to the highest resolution shell. 
 
Data collection 
Space Group P 43 2 2 
a, b, c (Å) 103.9, 103.9, 142.1 
α, β, γ (°) 90, 90, 90 
Resolution (Å) 103.9-1.94 (1.99-1.94) 
Rp.i.m. (%) 2.6 (22.2) 
<i>/<σi> 7.39 (0.74) 
Completeness (%) 99.2 (94.4) 
Redundancy 10.3 (8.2) 
Refinement 
No. reflections 613,895 
Rwork/Rfree (%) 15.8/17.9 (21.8/27.1) 
No. atoms 
    Protein 3753 
    Ligand 68 
    Water 237 
RMSD 
    Bond lengths (Å) 0.020 
    Bond angles (°) 1.128 
Ramachandran plot 
    Favored 466 
    Allowed 14 
    Outliers 0 
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Figure 5-7. The 2Ia_KARI-DD backbone trace highlighting structural differences between 
it and IaKARI. The outline of IaKARI is shown in grey (Rossmann domains) and magenta 
(knotted domains). The backbone of 2Ia_KARI-DD has been aligned to it. The coloring 
and width of the 2Ia_KARI-DD backbone are proportional to the Cα- Cα distances between 
the structures (plotted in Figure 5-8). Differences cluster around the interface with the 
eliminated Rossmann domain. The NADP cofactor and N-isopropyloxamate inhibitor are 
drawn with ball-and-stick, showing that the active site remains entirely unperturbed. 
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Figure 5-8. The Cα- Cα distances between 2Ia_KARI-DD and IaKARI. The lines are 
colored by which monomer of IaKARI is closer, blue for the first monomer and green for 
the second. When multiple Cα are present for a given residue, due to alternate 
conformations, the greater distance is shown in a lighter color. The residues between 330 
and 339 are not structurally resolved. 
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Figure 5-9. The α5+1-helix, showing two distinct conformations visible in the 2Fo-Fc map, 
contoured to 1.2σ (blue) and 0.65σ (cyan). 
 
 
Discussion 
Several potential forces have been suggested as favoring the evolution of 
pseudodimeric folds. Among these are removal of the constraint of symmetry, which 
allows the two pseudo-monomers to specialize,8,11,25 or an increase in the range of 
movement that can be tolerated with a covalent linkage.8 This demonstration that a crude 
domain-duplicated enzyme can retain catalytic efficiency comparable to that of the wild-
type protein supports the simpler explanation that domain duplication was an essentially 
neutral change in protein structure. The role of neutral drift in evolution has long been 
appreciated at a sequence level,51-53 and our results lend experimental support to the 
extension of the concept of neutral drift to the generation of structural novelty by domain 
duplication.54 Other forms of protein topological variation that do not necessarily come at 
the cost of function are well known: proteins may tolerate proteolysis or expression from 
artificially split genes,55 single-chain proteins have been created from heterodimers,56 many 
proteins are known to form functional domain-swapped dimers,57 and proteins can often be 
expressed as circular permutants,4,58  all while preserving function. These studies all 
  
103 
showcase that protein function is contingent upon an arrangement of key residues and 
associated secondary structures and depends less on the connectivity among them.55,59 As 
such, as long as function is preserved, evolution is blind to topology.  
While topological changes may have minimal effects on function or even stability 
of the fold,55 their effects on the kinetics of folding can be significant. When King et al. 
engineered a comparatively simple and shallow protein knot by dimerization of HP0242, 
they found that the dimer folded approximately 20 times slower than a control unknotted 
monomer.33,60,61 It remains an open question how the folding pathway of 2Ia_KARI-DD 
resembles or differs from that of the parent IaKARI, or how it compares to that of 
evolutionarily mature class II KARIs. It would also be interesting to see how 2Ia_KARI-
DD might further evolve and whether it takes on the structural or sequence features seen in 
known class II KARIs, allowing us to replay in real time the evolution of this unique 
enzyme family. 
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C h a p t e r  6  
MUTATIONS IN ADENINE-BINDING POCKETS ENHANCE CATALYTIC 
PROPERTIES OF NAD(P)-DEPENDENT ENZYMES 
Material from this chapter appears in Cahn J. K. B., Baumschlager A., 
Brinkmann-Chen S., Arnold F. H. (2016). Artificial domain duplication 
replicates evolutionary history of ketol-acid reductoisomerases, 
Protein Engineering, Design and Selection 29(1), 31-38, and is reprinted 
by permission from Oxford University Press.  
Abstract 
NAD(P)-dependent enzymes are ubiquitous in metabolism and cellular processes and are 
also of great interest for pharmaceutical and industrial applications. Here, we present a 
structure-guided enzyme engineering strategy for improving catalytic properties of 
NAD(P)-dependent enzymes toward native or native-like reactions using mutations to the 
enzyme's adenine-binding pocket, distal to the site of catalysis. Screening single-site 
saturation mutagenesis libraries identified mutations that increased catalytic efficiency up 
to 10-fold in seven out of ten enzymes. The enzymes improved in this study represent three 
different cofactor-binding folds (Rossmann, DHQS-like, and FAD/NAD binding) and 
utilize both NAD and NADP. Structural and biochemical analyses show that the improved 
activities are accompanied by minimal changes in other properties (cooperativity, 
thermostability, pH optimum, uncoupling), and initial tests on two enzymes (ScADH6 and 
EcFucO) show improved functionality in Escherichia coli.  
Introduction 
Engineering novel or improved metabolic pathways often changes the demands 
placed on enzymes evolved to carry out their natural functions in specific contexts. For 
instance, it has been proposed that enzymatic KM values have evolved to match 
physiological substrate concentrations,1 which can change as a result of heterologous 
expression or pathway engineering that changes steady-state metabolite concentrations. 
Such changes in metabolic context might require alterations in enzyme kinetics through 
protein engineering for optimal metabolic flux and cell physiology. Beyond the room for 
improvement created by a novel physiological context, it has been hypothesized that the 
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kinetics of many enzymes have not been maximized by evolution, particularly the 
‘moderately efficient’ enzymes of secondary metabolism where kinetic enhancement is of 
minimal benefit to host fitness.2,3 Despite the suggestions that there is potential to improve 
native activities, engineering enzymes for the direct improvement of activities on their 
natural substrates under biologically relevant reaction conditions has proven challenging 
and, to our knowledge, broadly unsuccessful.2,4,5 Instead, enzyme engineering usually 
improves reactivity toward non-natural substrates, increases promiscuous, reactivities or 
alters selectivity.6-9 Unlike these goals, in which functional changes can often be ascribed to 
specific remodeling of the active site to accommodate or exclude certain substrates or 
transition states, the precise structural origins of an enzyme's kinetic properties are more 
enigmatic and to-date have been resistant to prediction. In this chapter, we empirically 
identify structural positions in NAD(P)-dependent enzymes where mutations can provide 
significant boosts in enzyme activity and catalytic efficiency.  
NAD(P)-dependent enzymes are involved in a wide range of metabolic reactions, 
which makes them of interest for pharmaceutical and industrial applications. Protein 
engineering has been used to study and change cofactor binding to NAD(P)-dependent 
enzymes.10-13 Previous work from the Arnold laboratory on engineering of cofactor 
specificity of ketol-acid reductoisomerase (KARI) enzymes revealed that mutation at a 
single position on a helix that runs parallel to the cofactor adenine moiety improved the 
catalytic activity of several KARIs, including both wild type and, in Chapter 1, cofactor-
switched.11,12 This finding was replicated in another KARI by Reiße et al.14 
While screening a random mutant library of the Arabidopsis thaliana glyoxylate 
reductase (AtGR1) prepared for an unrelated study (Chapter 7), we observed similar 
activating effects from a mutation adjacent to the position corresponding to that in the 
KARIs. AtGR1 with mutation C68R showed a significant improvement in activity in 
lysate, which we later established was due largely to a ∼5-fold decrease in KM for the 
substrate (this work). AtGR1 and KARIs possess similar overall folds, with highly similar 
Rossmann domains, and both are specific for NADP over NAD. Because it is rare to find 
mutations that boost the activity of an enzyme for its native reaction, we set out to 
investigate whether modifications at similar positions with respect to the adenine could 
improve the activities of enzymes with more diverse folds and cofactor utilization profiles. 
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These amino acids are situated in the internal lining of the adenine-binding pocket. More 
specifically, they contain atoms located within 5 Å of the N6 atom of the NAD(P) adenine 
(see Figure 6-1), but are not involved in determining cofactor preference through 
interaction with the phosphate or hydroxyl in the 2′-position of the ribose. Libraries of 
enzyme variants made by site-saturation mutagenesis at these positions can be screened 
rapidly for increased enzyme activity in lysate. We demonstrate that this simple structure-
guided engineering strategy works to improve the activities of a surprising range of 
enzymes, opening the door to improving the catalytic properties of a broad array of 
industrially relevant enzymes and metabolic pathways. 
 
 
 
Figure 6-1. The standard numbering of atoms in the NAD(P) adenine moiety (a). An 
example of the amino acid positions around the adenine N6 (b) mutated in this study 
(yellow spheres), in this case S. cerevisiae ADH6 (ScADH6), whose structure was reported 
in Valencia et al. (PDB 1PIW15). 
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Materials and Methods 
Cloning and library construction 
All genes were obtained from Integrated DNA Technologies (IDT) as gBlock 
linear fragments and were cloned into pET22b(+) in frame with the C-terminal His6-tag for 
expression in Escherichia coli using Gibson cloning16 with overlap at the T7 promoter and 
terminator sequences. Mutagenic primers for site-saturation mutagenesis were obtained 
from IDT and treated as suggested by IDT protocols. Splicing by overlap extension 
polymerase chain reaction (SOE-PCR) was performed as described previously.11,17 The 
quality of the library was assessed using DNA sequencing performed by Laragen (Los 
Angeles, CA, USA). Standard molecular biology methods were taken from Sambrook et 
al.18 
Heterologous gene expression for high-throughput screening and protein purification 
All expression cultures were grown in Luria-Bertani broth, supplemented with 
ampicillin for selection (LB+Amp). 
For high-throughput screening, pre-cultures of 300 µL LB+Amp were inoculated 
with single colony forming units (CFUs) in 96-deep-well plates (DWPs) using toothpicks. 
For each library, 84–88 CFUs were screened, corresponding to 93–95% theoretical library 
coverage,19,20 along with the parent protein and the pET22b(+) vector as positive and 
negative controls. The pre-cultures were grown overnight at 37°C, 200 rpm and 80% 
humidity. The next day, expression cultures of 600 µL were inoculated with 50 µL of the 
overnight cultures in 96-DWPs. The pre-cultures were stored at 4°C until the screening was 
completed to serve as temporary stock from which positive hits were regrown. After 
incubation of the expression cultures for 4 h at 37°C, 200 rpm and 80% humidity, 
expression was induced by adding isopropyl thiogalactopyranoside (IPTG) to a final 
concentration of 0.25 mM. Expression occurred for 21 h at temperatures indicated in Table 
6-1 and 200 rpm without humidity control. The expression cultures were harvested through 
centrifugation, and the DWPs containing the cell pellets were stored at −20°C until 
screening.  
  
113 
For purified protein, pre-cultures grown overnight at 37°C and 200 rpm were used 
for inoculation of 200 mL expression cultures to an OD600 of 0.05–0.1 and incubated at 
37°C and 210 rpm until an OD600 of ∼0.8 was reached. At this point, the expression cultures 
were cooled to their expression temperatures (Table 6-1) before induction with IPTG to a 
final concentration of 0.5 mM and growth for an additional 21 h. The expression cultures 
were harvested by centrifugation, the supernatant was discarded and the pellets were frozen 
at −20°C until further use.  
Table 6-1. Expression temperatures and screening conditions used for respective enzymes. 
Enzyme 
 
Expression 
Temperature 
Substrate Assay Buffer 
AtGR1 25 °C Sodium glyoxylate 100 mM HEPES, 
pH 7.8 
ScADH6 20 °C Trans-cinnamaldehyde 50 mM sodium 
phosphate, pH 7.0 
LlAdhA 20 °C Isobutyraldehyde 50 mM sodium 
phosphate, pH 7.0 
DmAdhA 20 °C Isobutyraldehyde 50 mM sodium 
phosphate, pH 7.0 
KpDhaT 20 °C Isobutyraldehyde 50 mM sodium 
phosphate, pH 7.0 
EcFucO 20 °C Furfural 50 mM sodium 
phosphate, pH 7.0 
TeXR 20 °C D-xylose 50 mM potassium 
phosphate, pH 7.0 
LsNOX 20 °C Oxygen gas 50 mM sodium 
phosphate, pH 7.0 
 
 
Enzyme assays and high-throughput screening 
Escherichia coli cells were resuspended in the respective assay buffer (Table 6-1) 
containing 750 mg/L lysozyme, 10 mg/L DNaseI and 2 mM MgCl2. Lysis was 
accomplished at 37°C for 1 h. Enzyme activities were then assayed by monitoring 
NAD(P)H consumption in the presence of the respective substrate (Table 6-1) and 250 µM 
NAD(P)H at 340 nm in a plate reader.  
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Thermostability was measured through determination of T50, the temperature where 
the enzyme activity is reduced to 50% of its initial activity after incubation for 10 min. The 
pH optimum was determined using a selection of four different buffer systems to cover the 
relevant pH scale from pH 3 to 10 (pH 3–6: 50 mM sodium citrate buffer, pH 6–8: 50 mM 
sodium phosphate buffer, pH 8–9: 50 mM Tris–HCl buffer, pH 9.2–10: 50 mM carbonate–
bicarbonate buffer). All observations are averages of at least three replicates.  
Protein purification and enzyme kinetics 
Escherichia coli cell pellets were resuspended in 10 mL buffer A (25 mM Tris, 100 
mM NaCl, 20 mM imidazole, pH 7.4) and lysed by sonication. The lysate was centrifuged, 
and the enzymes were purified via their C-terminal His6-tag using High Performance (HP) 
Ni-NTA Sepharose columns (GE Healthcare, Waukesha, WI, USA) on an Äkta Xpress 
FPLC (GE Healthcare). The concentration of purified protein was determined using the 
Bradford assay (Bio-Rad, Hercules, CA, USA).  
For rate measurements, kcat values were determined using the same assay 
conditions as above with saturating cofactor and substrate, while Michaelis–Menten 
constants were determined by varying each individually. At least six cofactor 
concentrations and at least five substrate concentrations were used for these determinations, 
and all measurements were performed at least three times. MatLab (Mathworks, Natwick, 
MA, USA) was used for parameter fitting.  
Protein crystallization and structure determination 
Screening of crystallization conditions was conducted at the Beckman Molecular 
Observatory at the California Institute of Technology using commercially available crystal 
screens. Crystallization occurred with purified EcFucOM185C at a concentration of 15 
mg/mL, 10 mM NAD+ and 10 mM isobutyraldehyde using the sitting drop method at 
ambient temperature. Crystals were obtained with 12% PEG 3350 and 200 mM NH4Cl as 
precipitant. The crystals were soaked with mother liquor containing 17% glycerol and 6.9 
mM NAD+ before flash freezing in liquid nitrogen. Diffraction data were collected using a 
Dectris Pilatus 6 M detector on beamline 12–2 at the Stanford Synchrotron Radiation 
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Laboratory at 100 K. Diffraction datasets were integrated with XDS21 and scaled using 
SCALA.22  
The structure of EcFucO (PDB 1RRM23) was used for molecular replacement. 
Refinement was conducted by iterating automatic refinement with Refmac5 (CCP4 suite) 
and manual refinement using Coot.24 The structure was deposited in the RCSB Protein Data 
Bank with accession code 5BR4.  
In vivo growth assays 
For the in vivo growth assays, cells were grown in 24-well round-bottom plates 
(Invitrogen, Carlsbad, CA, USA). In each well, 3 mL of LB broth with 100 µg/mL 
ampicillin and 500 µM IPTG were inoculated with 10 µL of saturated overnight culture. 
After 3 h of growth, an additional 3 mL of LB (with ampicillin and IPTG at the same 
concentrations) were added, which contained 10 mM of furfural or trans-cinnamaldehyde. 
After 10 h, the OD600 of a 200 µL aliquot was measured on a plate reader (Tecan, 
Männedorf, Switzerland). All observations are averages of at least five replicates.  
Results 
Improvement of catalytic properties through mutations around adenine N6 
In addition to the KARI enzymes previously studied, we selected eight distinct 
enzymes representing a range of cofactor preferences and cofactor-binding folds to test 
whether mutations at positions around the N6 nitrogen of adenine led to higher activity. 
The enzymes selected for this study include enzymes previously studied in our group and 
enzymes with potential for industrial applications. Saccharomyces cerevisiae cinnamyl 
alcohol dehydrogenase (ScADH6) is used by yeast for the detoxification of aromatic 
aldehydes.25 Arabidopsis thaliana glyoxylate reductase (AtGR1) is involved in the 
glyoxylate-glycolate shuttle for the regulation of photosynthesis.26 Lactococcus lactis and 
Drosophila melanogaster alcohol dehydrogenases (LlAdhA and DmADH) are 
promiscuous alcohol dehydrogenases previously investigated for use in microbial 
isobutanol production.27 Klebsiella pneumoniae propanediol dehydrogenase (KpDhaT) is 
one of the main enzymes for the metabolic pathway in K. pneumoniae that enables the 
species to metabolize glycerol as a sole source of carbon and energy by reduction of 3-
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hydroxypropanal to propane-1,3-diol.28 Escherichia coli lactaldehyde reductase (EcFucO) 
catalyzes the inter-conversion between L-lactaldehyde and L-1,2-propanediol during the 
anaerobic dissimilation of fucose29 and aerobic growth on L-1,2-propanediol.30,31 It also 
reduces furfural, the dehydration product of xylose and an important fermentation inhibitor 
in sugar syrups derived from woody biomass, to the less toxic furfuryl alcohol.31 Xylose 
reductase is the first enzyme of xylose metabolism in fungi; the enzyme from Talaromyces 
emersonii (TeXR) is a highly active and thermostable member of this family.32 NAD(P)H 
oxidase from Lactobacillus sanfranciscensis (LsNOX) is an important enzyme in 
maintaining redox balance33 and has been used for NAD(P)+ regeneration.34 Tables 6-2 and 
6-3 also include information on two KARIs, EcIlvC from Bastian et al.11 and MrKARI 
from Reiße et al.,14 which come from the two distinct structural classes of KARIs (Chapter 
5). EcIlvC is also notable for undergoing a cofactor-induced conformational change 
opposite that observed in other KARIs studied (Figure 4-8c).35 
For each enzyme, we identified residues within 5 Å of the N6 atom of the NAD(P) 
adenine, based on published crystal structures or homology models produced using the 
SWISS-MODEL server.36 A site-saturation mutagenesis library was generated at each 
position listed in Table 6-2, and the enzyme variants were screened for activity on both 
NADH and NADPH using the substrates indicated in Table 6-1. Mutants with significant 
activity enhancements toward either cofactor were purified, and Michaelis–Menten kinetic 
parameters were determined for the cofactors and the substrate. Improved kinetics were 
found in variants of five out of the eight new enzymes tested, in addition to the KARIs 
previously studied by Bastian et al.11 and Reiße et al.14 This number is notable given that 
these mutations are (i) boosting kinetic properties of native or native-like reactions, (ii) 
distal to the active sites, and (iii) obtained by screening small saturation libraries made at 
only a very few positions (between 1 and 4; see Table 6-2).  
The combined results are summarized in Table 6-3 where improvements in kcat 
(1.2–11.0-fold increase) as well as in the KM for substrate (1.2–11.5-fold decrease) and 
cofactor (1.1–7.7-fold decrease) are reported for seven out of ten enzymes. (Here, and 
elsewhere, we use KM to refer to both the Michaelis constant and the dissociation constant 
KH for enzymes displaying cooperativity. Such enzymes are indicated in Table 6-3. No 
significant changes in the Hill coefficient were observed for these cooperative enzymes.) 
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Accordingly, the catalytic efficiencies were increased from 1.2-fold to as much as 83-fold 
with respect to cofactor or substrate (Table 6-3). The improved enzymes contained 
Rossmann (KARIs, AtGR1, DmADH, ScADH6), FAD/NAD-binding (LsNOX) and 
DHQS-like (EcFucO) cofactor-binding folds and included enzymes with both cofactor 
preferences. We were unable to find beneficial mutations at the targeted positions in three 
enzymes: LlAdhA (Rossmann fold), KpDhaT (DHQS-like fold) and TeXR (TIM barrel 
fold).  
Because we identified beneficial mutations at multiple residues in the LsNOX 
enzymes, we also tested the double and triple combinatorial mutations. All three double 
mutants showed activity enhancements with respect to wild type, although not necessarily 
above the single mutants (Table 6-3). The triple mutant had considerably elevated kcat 
values but expressed quite poorly compared with the wild-type enzyme and the other single 
and combinatorial mutants (data not shown). Losses in expression or stability upon the 
accumulation of mutations are to be expected; stability can often be recovered by further 
mutagenesis, without compromising activity.37-39 Although expression levels were not 
quantified here, no other large changes in purified protein yields were observed for the 
other mutants of LsNOX or any other protein tested.  
The evolutionary fitness of an enzyme, that is how it contributes to the survival and 
fitness of its source, is determined by factors beyond catalytic efficiency, and thus catalytic 
efficiency may have been sacrificed by evolution to achieve other properties. In this case, 
improving activity might be expected to come at the expense of those other properties. To 
test whether other enzyme properties may have been perturbed by the mutations we 
identified, we analyzed selected enzymes for changes in pH optimum (DmADHV108I) and 
thermostability (DmADHV108I, EcFucOM185A, and EcFucOM185C). We found no significant 
changes in the improved variants compared with the wild-type enzymes (Figure 6-2, Table 
6-4). Additionally, none of the enzymes characterized were shown to be uncoupled—that 
is, none consumed cofactor in the absence of substrate—although we did not test LsNOX 
for uncoupling (its molecular oxygen substrate would require a controlled atmosphere for 
kinetic measurements). We also examined the in vivo activities of two of the enzymes 
(ScADH6 and EcFucO) whose activities could be directly tied to cell survival.25,31 Under 
standard E. coli expression conditions, no growth defect was observed as a result of the 
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mutations (Figure 6-3, top row). Upon the addition of a toxic aldehyde (trans-
cinnamaldehyde or furfural, respectively), growth was enhanced with the mutant ScADH6 
and EcFucO enzymes providing improved reductive detoxification ability compared with 
the wild-type enzymes (Figure 6-3, bottom row).  
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Table 6-2. The enzymes tested in this study (below the line) and previously reported 
(above), including the Structural Classification of Proteins (SCOP) classification of their 
cofactor-binding fold and a list of positions mutated. Positions indicated in bold are those 
where one or more beneficial muations were discovered. 
 
Enzyme PDB code Cofactor-
binding fold 
Cofactor 
preferrence 
Positions 
mutated 
EcIlvC 3ULK40 Rossmann 
(c.2.1.6) 
NADP Q11011 
MrKARI None Rossmann 
(c.2.1.6) 
NADP T8414 
AtGR1 3DOJ (Cofactor from 
3PEF)26,41 
Rossmann 
(c.2.1.0) 
NADP C68, A69 
ScADH6 1PIW15 Rossmann 
(c.2.1.1) 
NADP S253, T255, 
D256 
LlAdhA 4EEX (Cofactor from 
4GKV)27,42 
Rossann 
(c.2.1.1) 
NAD A242, A245 
DmAdhA 1MG543 Rossmann 
(c.2.1.2) 
NAD D65, V66, 
R104, V108 
KpDhaT 3BFJ (Cofactor from 
3OX4)28,44 
DHQS-like 
(e.22.1.2) 
NAD K187 
EcFucO 1RRM23 DHQS-like 
(e.22.1.2) 
NAD T140, M185 
TeXR 1K8C45 (Homology) TIM barrel 
(c.1.7.1) 
NADP F217, A254, 
Q280, N281 
LsNOX 2CDU46 FAD/NAD-
binding 
(c.3.1.5) 
Bispecific I122, I155, 
V214, I243 
Abbreviations: Arabidopsis thaliana glyoxylate reductase (AtGR1), Saccharomyces 
cerevisae cinnamyl alcohol dehydrogenase (ScADH6), Lactococcus lactis alcohol 
dehydrogenase (LlAdhA), Drosophila melanogaster alcohol dehydrogenase DmADH, 
Klebsiella pneumonia 1,3-propanediol dehydrogenase (KpDhaT), Escherichia coli 
lactaldehyde reductase (EcFucO), Talaromyces emersonii xylose reductase (TeXR), 
Lactobacillus sanfranciscensis NAD(P)H-oxidase (LsNOX), dihydroquinoate synthase 
(DHQS), flavin adenine dinucleotide (FAD). 
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Table 6-3. Kinetic parameters of characterized enzymes. Numbers in parentheses refer to α, the Hill coefficient. Substrate KM was assayed in the presence of the 
cofactor with greater kcat/KM Due to low enzymatic activity with NADPH as cofactor, kcatNADPH and KMNADPH could not be determined for wild-type and variant 
enzymes of EcFucO and DmADH. KMsubstrate could not be determined for LsNOX due to experimental constraints. 
  
kcat 
(min-1)  
KM 
(µM) 
 kcat/KM 
(mM-1 min-1) 
Specificity 
(NADH / 
NADPH)  Mutation NADH NADPH  NADH NADPH Substrate NADH NADPH Substrate 
AtGR1 Wild Type 7.3 ± 0.9 27 ± 3.9  76 ± 24 20 ± 6 690 ± 160  96 ± 33 1400 ± 450 39 ± 16 0.07 ± 0.03 
AtGR1 C68E 2.7 ± 0.2 13 ± 0.8  66 ± 29 10 ± 3 60 ± 11  41 ± 18 1300 ± 400 220 ± 77 0.03 ± 0.02 
AtGR1 C68R 13 ± 3.1 7.3 ± 1.8  53 ± 11 24 ± 9 120 ± 46  250 ± 78 300 ± 140 61 ± 36 0.81 ± 0.44 
ScADH6 Wild Type 1300 ± 370 16000 ± 2300  130 ± 51 140 ± 15 170 ± 26  10,000 ± 4800 110,000 ± 20,000 94,000 ± 22,000 0.09 ± 0.05 
ScADH6 T255K 3200 ± 87 9000 ± 1100  240 ± 13 37 ± 21 56 ± 4  13,000 ± 810 240,000 ± 140,000 160,000 ± 94,000 0.05 ± 0.03 
DmADH Wild Type 7.8 ± 1.6 -  57 ± 6 - 130 ± 33  140 ± 32 - 60 ± 21 - 
DmADH V108I 9.2 ± 3.4 -  42 ± 6 - 100 ± 24  220 ± 87 - 92 ± 43 - 
EcFucO 
 
EcFucO 
Wild Type 
 
M185A 
1.8 ± 0.2 
 
6.2 ± 2.0 
- 
 
- 
 
70 ± 8 
(2.9 ± 0.8) 
39 ± 4 
(2.7 ± 0.6) 
- 
 
- 
1400 ± 130 
 
390 ± 87 
 26 ± 4.1 - 1.3 ± 0.24 - 
160 ± 54 - 16 ± 6.4 - 
EcFucO M185C 6.5 ± 1.8 -  55 ± 2 (3.0 ± 0.3) - 910 ± 140 
 120 ± 33 - 7.1 ± 2.3 - 
LsNOX Wild Type 1200 ± 94 890 ± 170  85 ± 12 73 ± 60 -  14,000 ± 2300 12,000 ± 10,000 - 1.2 ± 0.99 
LsNOX I122V 4000 ± 240 1400 ± 280  20 ± 9.3 110 ± 64 -  200,000 ± 93,000 13,000 ± 7800 - 16 ± 12 
LsNOX I155L 2700 ± 520 3500 ± 360  100 ± 80 32 ± 8.4 -  27,000 ± 22,000 150,000 ± 58,000 - 0.18 ± 0.16 
LsNOX I243M 2800 ± 370 3100 ± 120  150 ± 175 56 ± 48 -  19,000 ± 22,000 55,000 ± 48,000 - 0.34 ± 0.49 
LsNOX I122V-I155L 2700 ± 490 5000 ± 540  70 ± 12 120 ± 30 - 
 39,000 ± 9600 42,000 ± 11,000 - 0.93 ± 0.34 
LsNOX I22V-I243M 5500 ± 290 4500 ± 49  59 ± 22 31 ± 21 - 
 93,000 ± 35,000 150,000 ± 98,000 - 0.64 ± 0.50 
LsNOX I155L-I243M 2500 ± 290 2400 ± 93  83 ± 7.6 120 ± 24 - 
 30,000 ± 4500 20,000 ± 4100 - 1.5 ± 0.38 
LsNOX 
I122V-
I155L-
I243M 
7900 ± 520 11000 ± 360  93 ± 96 140 ± 300 - 
 
85,000 ± 88,000 79,000 ± 170,000 - 1.1 ± 2.6 
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Figure 6-2. The pH activity profiles of DmADH and its V108I mutant. 
 
 
Table 6-4. Thermostability of indicated enzymes. T50 is defined as the temperature at which 
50% of the initial activity is retained after 10 min incubation. 
 
Enzyme T50 (°C) 
DmADH WT 46.6 ± 0.6 
DmADH V108I 48.8 ± 0.8 
EcFucO WT 44.7 ± 0.7 
EcFucO M185A 45.3 ± 4.0 
EcFucO M185C 40.8 ± 2.9 
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Figure 6-3. In vivo growth of cells containing mutant enzymes. Top row shows cells under 
normal growth conditions. None of the characterized mutations cause a growth defect 
relative to overexpression of the wild-type enzyme. In the presence of toxic aldehydes 
(bottom row), the respective wild-type enzymes improved growth rate compared to no 
enzyme, and the mutant enzymes led to higher growth rates than the wild-type enzymes. 
Error bars indicate the standard deviation of the measurements. 
 
 
Structural alterations in EcFucO 
The X-ray crystal structure of EcFucOM185C was solved at a resolution of 0.91 Å 
(Table 6-5), which allowed us to investigate whether the mutation at position M185 caused 
structural changes in the enzyme or the bound cofactor. In EcFucOM185C, activity was 
enhanced when M185 was substituted by a smaller and slightly more polar cysteine. The 
side chain of this cysteine lies almost perfectly along the β- and γ-carbons of the wild-type 
methionine, and aligning the structure of EcFucOM185C to the previously published wild-
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type structure23 reveals no major changes in the protein structure or the cofactor-binding 
pocket. However, the axis of the cofactor is tilted slightly, and the adenine is slightly shifted 
(0.3 Å) in the direction of the active site (Fig. 6-4). This leads to a more significant shift of 
1.1 Å at the N1 of the nicotinamide at the other end of the cofactor (Fig. 6-4). As the 
nicotinamide is the catalytically active part of the cofactor, we assume that this change in 
position in the active site enhances catalysis in the EcFucOM185C variant, mainly via the 3.6-
fold increase in kcat.  
In Chapter 1, a similar repositioning of the cofactor was also observed in the 
crystal structure of SeKARIDDV with mutation I95V close to the adenine of the cofactor.12 
Mutations in SeKARIDDV caused a 1 Å shift of the adenine compared with the parent 
structure, and we proposed that this readjustment placed the cofactor in a more favorable 
position for catalysis,12 although the presence of two additional mutations and a reversal of 
the cofactor specificity made it impossible to attribute the shift to I95V alone. 
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Table 6-5. Data collection and refinement statistics for the crystal structure of EcFucOM185C 
(PDB ID 5BR4). Values in parentheses refer to the highest-resolution shell. 
Data Collection 
Space Group P 21 
Cell Dimensions 
    a,b,c (Å) 69.7, 68.3, 91.7 
    α,β,γ (°) 90, 111.2, 90 
Resolution (Å) 85.50-0.91 (0.96-0.91) 
Rp.i.m. (%) 4.4 (166.9) 
Mn(I)/sd 8.8 (0.4) 
Completeness (%) 91.8 (74.6) 
Redundancy 2.7 (2.5) 
Refinement 
No. of reflections 466,646 (22,931) 
Rwork/Rfree (%) 12.9/14.7 (35.9/37.1) 
No. atoms 
    Protein 5,818 
    Ligand/ion 112 
    Water 1,167 
RMSD 
    Bond lengths (Å) 0.021 
    Bond angles (°) 2.035 
Ramachandran map analysis 
    Favored 774 
    Allowed 11 
    Outliers 0 
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Figure 6-4. Structures of wild-type EcFucO (purple) and the M185C mutant (cyan), 
showing two angles on the adenine and one of the nicotinamide. The nicotinamide moiety 
is not resolved in the wild-type structure.  
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Discussion 
It is often assumed in protein and metabolic engineering that enzymes have already 
been optimized toward their native functions and that their native catalytic efficiencies 
cannot be improved.47 Despite evidence that metabolically crucial enzymes display, on 
average, faster kinetics than those involved in secondary metabolism and the corresponding 
prediction that the kinetics of secondary metabolic enzymes could be improved,2 the 
engineering of more active enzymes has remained elusive.3 Even when modest successes 
have been described (e.g., as in Bastian et al.48), no method for finding activating distal 
mutations (other than random mutagenesis) has been reported. In this study, we have 
empirically identified structural positions across a broad category of enzymes where 
mutations can improve kinetics of native or native-like reactions. Our results with ScADH6 
and EcFucO also indicate improved overall functionality in an in vivo context where higher 
activity promotes better growth in the presence of toxic substrates.  
We propose a few factors that may contribute to this unusual finding. The 
mutations identified in this study are remote from the catalytically active centers in the 
proteins (the average distance between the Cα of residues targeted in this study and the 
hydride-carrying C4N atom of the cofactor is 16.9 Å), lowering the chance of disrupting the 
active sites. Nevertheless, the extended NAD(P) cofactor can transmit perturbations to the 
active site and may even magnify them.49,50 This is particularly relevant given the role of 
adenosine as a common energetic and recognition ‘handle’ in the binding of enzyme 
cofactors.51,52 Furthermore, despite (or perhaps because of) its ubiquity, structurally diverse 
binding pockets for adenine have evolved.51-55 In contrast to moieties with more 
specialized, conserved binding motifs, adenine binding is governed by a ‘fuzzy recognition 
template’ consisting of hydrophobic residues above and below adenine rings and polar 
residues around its rim.51,54 This might suggest that the adenine-binding pocket can tolerate 
mutations that fine-tune the kinetics or energetics of binding as long as these general 
structural elements are present. Although no pattern in the beneficial mutations described 
here is readily apparent, such as an increase or decrease in steric bulk, side chain polarity or 
conformational entropy, a number of structural factors can potentially be linked to the 
catalytic efficiency of enzymes. We offer two possible mechanisms for the enhancements 
observed and discuss them below in the specific context of nicotinamide cofactor binding.  
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In a 1997 study of isocitrate dehydrogenase, Mesecar et al. observed that subtle 
chemical modification of the adenine ring of NADP significantly reduced catalytic activity. 
High-resolution crystal structures showed how the change to the adenine binding resulted in 
a slight shift in the position of the nicotinamide with respect to the substrate, and the large 
decrease in catalytic activity was attributed to this subtle misalignment.49 In a study of 
aldo–keto reductases, Campbell et al. similarly concluded that the relative positioning of 
the cofactor and substrate in the active site was the major factor contributing to efficient 
turnover.56 Although the structure of wild-type EcFucO does not have the nicotinamide 
resolved and the structure of EcFucOM185C lacks the substrate, it is possible that the 
beneficial mutations identified here realign the cofactor in a way that improves catalytic 
preorganization with respect to the substrate and active site.  
Alternately, the mutations may affect the binding and unbinding kinetics of the 
cofactor. In a comprehensive study of adenine-binding pockets, Nobeli et al. found that 
protein-bound adenine moieties form, on average, only 67% of theoretically possible 
hydrogen bonds,54 suggesting that modulating the binding energy to fine-tune kon and koff is 
more important than achieving the tightest possible binding. Furthermore, for several kinds 
of NAD(P)-dependent enzymes, it has been shown that long-range conformational changes 
occur during binding of cofactor and/or substrate, resulting in allosteric 
cooperativity,27,45,56,57 which could explain why, in some of the enzymes tested, mutations 
affect the substrate KM, even though they are far from the substrate-binding portion of the 
enzyme.  
Bar-Even et al. postulate in a recent paper that the sub-optimality of moderately 
efficient enzymes (enzymes whose second-order rate constants lie well below the diffusion 
limit) reflects, at least in part, a high proportion of ‘futile encounters’ between enzyme and 
substrate before a productive complex forms.58 In this context, the mutations we observed 
could increase the likelihood of formation of productive enzyme–substrate complexes 
either by improving the energetics of proper cofactor alignment or by increasing the rate at 
which futile complexes dissociate. The observation that enhancements in all three kinetic 
parameters (kcat, cofactor KM and substrate KM) arise from mutations distal to the site of 
catalysis or substrate binding may seem counter-intuitive. In this context, it is useful to 
remember that kcat and KM values are indirect ‘black-box’ measures of the formation and 
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dissociation of a catalytically productive enzyme–cofactor–substrate complex.58 Therefore, 
cofactor binding that is better suited to the formation of a productive complex can be 
manifested in the turnover rate (kcat) or may promote substrate binding that is more likely to 
be catalytically productive. Measurement of the microscopic or single-turnover kinetic 
parameters governing these reactions may be able to de-convolute these effects and shed 
more light on how the mutations described here promote activity.  
In three out of ten enzymes tested thus far (LlAdhA, KpDHAT, and TeXR), no 
single mutation at these positions created variants with improved kinetics, indicating that 
these enzymes already lie at a local fitness optimum with respect to the targeted residues. 
No clear factor unites these three enzymes as distinct from the others studied, suggesting 
that the optimality of these positions is determined stochastically by the balance of genetic 
drift and natural selection.59,60  
In this study, we have empirically identified structural sites that have a strong 
effect on activity without themselves being catalytically crucial and demonstrated that we 
can find mutations that boost the catalytic efficiency of the enzyme through subtle 
structural and/or energetic changes that cannot be rationally designed or predicted. We 
propose targeting mutations near the adenine for site-saturation mutagenesis and screening 
for improved kinetics as a fast and simple way to improve or tune the catalytic properties of 
NAD(P)-dependent enzymes. With a demonstrated success rate of seven in ten, including 
the two previously published KARIs, this is the first general strategy that has been 
proposed for improving a broad category of enzymes for their natural functions. 
Furthermore, different kinetic properties of the enzymes were changed, including substrate 
and cofactor affinity as well as turnover rate, allowing for fine-tuning of enzymatic 
properties for specific applications. Finally, these results demonstrate that many enzymes 
have room for improvement of catalytic properties in vitro and likely also in vivo, which 
holds promise for the engineering of improved biocatalysts and metabolic pathways.  
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C h a p t e r  7  
A GENERAL TOOL FOR ENGINEERING THE NICOTINAMIDE COFACTOR 
SPECIFICITY OF ENZYMES 
Abstract 
The need to reverse the cofactor specificity of NAD/NADP dependent enzymes is a 
recurrent challenge in synthetic biology. Despite more than sixty enzymes having been 
engineered to switch cofactor specificity, specificity reversal remains difficult to 
accomplish and no one method easily and reliably identifies a set of mutations sufficient to 
the task. Drawing inspiration from a comprehensive survey of previous studies and our own 
engineering successes, we have developed a structure-guided semi-rational strategy for 
engineering the reversal of cofactor specificity. The efficacy of this strategy has been 
demonstrated by reversing the specificity of four structurally diverse NADP-dependent 
enzymes (glyoxylate reductase, cinnamyl alcohol dehydrogenase, xylose reductase, and 
iron-containing alcohol dehydrogenase). Finally, we have also implemented this approach 
as an easy-to-use web tool, Cofactor Specificity Reversal – Structural Analysis and LibrAry 
Design (CSR-SALAD), to enable use by a broad user base. 
Introduction 
The prospect of a transition from petroleum-based chemistry to bio-based 
manufacturing is one that is gaining traction. The USDA projects the market share for 
industrial production of bio-based specialty chemicals and biofuels to grow by more than 
10-fold by the end of the next decade.1 However, engineering highly efficient biosynthetic 
pathways and processes remains a challenging multi-factorial task, often requiring 
optimization of the reaction conditions, host strains, pathway expression levels, and the 
enzymes themselves.2-4  One common hurdle in the development of efficient pathways is 
the need to balance the production and consumption of the hydride transport cofactors 
nicotinamide adenine dinucleotide (NAD) and nicotinamide adenine dinucleotide 
phosphate (NADP).5  Several studies have shown how balancing cofactor availability can 
increase pathway yields by removing carbon inefficiencies and side products, eliminating 
oxygen requirements, or improving equilibrium metabolite levels.6-12  Although metabolic 
engineering approaches have been used to increase the availability of nicotinamide redox 
equivalents, the best results have come from the direct engineering of enzymes to alter their 
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specificities so that a given cofactor produced in one or more pathway steps is consumed in 
others.6,10  
Since the first report of engineered specificity reversal in 1990 by Scrutton and co-
workers, wherein an NADP-preferring glutathione reductase was engineered to use NAD 
by the introduction of seven residues from an NAD-preferring homologue,13 altering 
nicotinamide cofactor specificity has frequently been a target of protein engineering both 
for industrial applications as well as to address the fundamental question of how sequence 
and structure contribute to cofactor specificity. Tables 1-1 and 1-2 contain a list of more 
than 25 examples of cofactor switching in each direction (NADP-to-NAD and vice versa), 
updated from that of Khoury et al.14 However, as with the field of protein engineering more 
generally, the engineering of these proteins has occurred on an individual, piecemeal basis, 
with no single approach having proven consistently effective. Furthermore, such 
engineering has remained the province of experts, rather than becoming a tool for end-users 
such as metabolic engineers due to a requirement for specialized knowledge or software, or 
the equipment for high-throughput screening. Cofactor specificity reversal is a particularly 
challenging protein engineering task because the phosphate that distinguishes NAD from 
NADP possesses significant steric and electrostatic bulk. As a result, multiple simultaneous 
mutations have almost always been required for effective cofactor switching due to strong 
non-additivities in the effects of mutations.9,15,16 This renders ineffective most of the 
common tools in the directed evolution toolkit, such as random mutagenesis by error-prone 
PCR or iterative single site-saturation mutagenesis, both of which operate on an uphill-walk 
model for optimization. 
In Chapter 1, we developed a simple recipe for the cofactor specificity reversal of 
any member of the ketol-acid reductoisomerase (KARI) enzyme family.17  However, the 
diverse structural motifs that give rise to cofactor specificity18 prevent the direct extension 
of this recipe to the multitude of other NAD(P)-dependent enzyme families. In this chapter 
we provide a general approach that functions independent of protein fold and family. 
Additionally, we have designed this approach towards sufficient simplicity to make it 
accessible to non-specialist researchers. This semi-rational approach selects codons 
containing mixed nucleotides (degenerate codons) at structurally-identified positions so as 
to focus screening on mutations found to be most beneficial in previous studies. As such, it 
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balances the desire to keep library sizes small with the practical reality that the complex and 
dynamic nature of a binding pocket19-22 and the sensitivity to small changes in binding 
energy or orientation23,24 severely limit our ability to rationally predict functional 
sequences. 
To accompany this engineering framework, we have developed an easy-to-use 
online tool, CSR-SALAD (Cofactor Specificity Reversal – Structural Analysis and LibrAry 
Design; Figure 7-1ab) which analyzes NAD(P)-bound structures and suggests these small, 
semi-rational libraries. We demonstrate the efficacy of CSR-SALAD by reversing the 
cofactor specificity of four NADP-dependent enzymes from three different fold families.  
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Figure 7-1. The web interface of CSR-SALAD (a), and an example of the output (b). CSR-
SALAD performs three tasks (c): structure analysis, design of cofactor-switching libraries, 
and identification of positions for activity recovery. 
  
(a)$ (b)$
Analyze$
• Detect$residues$that$determine$cofactor$speciﬁcity$
• Classify$based$on$posi<on$and$orienta<on$
Switch$
• Design$small$degenerate$codon$library$for$reversal$of$speciﬁcity$
Recover$
• Iden<fy$structural$hotspots$likely$to$harbor$compensatory$muta<ons$
(c)$
Figure$1.$$The$web$interface$of$CSRHSALAD$(a),$and$an$example$of$the$output$(b).$$CSRHSALAD$performs$
three$tasks,$structure$analysis,$design$of$cofactorHswitching$libraries,$and$iden<ﬁca<on$of$posi<ons$for$
ac<vity$recovery$(c).$
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Approach 
In Chapter 1, we described a three-step process for reversing the cofactor 
specificity of KARIs: (a) identification of the residues involved in determining cofactor 
specificity, (b) creation of a small library by combinatorial mutation of these positions and 
screening for reversed cofactor preference, and (c) recovery of catalytic activity by 
mutagenesis outside the cofactor specificity-determining region (Figure 1-2).17 As shown in 
Figure 7-1c, the approach described herein and implemented in the CSR-SALAD web tool 
first generalizes these steps to a variety of cofactor-binding folds and both nicotinamide 
cofactors, and then uses the lessons of the accumulated literature on cofactor specificity to 
reduce each step to experimentally tractable levels. Computational formalization of these 
shortcuts serves to provide ease-of-use and reproducibility. The precise details of these 
formalizations can be found in the CSR-SALAD documentation (Chapter 8); here we focus 
on the lessons that guide them. 
Structural analysis 
As might be intuitively expected, nearly all of the experimentally-determined 
specificity-conferring residues lie in the immediate vicinity of the 2’ moiety of the 
NAD/NADP cofactor (the hydroxyl or phosphate; see Figure 1-1). While residues outside 
this vicinity have occasionally been mutated in cofactor-switched proteins, they have only 
rarely been shown to directly contribute to the reversal of specificity. In CSR-SALAD, the 
specificity-determining residues are therefore defined as those that contact the 2’ moiety 
directly, are in position to contact it through water-mediated interactions, or – specifically 
for NAD-to-NADP switching – can be mutated to contact the expanded 2’ moiety of the 
NADP cofactor. 
To assist with engineering, it is useful to obtain more information about a residue 
than simply whether or not it contacts the cofactor. Therefore, we have developed a system 
of residue classifications that describe the role of each residue in forming the cofactor-
binding pocket. This classification scheme was informed by that introduced in 1997 by 
Carugo and Argos.18 Like those classifications, it was developed using a structural 
alignment of NAD(P)-bound proteins – in this case, nearly 1,000 proteins instead of 32 – 
and an analysis of the properties of the contacting residues. These classifications are 
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assigned on the basis of which atoms of the cofactor a residue contacts and its position with 
respect to the adenine moiety (examples of the six classifications are shown in Figure 7-2). 
Structural classifications are important because the useful mutations to a ‘face’ histidine, 
for instance, might differ considerably from those made to an ‘edge’ or ‘bidentate’ 
histidine. 
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Figure 7-2. Examples of the six structural classifications used by CSR-SALAD. For more 
details, see the Table 8-2. Figures are from structures 1VC2, 1AMO, 1AMO, 1EZ0, 1CYD, 
and 1CYD, respectively. 
 
  
(a)$ (b)$ (c)$
(d)$ (e)$ (f)$
Figure$2.$$Examples$of$the$six$structural$classiﬁca<ons$used$by$CSRHSALAD.$$For$more$details,$see$the$CSRH
SALAD$documenta<on$online$or$in$the$Supplementary$Material.$$Figures$are$of$structures$1VC2,$1AMO,$
1AMO,$1EZ0,$1CYD,$and$1CYD$respec<vely.#$
Edge$ Bidentate$ Face$
Pyrophosphate$ Mo<f$ Other$
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Library design 
To keep library sizes small and easy to construct experimentally, CSR-SALAD 
uses sub-saturation degenerate codon libraries.25-27  This technique specifies mixtures of 
nucleotides (see Table 8-1)28 to generate specific mixtures of amino acids at each targeted 
position. Previous studies have selected degenerate codons on the basis of natural sequence 
variability or desired properties (i.e., NYC for hydrophobic amino acids or RRK for 
charged amino acids);27 selection of codons for cofactor switching in CSR-SALAD was 
guided by three considerations: 
a) Inclusion of mutations to structurally similar residues that have previously been 
shown to be useful for cofactor specificity reversal in the desired direction 
b) Inclusion of mutations to structurally homologous residues in proteins which 
naturally bind the desired cofactor 
c) Inclusion of mutations based on structural and engineering intuition about binding 
the desired cofactor or achieving reversed selectivity. 
To allow for library sizes to be tailored to the experimental throughput capabilities 
of the user, CSR-SALAD possesses a range of degenerate codons of different sizes for each 
residue in each structural class. The precise prioritization of residues within these codons, 
and the prioritizations of which positions are given the larger codons when library size 
limitations come into play, are subjective and based on an analysis of the engineering 
successes of prior studies by ourselves and others. We hope the application of the software 
will result in feedback that will further improve the algorithm as the available data 
increases.   
Activity recovery  
Cofactor-switched enzymes – or any enzymes with multiple mutations away from 
wild type – often suffer a significant loss of activity,17,29,30 and compensatory mutations 
must be found to recover this activity. These mutations re-stabilize or re-activate the protein 
with the new cofactor, and often lie remote from the cofactor switching mutations. In our 
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previous work on KARIs in Chapter 1, we recommended using random mutagenesis 
methods such as error-prone PCR and screening to discover these mutations. While highly 
effective, this may be beyond the capabilities of non-specialist labs. For CSR-SALAD, we 
have taken the unprecedented step of using structural information to predict residues with 
increased probabilities of harboring compensatory mutations. This allows single-site 
saturation libraries (generally 3–5 of them) to be rapidly screened and the best mutations 
combined to produce active enzymes. The activity-recovery positions fall into a number 
categories suggested by common features of previous engineering efforts, as outlined in the 
CSR-SALAD documentation (Chapter 8). In our hands the most effective have consistently 
been mutations around the adenine ring, and all of the mutations used in the experimental 
validation below fall into this category. In Chapter 6 we demonstrated the power of these 
mutations, in the absence of any other mutations, to boost the activities of native-like 
reactions for a number of NAD(P)-dependent enzymes.23  In cofactor-switched enzymes, 
the effects are even more dramatic, as we discovered by random mutagenesis and screening 
in several of the KARIs as described in Chapter 1.17,31 
Materials and Methods 
CSR-SALAD development 
CSR-SALAD was built in Python, relying heavily on the PDB module of the 
Biopython package.32 The analysis component was tested on a representative set of 499 
NAD-bound structures and 463 NADP-bound structures selected on the basis of sequence 
identity and resolution. Degenerate codon selection was assisted by the LibDesign26 and 
AA-Calculator33 tools and optimized using the Ambiguous Nucleotide Tool (ANT) 
framework.27 CSR-SALAD has been implemented as a PHP-based web-server that is 
available at http://www.che.caltech.edu/groups/fha/CSRSALAD/index.html. Further 
documentation of CSR-SALAD’s internal workings and guidelines for use can be found at 
that website or in the Chapter 8. 
Structure analysis  
Homology models were created using the SWISS-MODEL server34. For proteins 
crystallized without bound cofactor, cofactor was manually placed by alignment with a 
homologous protein, followed by manual side-chain rotamer adjustments in PyMol.35  
  
144 
Cloning and library creation 
Genes were either obtained from Integrated DNA Technologies (IDT) as gBlock 
linear fragments or cloned from pre-existing vectors, and were cloned into pET22b(+) in 
frame with the C-terminal His6-tag for expression in Escherichia coli BL21(DE3) ‘E. 
Cloni’ (Lucigen) using Gibson cloning36 with overlap at the T7 promoter and terminator 
sequences. Mutagenic primers for site-saturation mutagenesis were obtained from IDT and 
treated as suggested by IDT protocols. Libraries were generated using a modified version of 
the QuikChange method (Stratagene) as described previously.37  Some of the libraries 
screened were based on early versions of the CSR-SALAD algorithm, but all reported 
mutants are found in the CSR-SALAD libraries generated using default parameters. 
Following transformation with library DNA, single colonies were picked with 
sterile toothpicks and inoculated into 300 µL of Luria broth supplemented with 100 µg/mL 
ampicillin (LB-Amp) in shallow-well 96-well plates. Following overnight growth at 37 °C 
with shaking at 225 rpm and 80% humidity, 50 µL of the precultures were added to 600 µL 
of fresh LB-Amp media in deep-well 96-well plates and grown for 3 h at 37 °C. Then, 50 
µL of additional LB-Amp containing 0.25 mM isopropyl thiogalactopyranoside (IPTG) 
were added and expression was continued at a reduced temperature. For expression 
temperatures and times, see Table 7-1. The expression cultures were harvested through 
centrifugation, and the plates containing cell pellets were stored at -20 °C until screening. 
Library screening 
Assay procedures varied depending on the protein. The following is the general 
protocol, but deviations for specific proteins are listed in Table 7-1. E. coli cells were 
resuspended in the appropriate lysis buffer (Table 7-1) containing 750 mg/L lysozyme, 10 
mg/L DNase I, and 2 mM MgCl2. Lysis was accomplished at 37 °C for 1 h. Enzyme 
activities were then assayed by monitoring NAD(P)H consumption in the presence of the 
substrate molecule at 340 nm in a plate reader. 
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Table 7-1. Details for expression, lysis, and assay conditions for enzymes used for validation of CSR-SALAD. 
Enzyme 
  
Expression 
Conditions 
Lysis Conditions Assay Conditions Notes 
Arabidopsis thaliana 
glyoxylate reductase 
Luria broth 
24 °C, 18 h 
100 mM hydroxyethyl-
piperazineethanesulfonic 
acid (HEPES) pH 7.8 
100 mM HEPES pH 7.8 
1 mM sodium glyoxylate 
 
Saccharomyces 
cerevisae cinnamyl 
alcohol dehydrogenase 
Luria broth 
20 °C, 18 h 
33 mM sodium 
phosphate pH 7 
10% 10x BugBuster 
33 mM sodium phosphate pH 7 
0.5 mM trans-cinnamaldehyde 
 
Talaromyces emersonii 
xylose reductase 
Luria broth 
25 °C, 18 h 
50 mM potassium 
phosphate pH 7 
50 mM potassium phosphate pH 7 
400 mM xylose 
 
Thermotoga maritima 
iron-containing alcohol 
dehydrogenase 
Luria broth 
20 °C, 18 h 
33 mM sodium 
phosphate pH 7 
10% 10x BugBuster 
33 mM sodium phosphate pH 7 
0.1% (v/v) n-butanal (~10 mM) 
Enzyme had no prior experimental characterization. 
Initial tests showed it was more active on n-butanal 
than on propanal or furfural. 
Thermobifida fusca 
phenylacetone 
monooxygenase 
Luria broth 
30 °C, 4 h 
50 mM potassium 
phosphate pH 7 
50 mM potassium phosphate pH 7 
0.5 mM phenylacetaldehyde 
Used Breathe Easier membranes (Diversified 
Biotech) instead of polystyrene lid when growing in 
96-well plates. 
 
Preferred substrate (phenylacetone) is a Schedule II 
controlled substance, but PAMO is active with 
phenylacetaldehyde as well.38 
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Enzyme expression, purification, and kinetic measurements 
For larger-scale expression, 5–50 mL pre-cultures were grown overnight and diluted 1:250 
into fresh media for expression. After expression cultures reached an OD600 of 0.6–0.9, they were 
induced with IPTG to a final concentration of 0.5 mM. Expression then proceeded for the same times 
and temperatures used for library expression. Expression cultures were harvested by centrifugation, 
the supernatant was discarded, and the pellets were frozen at -20 °C. 
For purification, cell pellets were resuspended in 10–20 mL buffer A (25 mM Tris, 100 mM 
NaCl, 20 mM imidazole, pH 7.4) and lysed by sonication or using BugBuster protein extraction 
reagent (EMD Millipore). The lysate was clarified by centrifugation, and the enzymes were purified 
via their C-terminal His6-tag using High Performance (HP) Ni-NTA Sepharose columns (GE 
Healthcare, Waukesha, WI, USA) on an Äkta Xpress FPLC (GE Healthcare). The concentration of 
purified protein was determined using the Bradford assay (Bio-Rad, Hercules, CA, USA).  
For rate measurements, kcat values were determined using the same assay conditions as 
above with saturating cofactor and substrate. Michaelis–Menten constants were determined by 
varying cofactor concentration, and activity was monitored using fluorescence (excitation 340 nm, 
emission 440 nm) for improved sensitivity. At least six cofactor concentrations were used for these 
determinations, and all measurements were performed at least three times. MatLab (Mathworks, 
Natwick, MA, USA) was used for parameter fitting. 
Results 
Comparison to previous studies 
Because this study relies heavily on the results of previous studies, and as a positive control, 
we first determined whether modestly-sized CSR-SALAD libraries could recapitulate the mutations 
discovered in previous experiments. Because there may be several sets of mutations that will reverse 
cofactor specificity for a given enzyme9,39-41 and because not all results of prior studies have been 
highly successful, we do not expect a perfect match. Nevertheless, of the 12 previous NADP-to-
NAD and 17 NAD-to-NADP studies that reported a reversal of specificity and a final activity greater 
than 10% of initial activity, CSR-SALAD libraries generated using default parameters contained the 
best individual mutants (not including distal compensatory mutations) for 7 (58%) and 11 (65%), 
respectively. (Table 7-2). Full data on mutant recapitulation are found in Tables S7-1 and S7-2. 
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Table 7-2. Recapitulation of mutants from previous successful nicotinamide cofactor specificity 
reversals. For a full breakdown of mutant recapitulation, see Tables S7-1 and S7-2. 
Percent mutations 
recapitulated 0% 1-49% 50-99% 100% 
NADP-to-NAD 0 1 4 7 
NAD-to-NADP 1 4 1 11 
Includes only mutants that had kcat/KM for the switched cofactor greater than the wild type’s preferred 
cofactor and where mutant kcat/KM was at least 10% of wild type. This count excludes residues distal 
to the 2’ binding pocket. 
 
 
Experimental validation 
To demonstrate the utility of CSR-SALAD for predicting cofactor-switching mutations, we 
selected a test set of five enzymes drawn from those previously studied in our lab and enzymes with 
industrial potential: Arabidopsis thaliana glyoxylate reductase (GR), Saccharomyces cerevisae 
cinnamyl alcohol dehydrogenase (CinADH), Talaromyces emersonii xylose reductase (XR), 
Thermotoga maritima iron-containing alcohol dehydrogenase (FeADH), and Thermobifida fusca 
phenylacetone monooxygenase (PAMO) (Table 7-3). Although CSR-SALAD is capable of 
processing NAD and NADP-bound structures, we focused only on NADP-preferring enzymes, 
because NADP-to-NAD switching is generally considered to be more industrially relevant42-44 and 
has also proved to be more difficult to achieve in the past (Tables 1-1 and 1-2). The selected 
enzymes include the most common NAD(P)-binding fold, the Rossmann fold, as well as other folds 
less commonly used for nicotinamide cofactor binding (TIM barrel, dihydroquinoate synthase-like, 
and FAD/NAD-binding fold). To demonstrate the robustness of CSR-SALAD analysis, we also 
included one protein (T. emersonii XR) without a crystal structure, but for which the structure of a 
homologous enzyme with high sequence identity was known, and one enzyme (A. thaliana GR) that 
was crystallized in the absence of the cofactor. For each of these, we generated the library predicted 
using CSR-SALAD and screened it for cofactor-switched variants. The best of these variants were 
then subjected to between zero and two rounds of single-site saturation mutagenesis for activity 
recovery, and the best final variants were purified and characterized for Michaelis-Menten kinetics 
(Tables 7-3 and 7-4). 
For the four oxidoreductases – A. thaliana GR, S. cerevisae CinADH, T. emersonii XR, and 
T. maritima FeADH – cofactor specificity was successfully reversed, and for three of those four the 
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catalytic activity was recovered back to significant levels (>10% of wild type). Indeed, these 
represent three of the most successful NADP-to-NAD cofactor specificity reversals ever reported 
(Table 1-1). For T. emersonii XR, which we were also able to switch, the activity recovery was less 
successful. We suspect that, should greater activity be required, further compensatory mutations 
could be found by traditional directed evolution methods.17 
Notably, the sets of mutations found for each enzyme show no significant overlap or 
patterns. Indeed, the only mutation that shows up twice, serine-to-glycine in T. emersonii XR and T. 
maritima FeADH, occurs in residues that are in different structural classes. Further, while each set of 
mutations contains one or more mutations to a negatively-charged residue, these mutations come 
from residues with different structural classes in the wild-type binding of the cofactors (Figure 7-3), 
while the rest of the mutations introduce amino acids whose role in cofactor specificity is less 
immediately evident. This reinforces the assumptions underlying the CSR-SALAD approach: that 
the precise determinants of cofactor specificity are often difficult to predict but that active proteins 
can be selected from libraries containing reasonable sets of potential contacts.  
For T. fusca phenylacetone monooxygenase (PAMO), a Baeyer-Villiger monooxygenase 
(BVMO), we were also able to produce a mutant enzyme that consumed NADH faster than NADPH. 
However, the cofactor consumption of the purified enzyme was found to be nearly completely 
uncoupled from product formation, with cofactor oxidation rates that were entirely independent of 
substrate (phenylacetaldehyde) concentration. Because this enzyme displays activity on a 
considerable range of substrates, including compounds naturally present in E. coli lysate, it was 
impossible to perform a negative screen against uncoupling, and none of the mutations at recovery 
positions restored coupling. While previous studies on the nicotinamide cofactor specificity of 
BVMOs have proposed that the 2’-phosphate may be essential for catalytic function,45 the existence 
of naturally bispecific BVMOs rebuts this.46-48 We instead propose that in enzymes such as BVMOs, 
with multi-step electron-transfer pathways, the precise alignment of the donor-acceptor pairs is much 
more sensitive to perturbation than with oxidoreductases, resulting in premature loss of the hydride 
to acceptors such as molecular oxygen. Similar results have been seen in attempts to engineer the 
specificity of P450 reductases.49,50 Therefore, successfully switching the cofactor specificities of 
these enzymes may require the ability to more accurately predict the resultant cofactor geometries, 
or, more likely, the ability to screen much larger libraries while also monitoring uncoupling or 
product formation. 
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Table 7-3: NADP-preferring enzymes used for experimental validation in this study. UniProt IDs, PDB accession codes, and Structural 
Classification of Proteins (SCOP) classification of their cofactor binding folds are listed for each. Mutations in bold are those used for switching 
cofactor specificity, others are from recovery libraries. Fold changes from wild-type kinetics are provided, as is the log of the mutant’s NADH 
kcat/KM divided by the wild-type NADPH kcat/KM. Specific values for wild-type and mutant enzymes are provided in Table 7-4. 
     
Fold change from wild type 
log 
(NADHmut/ 
NADPHWT) 
     
NADH NADPH Specificity 
Enzyme UniProt 
RCSB 
PDB Fold (SCOP) Mutations kcat KM kcat/KM kcat KM kcat/KM 
(NADH/ 
NADPH)c 
Arabidopsis thaliana 
glyoxylate reductase Q9LSV0 3DOJa 
Rossmann 
(c.2.1.6) 
R31L, T32K, 
K35D, C68R 2.36 0.88 2.67 0.37 4.55 0.08 33 -0.71 
Saccharomyces 
cerevisae cinnamyl 
alcohol dehydrogenase Q04894 1PIW 
Rossmann 
(c.2.1.1) 
S210D, R211P, 
K215E, S253P 104.90 0.55 191.36 1.54 0.53 2.90 65 0.77 
Talaromyces emersonii 
xylose reductase C5J3R6 1K8Cb 
TIM Barrel 
(c.1.7.1) 
S272G, N273D, 
R277Y, Q280E 13.45 0.44 30.67 0.02 2.48 0.01 4900 -1.48 
Thermotoga maritima 
iron-containing alcohol 
dehydrogenase Q9X022 1VHD 
DHQS-like 
(e.22.1.2) 
G36E, S38N, 
S39G 0.88 0.15 5.87 0.20 2.29 0.07 84 0.47 
Thermobifida fusca 
phenylacetone 
monooxygenase Q47PU3 2YLR 
FAD/NAD 
pair (c.3.1.5) 
R217T, T218E, 
K336Y 0.29d 0.52 0.56 0.00d 7.29 0.00 3600 -3.67 
aStructure 3DOJ has no cofactor, so the cofactor was introduced from structure 3PEF (G. metallireducens γ-hydroxybutyrate dehydrogenase) on the 
basis of a backbone alignment. 
bT. emersonii xylose reductase (XR) has not been crystallized, so a homology model was generated from 1K8C, the structure of an XR from C. 
tenuis. 
cSpecificity is the ratio of NADH kcat/KM divided by NADPH kcat/KM for each enzyme. Presented here is fold change. 
dThe mutant enzyme displayed >99% uncoupling for both cofactors. 
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Table 7-4: Kinetics of proteins used for the validation of CSR-SALAD. 
 NADH  NADPH kcat/KM Specificity % Uncoupling 
Protein kcat (min-1) KM (µM-1) kcat/KM (min-1 µM-1)  kcat (min-1) KM (µM-1) kcat/KM (min-1 µM-1) NADH/NADPH NADH NADPH 
A. thaliana GR 440 ± 50 76 ± 24 5.8 ± 1.9  1600 ± 230 20 ± 6 79.8 ± 26.6 0.07 ± 0.03 N/Da N/D 
AtGR R31L, T32K, K35D, C68R 1030 ± 190 67 ± 15 15.4 ± 4.5  590 ± 140 91 ± 21 6.5 ± 2.1 2.36 ± 1.04 N/D N/D 
S. cerevisae CinADH 180 ± 70 55 ± 23 3.4 ± 2.0  12350 ± 50  113 ± 46 109.1 ± 43.9 0.03 ± 0.02 N/D N/D 
ScCinADH S210D, R211P K215E, S253P  19400 ± 7850 30 ± 23 648.7 ± 512.6  18970 ± 1670 60  ± 43 316.9 ± 231.5 2.05 ± 2.20 N/D N/D 
T. emersonii XR 8 ± 1 259 ± 18 0.03 ± 0.003  2540 ± 220 85 ± 73 29.7 ± 25.5 0.001 ± 0.0009 N/D N/D 
TeXR S272G, N273D, R277Y, Q280E 110 ± 40 114 ± 76 0.97 ± 0.74  40 ± 4 212 ± 19 0.2 ± 0.03 5.23 ± 4.04 N/D N/D 
T. maritima FeADH 1310 ± 140 749 ± 403 1.75 ± 0.96  1390 ± 270 402 ± 90 3.46 ± 1.02 0.51 ± 0.32 N/D N/D 
TmFeADH G36E, S38N, S39G 1160 ± 10 112 ± 112 10.29 ± 10.26  280 ± 80 1175 ± 1538 0.24 ± 0.32 42.70 ± 71.26 N/D N/D 
T. fusca PAMO 30 ± 6 182 ± 68 0.16 ± 0.07  10520 ± 530 26 ± 19 405.14 ± 294.74 0.0004 ± 0.0003 62% 2% 
TfPAMO R217T, T218E, K336Y 8 ± 1 94 ± 33 0.08 ± 0.03  10 ± 3 189 ± 66 0.06 ± 0.03 1.38 ± 0.77 >99% >99% 
aN/D = not detected 
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Figure 7-3. Structures of wild type proteins (or homology models) (left) and models of the mutations 
made (right) for A. thaliana GR (a), S. cerevisae CinADH (b), T. emersonii XR (c), T. maritima 
FeADH (d), and T. fusca PAMO (e). Mutations are colored with white carbons, and were introduced 
in PyMol without any structural minimization or optimization. Selected hydrophilic interactions are 
shown with yellow dashed lines. 
(a)$
(b)$
(c)$
(d)$
(e)$
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Discussion 
Semi-rational protein engineering, whether using degenerate codon libraries or other 
mutagenesis strategies, has become commonplace as a way to reap the advantages of both rational 
and evolutionary protein engineering.2,51-54 In this study, we have created a tool to guide the creation 
of semi-rational libraries for a common protein engineering task, reversal of nicotinamide cofactor 
specificity, in an attempt to render it reliable and accessible to a broad base of potential users. 
Nicotinamide cofactor specificity engineering provides a number of distinct advantages for 
an approach of this kind. First, despite the important role of the adenosine end of the cofactor in 
providing a recognition element and binding anchor for the nicotinamide moiety, there is 
considerable structural diversity among NAD(P)-binding proteins, both in their overall fold and in 
the specific motif for binding to the 2’-phosphate of NADP or the 2’ hydroxyl of NAD.18,55 In the 
past, this structural diversity has been a barrier to transferring cofactor engineering solutions between 
proteins,17 but it also suggests that protein engineers do not need to replicate a specific NAD- or 
NADP-binding mode, and instead that simply providing the right potential contacts in reasonable 
geometries to allow binding can be sufficient. This hypothesis is central to the semi-rational 
approach developed in this paper, which makes no predictions about specific binding pocket 
geometries but instead creates focused diversity that matches the diverse binding modes of known 
natural and engineered NAD(P)-binding proteins. 
Another feature of the cofactor specificity problem that makes it amenable to this approach 
is that the distinct spectral signature of reduced NAD(P) allows for rapid medium-to-high-throughput 
screening of libraries in lysate without the need for expensive equipment. Finally, the wealth of 
previous studies on the structural determinants of cofactor specificity and the numerous previous 
attempts to reverse specificity have generated a large data set from which we can seek inspiration. 
Though we validated CSR-SALAD only on NADP-to-NAD switching, the same advantages that 
apply equally to NAD-to-NADP switching, and CSR-SALAD has been developed to design libraries 
for this task based on the same criteria.  
As protein engineering grows as a discipline, methods will need to be developed that balance 
reliability with speed and ease-of-use. In current practice, each protein to be engineered is a new 
problem that must be approached with careful consideration of strategy and methods. With CSR-
SALAD, we have developed a framework for reliably performing a common and challenging protein 
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engineering task with modest experimental effort and with a minimum of required expertise. It 
remains to be seen whether similar structure-based semi-rational approaches can be developed for 
other protein engineering targets. Such targets would need to be localizable to a single region or class 
of residues on the protein, have sufficient prior literature to draw lessons, and have available high-
throughput screening methodologies. Nevertheless, we foresee that in the meantime CSR-SALAD 
will be of great utility for the fields of synthetic biology, metabolic engineering, and biocatalysts, and 
will make the reversal of cofactor specificity a routine task rather than a formidable engineering 
endeavor. 
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C h a p t e r  8  
COFACTOR SPECIFICITY REVERSAL – STRUCTURAL ANALYSIS AND LIBRARY 
DESIGN (CSR-SALAD) USERS MANUAL 
Material from this chapter appears online at http://www.che.caltech.edu/groups/fha/ 
CSRSALAD/About.html, and will updated as changes to the CSR-SALAD tool are 
made. 
Introduction 
The Cofactor Specificity Reversal – Structural Analysis and LibrAry Design (CSR-SALAD) 
web tool has been designed with the goal of taking a common protein engineering target – the 
alternation of NAD(P) cofactor specificity in an enzyme – and bringing it from the specialized realm 
of protein engineering to a level accessible to the end-users of these proteins, and to render this task 
as routine and dependable as can be achieved for such a complicated system as a protein. 
Cofactor switching has been a well-studied problem, and one for which many results – 
highly successful and less so – have been published. By learning from the successes of the past, we 
can design libraries in a semi-rational manner that allows for mutational solutions to be found in a 
targeted manner. By automating the analysis process, we hope to allow make CSR-SALAD a regular 
part of the bioengineering toolbox that does not require special training or skills. 
How to use CSR-SALAD 
CSR-SALAD requires an input structure in .pdb format for analysis, which must have an 
NAD(P)(H) ligand bound. For proteins that have already had structures published, you can access 
the pdb file directly using the 4-character accession code used in the RCSB PDB, PDBe, or PDBj. 
Accession codes are not case sensitive. If you want to make any changes to the PDB file, you’ll have 
to download it and make those changes manually. You can do this by going to the webpages for the 
PDB (www.rcsb.org/pdb/home/home.do) and downloading the files, which can be opened in any 
text editor. Also, it may take a few days after structures become available on the PDB for automatic 
download to work. These structures can still be downloaded manually and uploaded to CSR-
SALAD. 
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Files can also be uploaded from your computer using the “Choose File” button on the CSR-
SALAD homepage. For security reasons, any characters other than alpha-numerics, period, dash, and 
whitespace will be stripped from your file before processing. Files must be uploaded in standard .pdb 
format for proper recognition by the Bio.PDB Python package and CSR-SALAD. For more 
information on the PDB format, see http://www.wwpdb.org/documentation/file-format. All user-
uploaded files are stored as temporary variables, such that they are erased immediately after the 
output is generated. 
CSR-SALAD is capable of processing .pdb files with multiple chains, but if the cofactor is 
in different poses between the chains, the analysis will consider all of them. If you suspect that some 
of the cofactor-binding poses in your structure are not physiologically relevant, it may be preferable 
to delete these cofactor instances. If there are multiple cofactor molecules per chain, CSR-SALAD 
will not discriminate among them. Similarly, while CSR-SALAD automatically detects NAD and 
NADP and discriminates between them, structures with both may result in inappropriate analysis. 
One of the cofactor types should be deleted. 
Cofactors molecules must be named as NAD, NAI, NAP, or NDP, and atom names must be 
named according to the standard PDB nomenclature, as shown in Figure 8-1. Missing cofactor atoms 
at the nicotinamide end of the molecule are acceptable, but atoms of the cofactor required for the 
structural classification must be present. 
Because many structures use inconsistent numbering between chains, all residue numbers 
are considered modulo 500. That is, residue 121 is assumed to be the same residue as 621 and 1021. 
To our knowledge, no proteins bind cofactors with multiple residues separated by 500 residues or 
more, let alone by exactly 500 residues or 1000 residues, but if this poses problems for you consider 
renumbering certain residues to remove ambiguity. 
When a structure of your protein is not available, homology models can be created, i.e., with 
the SWISS-MODEL system (www.swissmodel.expasy.org), or the structure of a high-similarity 
protein can be used as a stand-in for your protein. Additionally, it may be useful to transfer the 
cofactor molecule from a protein with a similar fold if your protein has not been co-crystallized with 
the cofactor. When making adjustments such as these, it is important to manually inspect and adjust 
the positions of the side-chains (i.e., using PyMol or Coot) around the cofactor to approximate 
predicted physiological binding geometries. 
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Before running CSR-SALAD, select a maximum size for the cofactor-switching library. 
This size should be determined by the throughput of your experimental setup; you should aim to 
screen two to three colonies for each library member to ensure complete coverage. Ideal library sizes 
will depend on the complexity of the binding site in your cofactor, but values under 40 will be 
rejected. Recommended library sizes might be considerably lower than the maximum entered. 
Finally, CSR-SALAD allows for a handful of additional options to be selected manually 
under the ‘Advanced Options’ panel. Three allow you to exclude certain classes of residues from 
consideration in the cofactor-switching library. Exclusion of these residue classes (below) allows for 
the library to be more focused on the positions likely to be most useful in switching, but also misses 
the chance of finding beneficial mutations in the first step of engineering. 
i. Residues of the glycine-rich “fingerprint motif” which interact with the adenine. This motif 
is characteristic of the common Rossmann fold, where the glycines hydrogen-bond to the 
pyrophosphate that bridges the adenosine and nicotinamide moieties. While some of the 
(non-glycine) residues of this provide interactions with the 2’ position of the cofactor that 
may determine specificity, mutations here have not frequently been found to be useful in 
engineering specificity and are often very disruptive. 
ii. Residues that, in addition to interacting with the 2’ position of the cofactor, also interact with 
the pyrophosphate. These residues often provide a significant amount of binding energy for 
the cofactor as a whole and therefore mutations can be very detrimental to overall cofactor 
binding ability. 
iii. Peripheral residues that do not have obvious interactions with the 2’ position of the cofactor, 
but which might nevertheless play a role in cofactor specificity by means of transient 
interactions in alternate protein conformations or through interactions with the network of 
waters around the binding pocket. Mutations at these positions generally have minimal 
effects, but in some cases have been shown to be important for reversing cofactor 
specificity. 
The final option generates an expansive log of the calculations made by CSR-SALAD 
during the library design process, focused on the criteria behind residue exclusion/inclusion and 
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structural classification, as outlined below. This log is intended for debugging processes, such as if 
CSR-SALAD makes decisions you find questionable, but can also give a “peek under the hood”. 
CSR-SALAD results come in three sections. 
i. Messages: In some cases, minor problems in structure parsing may prevent proper 
completion of the CSR-SALAD analysis. These issues are reported in messages shown at 
the top of the output. It may be worthwhile to consider modifying the input structure or 
parameters to resolve these issues before rerunning CSR-SALAD. 
ii. Cofactor-switching library: The library suggested for cofactor specificity reversal is 
presented in a four column table. The first two columns describe the residue present in the 
wild-type structure, giving its identity, numbering, and a description of the structural role it 
plays in the protein. For more detail on these structural roles, see below. The second two 
columns give the library recommendation made by CSR-SALAD, the former being a 
degenerate codon (see Table 8-1) and the latter being the amino acids it codes for. If the 
codon is listed as ‘---‘ the DNA should be left unmutated. 
iii. Activity-recovery hotspots: Because cofactor-switching often leads to significant decreases 
in overall activity, CSR-SALAD recommends positions around the cofactor where 
mutations ought to have large effects on binding orientation and energetics. They are 
presented in 1-3 groups, starting from those most likely, in our experience, to provide 
activating mutations. The types of amino acids presented are: 
High Priority 
• Residues passed over for mutagenesis on the basis of library size limitations 
• Residues passed over for mutagenesis on the basis of the ‘exclude’ 
advanced options 
Medium Priority 
• Residues around the adenine but not involved in determining cofactor 
specificity.1 
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Low Priority 
• Residues that made hydrogen bond contacts in the input structure with 
residues included in the switching library (which now potentially have 
unsatisfied H-bond donors or acceptors) 
• Charged residues around the binding pocket that likely acted to create local 
charge balance with the direct 2’-specificity determining residues. 
Below this output is printed the verbose log file (if requested) and the options used for 
generation of the library. If you provide your email address the full output will be emailed to you. 
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Figure 8-1. Atom labels for NAD(H) and NADP(H) from the PDB. 
 
 
 
Table 8-1. The mixed base pair notations2 used by CSR-SALAD for the generation of degenerate 
codons, showing the base pairs included. Oligonucleotides containing mixed bases can be purchased 
from most oligonucleotide suppliers. 
A/T/G/C As normal N A C G T B C G T 
Y C T R A G D A G T 
S G C W A T H A C T 
K T G M A C V A C G 
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How to use CSR-SALAD results in the lab 
This section is not intended to be a comprehensive methodological tutorial, but to give an 
introduction to the relevant experimental techniques. While the methods described herein are those 
used by the Arnold Group, any other methods for the screening of mutant libraries should be 
compatible with CSR-SALAD. 
Before any engineering can take place, it is essential to have robust protocols established for 
the wild-type enzyme. We generally express the proteins in BL-21 E. coli with a pET vector and a C-
terminal His6-tag. Sufficient expression is necessary that activity can be detected in the lysate of sub-
mL cultures grown in 96-well plates, and the assay should give clear and consistent linear signal on 
the natively-preferred cofactor if not on the other. Expression can be optimized by media selection, 
expression time and temperature, and lysis conditions. Assay conditions can be optimized by varying 
lysate volume, cofactor and substrate concentrations, and buffer components. 
Libraries can be cloned using any desired method, including SOE-PCR, exponential quick-
change, or round-the-horn PCR. When sites of the switching libraries cannot be cloned in a single 
step, it’s best to clone the smaller sub-library first, and then use it as a template to clone the full 
library, rather than the other way around. Also, be careful to to include any mutations from the 
switching library when designing primers for recovery libraries to avoid accidentally reverting them 
to wild type. 
After cloning libraries, transform and plate on agar at a density that yields distinct single 
colonies. Screening of libraries is best accomplished in multi-well plates, such as 96-well blocks. 
Pick individual colonies into single wells containing 300 µL of culture media using toothpicks or 
pipette tips and grow overnight with shaking to produce saturated starter cultures. Transfer 50 µL of 
this starter culture to 600 µL of fresh media in a new plate for expression, and store the rest of the 
starter plate at 4 °C for up to a week. The expression plate should be grown and induced in whatever 
fashion is optimal for your protein, then harvested by centrifugation, and the supernatant discarded. 
Pellets can be stored at -20 °C for at least a month. 
Cell pellets are lysed with 200-300 µL of a buffered solution containing 2 mM MgCl2, 750 
mg/L lysozyme, and 10 mg/L DNaseI. One hour at 37 °C can be used for most proteins, although 
some respond better to lower temperatures and higher lysozyme concentrations or longer lysis 
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durations. Alternately, an extraction reagent such as BugBuster or SoluLyse can be added to speed 
lysis at room temperature, although some proteins are inhibited by the detergents. 
After lysis, lysates should be clarified by centrifugation and the supernatant aliquoted to 96-
well assay plates, where it is combined with the assay buffer (containing substrate and cofactor) and 
the reaction progress is monitored by the change in absorbance at 340 nm on a plate reader, or by the 
change in fluorescence if the plate reader is equipped for that (excitation 340 nm, emission 440 nm). 
Starting cofactor and substrate concentrations should be near the natural KMs of the enzyme. Most 
reactions will go to completion within 5 minutes, although some may be faster or slower. Faster 
reactions can be slowed by dilution of the lysate. 
The enzyme variants with the best rates on the desired cofactor should be rescreened before 
additional characterization is performed. From the starter plates, streak agar plates with the mutants 
of interest and pick new starter plates with multiple colonies from each ‘hit’. These plates should be 
expressed and assayed as before to ensure that cultures were monoclonal and that activities are 
reproducible. DNA can then be purified from the best hits for sequencing and subsequent 
mutagenesis. 
While for many applications only in-cell activity is relevant, it is important to characterize 
kinetics of purified protein in a more thorough fashion. In part, this can important for teasing apart 
the contributions of kcat and KM, but also because understanding activity in a protein-expression-
independent context can allow for an understanding of the expression effects of mutations. Some 
mutants, which appear significantly improved in lysate can show small or even nonexistent 
improvements in kinetic properties if they boost expression levels, while other seemingly small 
improvements can become much larger when decreased protein yields are considered. Understanding 
the relative contributions of expression, affinity, and activity can be useful in planning further 
experiments or in the optimization of applied setups to maximize substrate conversion. 
Protocols for protein purification and kinetic assays are widely available; here we provide 
only a short summary of our methods. After scaled-up (0.2-2 L, depending on expression levels) 
growth of E. coli and expression of proteins, cell pellets are frozen and thawed before resuspension 
in His-Trap buffer A. Lysis by sonication or detergent solubilization is followed by centrifugal 
clarification, and then the protein is purified on an FPLC with a Ni-NTA column, eluting with an 
imidazole gradient. If the protein is to be kept overnight or frozen for later characterization, it should 
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subsequently be buffer exchanged into an imidazole-free buffer by dialysis or centrifugal 
concentration and redilution, but we prefer to do kinetic characterization immediately. 
For the determination of cofactor KM, protein can be mixed with an assay buffer containing 
substrate and with cofactor, and the progress of the reaction monitored. We use fluorescence 
(excitation 340 nm, emission 440 nm) for kinetics because it is more sensitive and therefore allows 
for the detection of activity at lower cofactor concentrations which would be undetectable by 
absorbance alone. By varying cofactor concentration and keeping substrate and protein concentration 
constant (substrate concentration should be saturating), sufficient data can be collected to fit a 
Michaelis-Menten or Hill equation and solve for KM (or KH). Substrate affinity can be determined 
similarly, using constant saturating cofactor and varying the substrate concentration. When possible, 
check for uncoupling by running the reaction in the absence of substrate. Because fluorescence 
detection is not precisely linear with concentration, we prefer to use a separate experiment to 
determine kcat, where the rate of cofactor consumption (in the saturated range) is measured using 
absorbance, and compared to a calibration curve to determine precise activity. Protein concentration 
can be determined using a Bradford colorimetric or other assay. 
How CSR-SALAD works 
The website is hosted on the cheme.caltech.edu server, which is managed by the Department 
of Chemistry and Chemical Engineering at the California Institute of Technology. The CSR-SALAD 
webpage is implemented primarily in HTML 4.01. A PHP script parses user input and options and 
executes the CSR-SALAD algorithm, which is implemented as a Python script. Files and user input 
are retrieved using the HTML POST function and held as temporary variables. All information from 
a session is deleted upon completion of the execution of the script. As such, user-uploaded pdb files 
and email addresses are never recorded or saved on the server.  
CSR-SALAD is implemented in Python 2.7.x, and relies heavily on the Biopython PDB 
module (http://biopython.org/wiki/The_Biopython_Structural_Bioinformatics_FAQ) for structural 
analysis. The numpy, itertools, and operator modules are also used. 
Structural analysis 
Once the structure has been uploaded and parsed with Bio.PDB, the first step is to select and 
classify the residues. Table 8-2 contains the basic residue classifications used by CSR-SALAD. 
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Several of them have multiple names, based on differential geometry definitions, which are more 
useful for diagnostics than as indicators of structural function. 
Identification of specificity-determining residues works by first using an expansive distance-
based definition to identify potential residues and then paring back residues which fail to meet 
certain geometric criteria. Potential phosphate-binding residues are those which have atoms within 
4.2 Å of certain cofactor atoms. For NADP, these are the atoms of the phosphate, {O2B, P2B, O1X, 
O2X, O3X}. For NAD, this set is modified slightly to find residues that might be mutated to bind the 
phosphate but which currently do not interact with the 2’-hydroxyl. That set is {O2B, O3B, C4A, 
N3A}. Atoms within this distance are considered individually before being considered as members 
of an amino acid. Backbone residues are not considered, since they do not change upon mutation. 
Also, any atom not belonging to an amino acid is excluded, since they similarly cannot be mutated to 
alter selectivity. Hydrogen atoms are also not considered, because they are not present in most 
structures and the geometry definitions have not been developed with them in mind. Because the list 
of NAD atoms from which potential residues are found contains residues on the adenine ring, it is 
important to only consider residues that can be mutated to interact with the 2’ moiety. Specifically, 
residues must be on the same face of the adenine as the hydroxyls of the ribose. For that reason, 
atoms are excluded if they are 0.75 Å (or more) closer to O4B than to O2B. 
After this point, the atoms are considered on the basis of the residues to which they belong. 
Glycines in GX(X)GX(X)[G/A] motifs are excluded, as are the other amino acids of the motif if that 
option has been selected. Other glycines are excluded if their N is closer to the cofactor atom than 
their CA, which would indicate that mutations would produce side chains facing away from the 
cofactor. 
To check whether other residues point towards the cofactor, it is necessary to introduce the 
concept of the side-chain pseudocenter, which is adapted from Bahar and Jernigan.3 This is the 
geometric centroid, in 3D space, of the locations of a set of key atoms in the side-chain. These key 
atoms are listed in Table 8-3. Once the side-chain pseudocenter is determined the angle is measured 
from P2B for NADP or C2B for NAD to the CA to the pseudocenter. If this angle exceeds 100° for 
NAD or 90° for NADP, the residue is excluded. 
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If two or fewer residues are identified for a structure and peripheral residues are not 
manually excluded, this process is repeated with an expanded cutoff distance of 5.2 Å, and additional 
residues are added to the library design process.  
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Table 8-2. Summary of the residue classifications used by CSR-SALAD. 
Edge (aka Floor) 
 
These residues lie along the 
edge of the adenine residue 
and extend parallel to it 
toward the ribose moiety, 
frequently making contact 
with C2A, N3A, and C4A of 
the cofactor. In NADP-
binding structures, these 
often do not bind the 
phosphate, but can be 
mutated to make interactions 
with the O2’ hydroxyl. 
 
Bidentate In addition to making 
contact with the O2’ 
hydroxyl or phosphate, these 
residues also interact with 
the O3’ hydroxyl. 
 
Face (aka R-chain, 
Offset face, Ring-
binder) 
These residues make contact 
with the plane of the adenine 
moiety, and often also 
interact with the O2’ moiety. 
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Table 8-2. continued 
Pyrophosphate These residues, in addition 
to making contact with the 
O2’ moiety, also interact 
with the pyrophosphate 
moiety that bridges the 
adenosine and nicotinamide 
ends of the molecule. As 
such, these residues are not 
generally included for 
mutagenesis because they 
play a significant role in the 
binding energetics of the 
cofactor as a whole 
 
Motif These residues are the Xs in 
the GX(X)GX(X)[G/A] 
motif common to Rossmann 
folds. The glycines of this 
motif provide hydrogen 
bonds to the pyrophosphate, 
but the other amino acids are 
sometimes involved in 
binding other elements of 
the NAD(P) molecule. 
 
Other (includes 
Simple, 
Nonsimple, 
Simple*, and 
Peripheral 
All other residues which do 
not fit into these categories 
are given one of these other 
designations, which together 
contain a plurality of all 
specificity-determining 
residues. In our analysis, no 
specific constellations of 
residues exist within these 
classes capable of being 
defined as a distinct class. 
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Table 8-3. Key atoms of residue side chains used for pseudocenter calculations. 
Gly {CA} 
Ala {CB} 
Val {CG1, CG2} 
Ile {CG1, CG2, CD1} 
Leu {CD1, CD2, CG, CB} 
Ser {OG} 
Thr {OG1, CG2} 
Asp {OD1, OD2} 
Asn {OD1, ND2} 
Glu {OE1, OE2, CG} 
Gln {OE1, NE2} 
Lys {NZ, CE} 
Arg {NE, NH1, NH2} 
Cys {SG} 
Met/Mse {CE, SD/SE, CG} 
Phe {CG, CD1, CD2, CE1, CE2, CZ} 
Tyr {CE1, CE2, CZ, OH} 
Trp {CG, CD1, CD2, NE1, CE2, CE3, CZ2, CZ3} 
His {CG, ND1, CD2, CE1, NE2} 
Pro {CB, CG, CD} 
 
Residue classification 
Multiple criteria are considered when assigning a residue to one of the structural classes. The 
workflow of this classification is described below. 
The first step of residue classification is to, for each residue, get the ‘recontacts’. These are 
defined as atoms of the cofactor within 4.3 Å (or 5.3 Å for residues selected in the second round) of 
any of the pseudocenter-determining atoms shown in Table 8-3. For structures with multiple chains, 
only the equivalent residue with an atom closest to the nearest cofactor atom is considered for 
structure determination. However, if recontacts to certain atoms of the cofactor (O1A, O2A, O1N, 
O2N, O3, C5A, O3B) are present for any equivalent amino acid, they will be included even if the 
closest residue does not possess these recontacts. This allows for certain residue classifications to 
over-ride the rotamer of the closest equivalent amino acid if they occur anywhere in the crystal 
structure. 
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The residue classifications are made on the basis of the following dichotomous key: 
1a) Residue is in Rossmann fingerprint motif ........................................................... Motif 
1b) Else .................................................................................................................... Go to 2 
2a) Residue has no recontacts ................................................................................. Go to 3 
2b) Else .................................................................................................................... Go to 4 
3a) Residue side chain contains oxygen or nitrogen .......................................... Peripheral 
3b) Else ...................................................................................................... Exclude residue 
4a) Residue has no recontacts except 2’ phosphate or hydroxyl ........................... Go to 5 
4b) Else .................................................................................................................... Go to 7 
5a) Residue is arginine and has all side-chain atoms ............................................. Go to 8 
5b) Else ..................................................................................................................... Simple 
6a) Arginine CD atom within 4.2 Å of cofactor C4A and/or C5A ............................. Face 
6b) Else ..................................................................................................................... Simple 
7a) Residue recontacts C5A and at least one of {C4A, N3A, C2A, N1A, C6A, C8A, 
N7A} ............................................................................................................... Face 
7b) Else .................................................................................................................... Go to 8 
8a) Residue recontacts at least one of {N9A, C4A, N3A, C2A, N1A, C6A, C8A, N7A}
 .................................................................................................................... Go to 9 
8b) Else .................................................................................................................. Go to 19 
9) Compute <i,j,k> for residue (see below) .......................................................... Go to 10 
10a) |k| > 2.5 Å and (|i| + |j|) < 2.5 ............................................................................... Face 
10b) Else ................................................................................................................ Go to 11 
11a) |i| < 3 Å and -2 Å < j < 3 Å and ||<i,j,k>|| < 5.35 Å ............................................. Face 
11b) Else ................................................................................................................ Go to 12 
12a) Residue is not glycine and |k| < 3.2 Å and |k| < |j| and |i| < 5 Å ................... Go to 13 
12b) Else ................................................................................................................ Go to 15 
13) Compute <l,m,n> for residue (see below) ...................................................... Go to 14 
14a) |n| < max(|l|,|m|) and m < 0 .................................................................................. Edge 
14b) Else ................................................................................................................ Go to 15 
15a) Residue is in [Arg, Gln, Tyr, Phe, Glu, Trp, His, Pro] ................................ Go to 16 
15b) Else ................................................................................................................ Go to 19 
16) Compute normal vector v to residue sidechain (see below) .......................... Go to 17 
17) Compute angle θ between v and normal vector to adenine ........................... Go to 18 
18a) θ < 20° or θ > 160° .............................................................................................. Face 
18b) Else ................................................................................................................ Go to 19 
19a) Residue recontacts oxygen atoms of the diphosphate ........................ Pyrophosphate 
19b) Else ................................................................................................................ Go to 20 
20a) Residue recontacts O3B ............................................................................... Bidentate 
20b) Else ................................................................................................................ Go to 21 
21a) Cofactor is NAD ........................................................................................... Go to 22 
21b) Else ................................................................................................................ Go to 23 
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22a) O2B not within 4.4 Å of any pseudocenter-determining atom .................. Peripheral 
22b) Else ................................................................................................................ Go to 23 
23) All other residues ............................................................................................... Simple 
 
Three of the steps above (9, 13, and 16) require further explication. These steps are involved 
in determining the position of the residue not merely in terms of its distance from atoms of the 
cofactor but in terms of its orientation in 3D space. Because the cofactors are arbitrarily oriented in 
xyz-space, we must first establish a uniform coordinate space in which to work. To do this, we create 
a new basis set <x’,y’,z’> composed of three vectors based on adenine atoms (Figure 8-2). The x’ 
component is defined by the vector from C4A to N3A, and y’ is defined by the vector from C4A to 
C5A. The z’ coordinate is orthogonal to these, defined by the cross-product x’ × y’. 
This set of vectors forms an alternate coordinate space in which the positions of atoms or 
pseudocenters can be discussed, particularly relative to the adenine moiety itself. Two such positions 
are required for residue classification. The first vector, <i,j,k>, is the vector going from the cofactor 
C4A atom to the residue pseudocenter. The second,  <l,m,n> is the vector from C4A to the alpha 
carbon of the residue. Both of these vectors are expressed in the adenine-centered x’y’z’-space. 
For step 17, a vector v normal to a residues’ side-chain must be calculated. Unlike <i,j,k> and 
<l,m,n>, v is in xyz-space, and is compared to the z’ vector calculated above to determine if the 
residue side chain is parallel to the plane of the adenine. The vector v is calculated as the cross 
product of two other vectors, t and u, as defined by Table 8-4. 
If one or more face residues are identified but no edge residue is, the two amino acids prior to 
the face residue(s) in primary sequence are checked as potential edge residues using a loosed criteria, 
due to the frequency of this sequence-structure motif in Rossmann fold proteins. For each of these 
residues that are not glycine, three criteria are checked: 
1) The residue pseudocenter is closer to cofactor atom O2B than the residue alpha 
carbon. 
2) The angle between the vector r, running from the residue alpha carbon to the 
pseudocenter, and the bottom edge of the adenine (N3A to N9A) is less than 45°. 
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3) The angle between the r and z’, as defined above, is between 70° and 110°. 
If the residue meets all three criteria, its classification is replaced with ‘edge’ if it had 
previously been classified as anything other than face, or it is added as an edge residue if it had 
escaped inclusion in above. 
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Figure 8-2. The components of x’y’z’-space. 
 
Table 8-4. Atom pairs used to calculate vectors t and u and thereby v ≡ t × u. 
Residue t u 
Arg NE - NH1 NE - NH2 
Gln OE1 - NE2 OE1 - CD 
Tyr CE1 - CE2 CE1 - CZ 
Phe CG - CD1 CG - CD2 
Glu OE1 - OE2 OE1 - CG 
Trp CG - CD1 CG - CD2 
His CG - ND1 CG - ND2 
Pro CB - CD CB - N 
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Library design 
Once residues have been classified, the next step is to select the desirable amino acids for 
mutation and screening. For each residue and each classification, we have selected degenerate 
codons in a range of sizes that possess both the wild-type amino acid and the amino acids we believe 
are most likely to provide productive interactions with the switched cofactor. These amino acids are 
selected and prioritized subjectively and heuristically on the basis of three factors: (i) which 
mutations to residues like these have previously been shown to be useful in cofactor switching, (ii) 
which residues does structural intuition suggest could provide useful contacts in stabilizing the 
desired cofactor, and (iii) which amino acids exist at corresponding positions in the proteins that 
naturally bind the desired amino acid. 
The degenerate codons used by CSR-SALAD are provided in Tables 8-5 and 8-6. Codons 
have been optimized for expression in E. coli using the Automated Nucleotide Tool (ANT). When 
two codons of equal size but which coded for different numbers of amino acids were available, the 
codon which coded for greater diversity at the amino acid level was preferred. 
 
Table 8-5. Codons used for cofactor switching NADP-dependent proteins to NAD. 
 
Edge 
Bidentate/ Motif/ 
Pyrophosphate Face Simple/ Peripheral 
Phe 
KWC:DFVY KWC:DFVY ---:F KWC:DFVY 
KWK:DEFLVY* KWK:DEFLVY* TWC:FY KWK:DEFLVY* 
  BWK:DEFHLQVY KWC:DFVY   
    YWK:FHLQY   
Leu 
SWA:ELQV SWA:ELQV YWC:FHLY SWA:ELQV 
  SWK:DEHLQV WYK:FILMST SWK:DEHLQV 
Ile 
RWA:EIKV RWA:EIKV WWC:FINY RWA:EIKV 
    HWC:FHILNY   
Met 
RWG:EKMV RWG:EKMV WTK:FILM RWG:EKMV 
    HYK:FILMPST   
Val 
GWK:DEV GWK:DEV SWC:DHLV GWK:DEV 
SWA:ELQV   VWC:DHILNV   
RWK:DEIKMNV       
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Table 8-5. continued 
 Edge B/M/P Face S/P 
Ser 
ADC:INS RRC:DGNS RDC:DGINSV RRC:DGNS 
RDC:DGINSV RVC:ADGNST  VDC:DGHILNRSV 
Pro 
---:P SMC:ADHP MYA:ILPT SMC:ADHP 
SMC:ADHP       
Thr 
RMC:ADNT RMC:ADNT AHC:INT RMC:ADNT 
RMK:ADEKNT RMK:ADEKNT MMC:HNPT RMK:ADEKNT 
    ANK:IKMNRST   
Ala 
GMC:AD KCA:AS VCA:APT KCA:AS 
RMC:ADNT RVC:ADGNST VYA:AILPTV RVC:ADGNST 
Tyr 
WWC:FINY WWC:FINY TWC:FY DAK:DEKNY* 
HWC:FHILNVY DWC:DFINVY YWC:FHLY DWK:DEFIKLMNVY* 
    DHC:ADFINSTVY   
His 
VAC:DHN VAC:DHN MMC:HNPT VAC:DHN 
VAK:DEHKNQ VAK:DEHKNQ   VAK:DEHKNQ 
Gln 
---:Q ---:Q CHA:LPQ ---:Q 
SAA:EQ SAA:EQ   SAA:EQ 
Lys 
RAA:EK RRK:DEGKNRS MWG:KLMQ RAK:DEKN 
VAA:EKQ   MHG:KLMPQT RWK:DEIKMNV 
RWA:EIKV     DWK:DEFIKLMNVY* 
Asp 
---:D ---:D ---:D ---:D 
GAK:DE GAK:DE GAK:DE GAK:DE 
SAK:DEHQ SAK:DEHQ SAK:DEHQ SAK:DEHQ 
Glu 
---:E ---:E ---:E ---:E 
VAA:EKQ VAA:EKQ VAA:EKQ VAA:EKQ 
Cys 
KRC:CDGY KRC:CDGY KKC:CFGV KRC:CDGY 
KDC:CDFGVY   KDC:CDFGVY   
Trp 
WKG:LMRW YRG:QRW* TKK:CFLW YRG:QRW* 
YDG:LQRW* YRK:CHQRWY*   YRK:CHQRWY* 
Arg 
SRA:EQR SRK:DEGHQR YVC:CHPRSY SRK:DEGHQR 
SDA:EGLQRV 
 
YVC:CHNPRSTY RRK:DEGKNRS 
    HNC:CFHILNPRSTY VRK:DEGHKNQRS 
Gly 
GRC:DG GRC:DG RDC:DGINSV GRC:DG 
GDC:DGV GNC:ADGV   GNC:ADGV 
      RRK:DEGKNRS 
Asn 
---:N RAC:DN WWC:FINY RAC:DN 
RAK:DEKN VAK:DEHKNQ 
 
RMC:ADNT 
      RMK:ADEKNT 
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Table 8-6. Codons used for cofactor switching NAD-dependent proteins to NADP. 
 Edge 
Bidentate/ Motif/ 
Pyrophosphate Face Simple/ Peripheral 
Phe ---:F TYC:FS YKC:CFLR WHC:FINSTY 
WWK:FIKLMNY* YHC:FHLPSY YDC:CFHLRY   
Leu 
VWA:EIKLQV TYA:LS CKA:LR CKA:LR 
 
WYA:ILST CDC:HLR MDA:IKLQR 
    CDK:HLQR   
Ile AWK:IKMN ADK:IKMNRS AKA:IR ADL:IKMNRS 
    ANA:IKRT   
Met AWG:KM AWG:KM AKG:MR AWG:KM 
AWK:IKMN ADK:IKMNRS   ADK:IKMNRS 
Val RYA:AITV RKC:GISV RKG:GMRV RKC:GISV 
RHA:AEIKTV VDC:DGHILNRSV RBG:AGMRTV  VDC:DGHILNRSV 
Ser 
KCA:AS RGC:GS RGC:GS ---:S 
KYA:ALSV RSC:AGST RSC:AGST RGC:GS 
      RSC:AGST 
Pro 
CYA:LP YCA:PS MSC:PRST YCA:PS 
SYA:ALPV HCA:PST   HCA:PST 
  NCA:APST   NCA:APST 
Thr RCA:AT DCA:AST RSA:AGRT DCA:AST 
RMC:ADNT   VVC:ADGHNPRST   
Ala 
---:A RSC:AGST RSA:AGRT RSC:AGST 
KCA:AS       
KYA:ALSV       
Tyr WWK:FIKLMNY* HAC:HNY CHRY:YRC HAC:HNY 
  HAK:HKNQY*   HAK:HKNQY* 
His MWC:HILN MRC:HNRS MRC:HNRS MMC:HNPT 
      MVC:HNPRST 
Gln MWA:IKLQ MRA:KQR MVA:KPQRT MRK:HKNQRS 
  MVA:KPQRT     
Lys 
---:K AAK:KN ARK:KNRS AAK:KN 
AAK:KN AMK:KNT MRK:HKNQRS AMK:KNT 
  AVK:KNRST   AVK:KNRST 
Asp RVC:ADGNST RMC:ADNT RMC:ADNT RRC:DGNS 
RNC:ADGINSTV RVC:ADGNST VMC:ADHNPT RVC:ADGNST 
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Table 8-6. continued 
Edge B/M/P Face S/P 
Glu 
KMA:AES* VRA:EGKQR SRA:EGQR DMA:AEKST* 
KHA:AELSV* VRW:DEGHKNQRS VVA:AEGKPQRT DMK:ADEKNSTY* 
DHA:AEIKLSTV* 
   
Cys KSC:ACGS KSC:ACGS YRC:CHRY KSC:ACGS 
KBC:ACFGSV   HVC:CHNPRSTY   
Trp WKG:LMRW WVG:KRSTW* YRG:QRW* WVG:KRSTW* 
    YRK:CHQRWY*   
Arg 
---:R ARK:KNRS ---:R ARK:KNRS 
CKA:LR MRK:HKNQRS CRA:QR MRK:HKNQRS 
YDC:CFHLRY   CNA:LPQR   
Gly ---:G ---:G ---:G ---:G 
GBA:AGV RSC:AGST RSA:AGRT RSC:AGST 
Asn ARC:NS ARC:NS AVK:KNRST ARC:NS 
AWK:IKMN MRK:HKNQRS   MRK:HKNQRS 
 
Designing a library from the available sets of codons is dependent on the maximum library 
size provided by the user. As a first step, CSR-SALAD calculates the minimum possible library size 
for the residues selected. If this is above the provided maximum, the option to not mutate certain 
residues is added based on the frequency of those amino acids in the binding pockets of enzymes 
with the same cofactor preference. That is, CSR-SALAD steps through the following priority lists 
and adds to all amino acids of the indicated identity a ‘---‘ non-mutation option, and amino acids 
rarely used for NAD(P) binding pockets are more likely to be spared from mutation than those 
commonly used to make up binding pockets. 
    NADP: W<C<M<F<P<I<L<E<D<V<Q<H<A<Y<G<N<T<K<R<S 
    NAD:  C<W<M<Y<H<F<T<Q<A<P<G<R<S<N<L<V<E<K<I<D 
Once the minimum possible library size is below the selected maximum library size, selection 
of a specific library can begin. CSR-SALAD starts with the library that has the largest codon at each 
position, then steps through the residue classifications in the order [Motif, Pyrophosphate, Peripheral, 
Edge, Face, Simple, Bidentate]. For each residue classification, it moves through the residues of the 
library in primary sequence order and decreases each to the next largest. After each codon reduction, 
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the library size is checked, and if it is below the provided maximum then that library is selected, and 
the whole process is iterated until that threshold is reached.  
Activity recovery 
Cofactor switched enzymes – or any enzymes with multiple mutations away from wild type 
– often lose significant amounts of activity. To recover this, compensatory mutations must be found, 
and we have empirically identified ‘hot-spots’ in the protein structure which seem to be enriched in 
compensatory mutations. CSR-SALAD locates and indicates these hotspots (five classes, sorted into 
three priority levels) and provides them to users. We recommend performing site-saturation 
mutagenesis (i.e., with an NNK codon) at each of these positions – either serially or in parallel 
followed by recombination or re-randomization – and screening for improved activities. 
The high priority level is composed of residues which would have been mutated if the 
library size was sufficient, but which were excluded from mutagenesis to keep library sizes tractable. 
These include any residues for which the ‘---‘ non-mutation codon was recommended and also 
residues from the motif, pyrophosphate-binding, or peripheral categories that were excluded on the 
basis of the advanced options. It may also be valuable to perform site-saturation mutagenesis on 
residues that were mutated in the library but kept their original identity in the best mutant. 
The next priority level contains residues around the adenine moiety of the cofactor, which 
we have previously shown to exert considerable control over cofactor binding and positioning. We 
have modified the definition somewhat from that used in Chapter 6,1 defining these residues as those 
containing atoms within 4.1 Å of N7A, C5A, N6A, or N1A (the top edge of the adenine moiety) but 
not included in the residues involved in specificity determination. 
The final set of residues includes those which do not directly interact with the cofactor. The 
first class of these is residues that hydrogen bond to residues identified above. Mutation of the latter 
would leave these residues with unsatisfied hydrogen bond donors or acceptors, which can be 
destabilizing or can lead to unfavorable protein conformations. These residues are identified on the 
basis of having a side-chain oxygen or nitrogen atom within 3.8 Å of a side-chain oxygen or nitrogen 
of one of the residues used for cofactor switching. The second class includes charged residues around 
the adenosine binding pocket (within 8.2 Å of the 2’ phosphate or hydroxyl) that putatively 
contribute to the charge balance of the pocket. That is, for NADP-bound structures, these would be 
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positively-charged lysines, arginines, or histidines, and for NAD-bound structures the negatively-
charged aspartates and glutamates. These residues are mutated in several early cofactor switching 
papers – generally on the basis of missing structural information or incorrect homology models 
suggesting they played a more direct role – but in some instances were found to be beneficial, and so 
are identified by CSR-SALAD. 
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Table S1-1. Analysis of multiple sequence alignments of  ketol-acid reductoisomerases (KARIs). 
Conservational degree at key residues Conservational degree at key residues for specificity identified in β2αB-loop: KARI sequences were obtained 
from the UniProt database using Swiss-Prot manually reviewed sequence data. To date, 643 reviewed KARI sequences are available: 588 from 
bacterial, 47 from archaeal, and 7 from eukaryotic origin. Archaeal KARIs seem to have loop lengths of either six or seven residues, eukaryotic 
KARIs a loop length of seven, and bacterial ones have 6-, 7-, or 12-residue loops. 
  
 Conserved residues responsible for cofactor contacts   
 N-terminal C-terminal   
Domain and 
loop length  Antepenultimate Penultimate Ultimate 
Compared 
sequences, n 
KARI 
sequences, % 
Bacteria       
  6 R(100%) -- K(65%), R(20%), S(6%) S(100%) 83 13 
  7 R(61%), Y(16%), K(12%) S(78%), G(22%) -- S(76%), T(18%) 388 61 
  12 R(93%) R(87%) -- S(99%) 117 18 
Archaea       
  6 + 7 R(64%) G(77%), S(17%) -- S(89%) 47 7 
Eukaryote       
  7 R(100%) S(57%), G(43%) -- S(100%) 7 1 
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Table S1-2. Sequence identities (%) of KARIs used in this study 
 EcIlvC ShKARI SeKARI MaKARI LlKARI AaKARI 
EcIlvC 100 72 20 20 21 22 
ShKARI  100 19 22 19 21 
SeKARI   100 48 53 50 
MaKARI    100 52 56 
LlKARI     100 57 
AaKARI      100 
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Supplementary Material S2-1. A simplified version of the python script used to identify putative NAD-utilizing sequences 
infile = open('alignment.fasta') 
lines = infile.readlines() 
infile.close() 
 
posns = [0,1,-3,-1] #first, second, preantepenultimate, ultimate 
 
for line in lines: 
    if line[0] == '>': 
        name = line[:-1] 
    else: 
        acidcount = 0 
        s = line[309:329].replace('-','') #ends of loop determined by visual inspection. Gaps removed. 
        if s != '': #catch fragmentary sequences 
            for p in posns: 
                if s[p] in ['D','E']: acidcount+= 1 
            if acidcount!= 0: 
                print '%i-point match %s: %s\n' % (acidcount, name, line[304:333]) 
            if len(s) not in [7,12,6]: #catch sequences of irregular length for visual inspection 
                print "irregular length %s: %s\n" %(name, line[304:333]) 
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Table S2-1. Table 2-1 with standard errors and Hill coefficients. 
Enzyme  KM or KH [µM] Hill coefficient kcat [s-1] kcat/KM or H [mM-1s-1] 
NADH/NADPH ratio of 
kcat/KM or H 
  NADH NADPH NADH NADPH NADH NADPH NADH NADPH  
EcIlvC  1,075 ± 370 41 ± 3 - - 0.3 ± 0.0 3.6 ± 0.4 0.3 ± 0.1 88 ± 11 0.003 ± 0.001 
EcIlvC6E6  30 ± 6 650 ± 80 - - 2.3 ± 0.2 0.20 ± 0.02 74 ± 15 0.40 ± 0.05 185 ± 50 
EcIlvCP2D1-A1  26 ± 1 > 1,400 - - 4.3 ± 0.3 0.54 ± 0.20 165 ± 22 < 0.4 > 412 
HsKARI  39 ± 1 46 ± 6 - - 0.12 ± 0.00 0.12 ± 0.01 3.2 ± 0.0 2.7 ± 0.1 1.2 ± 0.2 
IaKARI  < 1 <1 - - 0.02 ± 0.00 0.03 ± 0.00 > 20 >25 ~ 0.8 
MsKARI  24 ± 1 31 ± 2 3.0 ± 0.0 3.1 ± 0.6 0.06 ± 0.00 0.07 ± 0.00 2.5 ± 0.03 2.1 ± 0.03 1.2 ± 0.1 
SwKARI  57 ± 2 44 ± 3 3.6 ± 0.4 3.0 ± 0.0 0.28 ± 0.01 0.22 ± 0.01 5.0 ± 0.2 5.0 ± 0.4 1.0 ± 0.1 
AfKARI  5.0 ± 0.5 26 ± 1 3.5 ± 0.4 2.3 ± 0.3 0.1 ± 0.0 0.04 ± 0.00 20 ± 2 1.5 ± 0.1 13 ± 1 
DoKARI  32 ± 3 n.a. 3.5 ± 0.3 n.d. 0.25 ± 0.03 n. a. 8.0 ± 1.0 n. a. - 
TpKARI  <1 40 ± 4 n.d. 3.0 ± 1.0 0.46 ± 0.04 0.25 ± 0.04 460 ± 61 6.0 ± 1.0 74 ± 17 
UaKARI  1.1 ± 0.1 38 ± 2 3.5 ± 0.2 3.0 ± 0.0 0.22 ± 0.01 0.05 ± 0.00 200 ± 20 1.3 ± 0.1 152 ± 17 
All enzymes were His6-tagged and purified prior to characterization. Enzyme activities were determined in 100 mM potassium phosphate pH 7 with 
1 mM DTT, 200 mM NADPH or NADH, 2.5 mM S2AL, and 10 mM MgCl2. Concentrations of the purified enzymes were determined using the 
Bradford assay. The KM or KH values for the cofactors were measured with appropriate dilutions of NADPH and NADH in the presence of saturating 
concentrations of substrate S2AL. The Hill coefficients are given when applicable. Mutations located within the β2αB-loop of EcIlvC6E6: A71S, 
R76D, S78D, and Q110V. Additional mutations in EcIlvCP2D1-A1: D146G, G185R, and K433E. 
n.d. = not determined 
n.a. = not active 
  
191 
Table S4-1. Percent identity between class I KARIs as determined by Clustal Omega. 
%ID between AvKARI and 
IaKARI 46.9% 
PaKARI 93.2% 
SeKARI 55.9% 
 
Table S4-2. Amino acid identities and numberings in mesophilic class I KARIs. 
Position in PaKARI Position in AvKARI Position in SeKARI 
H107 H107 H118 
K130 K130 K141 
D190 D190 S201 
E194 E194 E205 
E226 E226 E237 
E230 E230 E241 
S249 S249 S260 
H134 H134 H145 
S26 S26 S37 
P132 P132 P143 
G133 G133 G144 
A131 A131 G142 
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Figure S4-1. Modelling error at P132-G133 in PaKARIapo (PDB 1NP3). The Fo-Fc omit map (red 
and green) shows the differential density around the peptide bond in the published structure 
(yellow) that is resolved by implementing a 180° peptide flip (white). This alteration is corroborated 
by improved backbone hydrogen bond interactions. (2Fo-Fc map (blue) contoured to 1.5σ, Fo-Fc 
map contoured to 2.9σ.) 
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Figure S5-1. The packing of the obtained crystal of 2Ia_KARI-DD. A single protein chain (cyan 
and magenta) composes the asymmetric unit, and symmetry mates are shown in grey. Spheres 
represent the residues flanking the structurally unresolved interdomain connector. 
  
  
194 
IaKARI           -------------------MAKIYKDEDI-SLEPIKNKTIAILGYGSQGRAWALNLRDSGLNVVVGLERQG-----DSWRRAIDD 
EcKARI           MANYFNTLNLRQQLAQLGKCRFMGRDEFADGASYLQGKKVVIVGCGAQGLNQGLNMRDSGLDISYALRKEAIAEKRASWRKATEN 
2Ia_KARI-DD      -------------------MAKIYKDEDI-SLEPIKNKTIAILGYGSQGRAWALNLRDSGLNVVVGLERQG-----DSWRRAIDD 
2Ia_KARI-HT      -------------------MAKIYKDEDI-SLEPIKNKTIAILGYGSQGRAWALNLRDSGLNVVVGLERQG-----DSWRRAIDD 
2Ia_KARI-LT      -------------------MAKIYKDEDI-SLEPIKNKTIAILGYGSQGRAWALNLRDSGLNVVVGLERQG-----DSWRRAIDD 
2Ia_KARI-2L      -------------------MAKIYKDEDI-SLEPIKNKTIAILGYGSQGRAWALNLRDSGLNVVVGLERQG-----DSWRRAIDD 
 
IaKARI           GFKPMYTKDAVAIADIIVFLVPDMVQKSLWLNSVKDFMKKGADLVFAHGFNIHFKIIEPPKDSDVYMIAPKSPGPIVRRSYEMGG 
EcKARI           GFKVGTYEELIPQADLVINLTPDK-QHSDVVRTVQPLMKDGAALGYSHGFNIVEVGEQIRKDITVVMVAPKCPGTEVREEYKRGF 
2Ia_KARI-DD      GFKPMYTKDAVAIADIIVFLVPDMVQKSLWLNSVKDFMKKGADLVFAHGFNIHFKIIEPPKDSDVYMIAPKSPGPIVRRSYEMGG 
2Ia_KARI-HT      GFKPMYTKDAVAIADIIVFLVPDMVQKSLWLNSVKDFMKKGADLVFAHGFNIHFKIIEPPKDSDVYMIAPKSPGPIVRRSYEMGG 
2Ia_KARI-LT      GFKPMYTKDAVAIADIIVFLVPDMVQKSLWLNSVKDFMKKGADLVFAHGFNIHFKIIEPPKDSDVYMIAPKSPGPIVRRSYEMGG 
2Ia_KARI-2L      GFKPMYTKDAVAIADIIVFLVPDMVQKSLWLNSVKDFMKKGADLVFAHGFNIHFKIIEPPKDSDVYMIAPKSPGPIVRRSYEMGG 
 
IaKARI           GVPALVAVY--QNVSGEALQKALAIAKGIGCARAGVIESTFKEETETDLFGEQVILVGGIMELIKASFETLVEEGYQPEVAYFET 
EcKARI           GVPTLIAVHPENDPKGEGMAIAKAWAAATGGHRAGVLESSFVAEVKSDLMGEQTILCGMLQAGSLLCFDKLVEEGTDPAYAEKLI 
2Ia_KARI-DD      GVPALVAVY--QNVSGEALQKALAIAKGIGCARAGVIESTFKEETETDLFGEQVILVGGIMELIKASFETLVEEGYQPEVAYFET 
2Ia_KARI-HT      GVPALVAVY--QNVSGEALQKALAIAKGIGCARAGVIESTFKEETETDLFGEQVILVGGIMELIKASFETLVEEGYQPEVAYFET 
2Ia_KARI-LT      GVPALVAVY--QNVSGEALQKALAIAKGIGCARAGVIESTFKEETETDLFGEQVILVGGIMELIKASFETLVEEGYQPEVAYFET 
2Ia_KARI-2L      GVPALVAVY--QNVSGEALQKALAIAKGIGCARAGVIESTFKEETETDLFGEQVILVGGIMELIKASFETLVEEGYQPEVAYFET 
 
IaKARI           VNELKLIVDLIYEKGLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEGST 
EcKARI           QFGWETITEALKQGGITLMMDRLSNPAKLRAYALSEQ-LKEIMAPLFQKHMDDIISGEFSSGMMADWANDDKKLLTWREETGKTA 
2Ia_KARI-DD      VNELKLIVDLIYEKGLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEGST 
2Ia_KARI-HT      VNELKLIVDLIYEKGLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEGST 
2Ia_KARI-LT      VNELKLIVDLIYEKGLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEKTA 
2Ia_KARI-2L      VNELKLIVDLIYEKGLTGMLRAVSDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEKTA 
 
IaKARI           IETVGRKLREMMFRGMKQISSH--------------------------------------------------------------- 
EcKARI           FETAPQYEGKI---GEQEYFDKG-------VLMIAMVKAGVELAFETMVDSGIIEESAYYESLHELPLIANTIARKRLYEMNVVI 
2Ia_KARI-DD      IETVGRKLREMMFRGMKQISSHETDLFGEQVILVGGIMELIKASFETLVEEGYQPEVAYFETVNELKLIVDLIYEKGLTGMLRAV 
2Ia_KARI-HT      IETVGRKLREMMFRGMKQISSH--------VILVGGIMELIKASFETLVEEGYQPEVAYFETVNELKLIVDLIYEKGLTGMLRAV 
2Ia_KARI-LT      FETAPQYEGKI---GEQEYFDKGV------VILVGGIMELIKASFETLVEEGYQPEVAYFETVNELKLIVDLIYEKGLTGMLRAV 
2Ia_KARI-2L      FETAPQYEGKI---GEQEYFDKGV------VILVGGIMELIKASFETLVEEGYQPEVAYFETVNELKLIVDLIYEKGLTGMLRAV 
 
IaKARI           ------------------------------------------------------------------------------------- 
EcKARI           SDTAEYGNYLFSYACVPL-----LKPFMAELQPGDLGKA-IPEGAVDNGQLRDVNEAIRSHAIEQVGKKLRGYM-TDMKRIAVAG 
2Ia_KARI-DD      SDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEGSTIETVGRKLREMMFRGMKQISSH- 
2Ia_KARI-HT      SDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEGSTIETVGRKLREMMFRGMKQISSH- 
2Ia_KARI-LT      SDTAKYGGITVGKFIIDKSVRDKMKIVLERIRSGEFAREWIKEYERGMPTVFKELSELEGSTIETVGRKLREMMFRGMKQISSH- 
2Ia_KARI-2L      SDTAKYGGITVGKACVPL-----LKPFMAELQPGDLGKA-IPEGAVDNGQLRDVNEAIRSHAIETVGRKLREMMFRGMKQISSH- 
 
 
Figure S5-2. An alignment of the sequences of IaKARI, EcKARI, and the for designed 2IaKARI 
constructs. Red text in the 2Ia_KARI constructs  shows sequence insertions or deletions coming 
from EcKARI. 
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Table S7-1. Recapitulation of successful mutants NADP-to-NAD in default-setting CSR-SALAD libraries. Residues are colored red if the mutation 
is found in the switching library, orange if the residue is targeted for mutagenesis but the mutations screened do not include the previously published 
mutant, blue if the residue is recommended for saturation as a recovery mutation, and black if the mutant would not be found by CSR-SALAD. 
Mutations indicated in italics are distal to the 2’ position. 
Protein	   Structure	   Method	   Best	  Mutant	   Switched?a	   Active?b	  
S.	  sp.	  A1-­‐R	   3AFN	   Loop	  Substitution	   H37N,	  G38S,	  R39H,	  K40V,	  A41D	   ✔	   	  
R.	  perezi	  ADH8	   1P0F	   Homology	   G223D,	  T224I,	  H225N	   ✔	   ✔	  
E.	  coli	  AdhZ2	   1UUF	  (1YQD)	   Rational	   T205D,	  T206I,	  S207N	   ✔	   ✔	  
E.	  coli	  AdhZ3	   1YQD	  (h)	   Semi-­‐Rational	   S199N,	  S200N,	  N201D	   ✔	   ✔	  
S.	  morelense	  AFDH	   2GLX	   Homology	   A13G,	  S33D	   ✔	   ✔	  
V.	  harveyi	  ALDH	   1EZ0	   Semi-­‐Rational	   T175E	   ✔	   ✔	  
C	  .lutantus	  BHSDH	   3QWF	   Homology	   Y49D	   ✔	   	  
E.	  coli	  CaADH	   1KEV	  (h)	   Homology	   G198D,	  S199V,	  P201E,	  Y218A	   ✔	   	  
A.	  sp.	  CHMO	   4RG3	   Semi-­‐Rational	   K326A	   	   	  
M.	  musculus	  CR	   1CYD	   Rational	   T38D	   ✔	   ✔	  
A.	  PCC7119	  FDNR	   2BSA	   Rational	   S223D	   	   	  
P.	  falciparum	  FDNR	   2OK7	   Rational	   Y258F	   	   	  
P.	  sativum	  FDNR	   4AF7	  (1QGA)	   Rational	   Y308S	   	   	  
S.	  cerevisae	  gDKR	   4PVD	   Semi-­‐Rational	   N9E	   	   	  
E.	  coli	  GTR	   1GET	   Homology	   A179G,	  A183G,	  V197E,	  R198M,	  K199F,	  H200D,	  R204P	   ✔	   	  
P.	  fluorescens	  HAPMO	   2YLR	  (h)	   Semi-­‐Rational	   K439F	   	   	  
E.	  coli	  IDH	   4AJ3	   Homology	   C201I,	  C332Y,	  K344D,	  Y345I,	  V351A,	  Y391K,	  R395S	   ✔	   	  
H.	  volcanii	  IDH	   1AI2	  (h)	   Homology	   R291S,	  K343D,	  Y344I,	  V350A,	  Y390P	   ✔	   ✔	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Table S7-1. continued 
Protein	   Structure	   Method	   Best	  Mutant	   Switched?a	   Active?b	  
T.	  thermophilus	  IDH	   2D1C	   Loop	  Substitution	   R231A,	  K283D,	  Y284I,	  N287G,	  V288I,	  I290A	   ✔	   	  
A.	  acidocaldarius	  KARI	   4TSK	   Semi-­‐Rational	   R48P,	  S51L,	  S52D,	  R84A	   ✔	   	  
E.	  coli	  KARI	   3ULK	   Semi-­‐Rational	   A71S,	  R76D,	  S78D,	  Q110V	   ✔	   ✔	  
E.	  coli	  KARI	   3ULK	   Rational	   R68D,	  K69L,	  K75V,	  R76D	   ✔	   ✔	  
L.	  lactis	  KARI	   4TSK	  (h)	   Semi-­‐Rational	   V48L,	  R49P,	  K52L,	  S53D,	  E59K,	  T182S,	  E320K	   ✔	   ✔	  
M.	  aeolicus	  KARI	   4KQW	  (h)	   Rational	   G50D,	  S52D	   ✔	   ✔	  
S.	  exigua	  KARI	   4KQW	   Rational	   S61D,	  S63D,	  I95V	   ✔	   	  
S.	  sp.	  KARI	   3ULK	  (h)	   Rational	   A71S,	  R76D,	  S78D,	  Q110V	   ✔	   	  
B.	  megaterium	  P450R	  	   4DQL	   Rational	   R966D,	  W1046S	   	   ✔	  
H.	  sapiens	  P450R	   3QFS	   Rational	   W676A	   	   ✔	  
R.	  norvegicus	  P450R	   1AMO	   Rational	   W677A	   ✔	   	  
B.	  megaterium	  P450R	   4DQL	   Semi-­‐Rational	   R966N,	  K972H,	  Y974F,	  W1046D	   	   	  
P.	  fluorescens	  PHBH	   1K0J	  (m)	   Rational	   R33S,	  Q34R,	  P36R,	  D37A,	  Y38E	   ✔	   	  
C.	  parapsilosis	  SCR	   3CTM	  (1CYD)	   Rational	   S67D,	  P69D	   	   ✔	  
C.	  boidinii	  XR	   1K8C	  (h)	   Computational	   K272G,	  S273G,	  N274D	   ✔	   	  
C.	  tenuis	  XR	   1K8C	   Rational	   K274R,	  N276D	   ✔	   	  
P.	  stipitis	  XR	   1K8C	  (h)	   Computational	   K21A,	  N272D	   ✔	   ✔	  
P.	  stipitis	  XR	   1K8C	  (h)	   Semi-­‐Rational	   K270R,	  N272D	   ✔	   	  
aA switched enzyme has 𝐶𝐸!"#!"# 𝐶𝐸!"#!"#$ > 𝟏 
bAn active enzyme is defined as one with !"!"#!"#!"!"!"#$ > 𝟎.𝟏 
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Table S7-2. Recapitulation of successful mutants NAD-to-NADP in default-setting CSR-SALAD libraries. Residues are colored red if the mutation 
is found in the switching library, orange if the residue is targeted for mutagenesis but the mutations screened do not include the previously published 
mutant, blue if the residue is recommended for saturation as a recovery mutation, and black if the mutant would not be found by CSR-SALAD. 
Mutations indicated in italics are distal to the 2’ position. 
Protein	   Structure	   Method	   Best	  Mutant	   Switched?a	   Active?b	  
K.	  pneumonia	  PDOR	   3OX4	  (h)	   Computational	   D41G	   ✔	   ✔	  
S.	  sp.	  A1-­‐R’	   4TKM	   Loop	  Substitution	   T16S,	  E17Q,	  N37H,	  S38G,	  H39R,	  V40K,	  D41A	   ✔	   ✔	  
S.	  sp.	  AlaDH	   2VHW	  (h)	   Rational	   D198A	   ✔	   ✔	  
S.	  cerevisae	  BDH	   2D8A	  (h)	   Homology	   E221S,	  I222R,	  A223S	   ✔	   ✔	  
R.	  norvegicus	  CB5R	   1IB0	   Homology	   D239T	   ✔	   ✔	  
E.	  coli	  DHLDH	   4JQ9	  (1GEU)	   Homology	   E205V,	  M206R,	  F207K,	  D208H,	  P212R	   ✔	   ✔	  
C.	  methylica	  FDH	   2FSS	  (2NAD)	   Rational	   D195S	   	   	  
M.	  vaccae	  FDH	   2GSD	  (h)	   Rational	   C145S,	  A198G,	  D221Q,	  C225V	   ✔	   	  
S.	  cerevisae	  FDH	   2NAD	  (h)	   Rational	   D196A,	  Y197R	   ✔	   	  
B.	  stearothermophilus	  
GAPDH	  
3CMC	   Rational	   D32A,	  L187A,	  P188S	   ✔	   	  
C.	  symbiosum	  GDH	   1BGV	  (4XGI)	   Rational	   F238S,	  P262S	   	   	  
G.	  oxydans	  Gox2181	   3AWD	  (2WDZ)	   Computational	   Q20R,	  D43S	   ✔	   ✔	  
P.	  mevalonii	  HMG-­‐CoAR	   4I4B	   Rational	   D146A,	  L148K	   	   	  
E.	  coli	  IMDH	   1CM7	  (2ZTW)	   Directed	  Evolution	   K100R,	  A229T,	  D236R,	  L248M,	  D289K,	  I290Y,	  A296V,	  G337Y	   ✔	   ✔	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Table 7-2. continued 
Protein	  
	  
Structure	   Method	   Best	  Mutant	   Switched?a	   Active?b	  
E.	  coli	  IMDH	   4XXV	  (h)c	   Directed	  Evolution	   K100R,	  A229T,	  D236R,	  L248M,	  D289K,	  I290Y,	  A296V,	  
G337Y	   ✔	   ✔	  
B.	  subtilis	  InDH	   3NT2	   Rational	   A12K,	  D35S,	  V36R	   ✔	   ✔	  
B.	  stearothermophilus	  
LDH	  
1LDN	   Rational	   D53S	   	   	  
B.	  stearothermophilus	  
LDH	  
1LDN	   Homology	   I51K,	  D52S	   ✔	   	  
L.	  delbruckii	  LDH	   1J49	   Rational	   D175A	   ✔	   ✔	  
T.	  intermedius	  LuDH	   1LEH	  (h,1BW9)	   Homology	   D203A,	  I204R,	  D210R	   ✔	   	  
H.	  sapiens	  m-­‐NAD-­‐ME	   1PJ3	   Rational	   Q362K	   ✔	   ✔	  
P.	  fluorescens	  M2DH	   1M2W	   Rational	   E68K,	  D69A	   ✔	   ✔	  
T.	  flavus	  MDH	   1BMD	   Homology	   E41G,	  I42S,	  P43E,	  Q44R,	  A45S,	  M46F,	  K47Q	   ✔	   ✔	  
S.	  mutans	  NOX	   2BC0	  (h,2CDU)	   Homology	   D192A,	  V193R,	  V194H,	  A199R	   ✔	   ✔	  
P.	  stutzeri	  PDH	   4E5K	   Semi-­‐Rational	   E175A,	  A176R	   ✔	   ✔	  
S.	  maltphilia	  SMFMO	   4A9W	  (2XLP)	   Homology	   H194T	   	   ✔	  
G.	  oxydans	  XDH	   1ZEM	   Rational	   D38S,	  M39R	   ✔	   ✔	  
P.	  stipitis	  XDH	   1PL6	  (h)	   Homology	   D207A,	  I208R,	  F209T	   ✔	   ✔	  
aA switched enzyme has 𝐶𝐸!"#!"#$ 𝐶𝐸!"#!"# > 𝟏 
bAn active enzyme is defined as one with !"!"#!"#$!"!"!"# > 𝟎.𝟏 
cA homology model generated using a cofactor-bound homologue gave a better approximation of the geometry of the binding site, we believe, than 
the insertion of the cofactor into the apo structure. This is reflected in the detection of one additional amino acid. 
